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Abstract
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This thesis describes a generic system capable of forming cell-populated 
alginate tubes either by seeding cells within its lumen, or integrating cells 
within the tube walls. The applications of an alginate tube are as diverse as 
applications of alginate beads, and could be used with many types of cells for 
many different purposes -  from cell therapy to tissue engineering. The aim of 
this work has therefore been on the ability: to reproducibly create alginate 
tubes with uniformly thick walls of predictable thickness; to be able to monitor 
and quality control said tubes and a generic cell suspension, including 
automating aspects of mammalian anchorage-dependent cell culture to 
improve reliability; and to integrate said cells into an alginate tube without 
compromise to wall thickness, cell viability and cellular spatial distribution 
within the alginate tube.
This work describes experimental verification a novel fluid dynamics 
model that predicts with any two fluids used in this reverse dip-coating device 
that the tube wall thickness will be approximately equal to % the gap width as 
gap width becomes negligible. Robustness testing of the tube-forming device 
prompted two base unit designs and a protocol in order to achieve coefficient 
of variation (CV) values under 5% of tube length for infusion rates up to 
100ml/min and alginate concentrations ranging from 0.50 -  1.00%. Tubes 
with wall thicknesses between 143.4 -  277.3pm can be reliably reproduced for 
tubes of any length. Optical coherence tomography (OCT) at ±10pm accuracy 
was adapted to directly monitor alginate wall thickness and rate of shrinkage in 
real-time through air. This was determined to be -12 minutes for tube walls to 
stabilise and a high speed camera showed no spherical regulator spin as the 
tube is formed, indicating that monitoring at one point is sufficient to determine 
the overall quality of the tube wall consistency. Cell sample homogeneity 
monitored by particle sizer revealed two distinct single-celled populations, and 
smaller peak of cytoplasmic residue. Capillary cytometer was determined the 
best way to enumerate cell quantity reliably and consistently. Holding time 
above 3 hours can significantly cause aggregation, but this can be controlled
5
using filtration of known pore size. Kenics static mixers were used to integrate 
cells into alginate prior to tube formation and showed equally good control to 
wall thickness as pure alginate tubes at ~CV 7%. Cell viability of above 90% 
after processing through the static mixer and the tube-forming mark 2 device 
was achievable using Pronova SLG 100 pre-liquified alginate. The Kenics 
mixers at 12 elements showed a 49.6% improvement in CV of spatial 
distribution of cells across alginate, although this could be bettered by 
increasing number of Kenics static mixing elements, at the cost of increasing 
dead volume.
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Ti Mean speed of propelling liquid in flow
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CLSM Confocal laser scanning microscopy
1 Literature Review
22
1.1 SODIUM ALGINATE
Alginate is a family of polyanionic copolymers derived from brown algae. It 
consists of 1,4 p-D-mannuronic (M) and oc-L-guluronic acid (G) residues in 
varying proportion, depending on the source of the alginate (fig. 1.1). These 
monomers are distributed sequentially in either repeating or alternating 
blocks. It is soluble in aqueous solutions at room temperature and forms a 
hydrogel when reacted with multi-valent cations such as Ca2+, Ba2+, Fe3+ or 
Sr2* to form ionic bridges between G-block carboxyl groups of different 
polymer chains. By manipulating this ratio, mechanical properties and pore 
size can be altered (Smidsrod and Skjak-Braek 1990). These mechanical 
properties are subject to loss over time due to outward flux of cross-linking 
cations in vitro, but covalent linkage may be achieved using bi-functional 
cross-linkers, PEG or adipic hydrozide using standard carbodiimide 
chemistry (Drury and Mooney 2003). The ability to re-solubilise in the 
presence of phosphate, citrate or other chelating agents is often seen as a 
drawback, but may also be used as an advantage (Jork et al. 2000; Peirone 
et al. 1998). Over the years, alginate has gained pharmaceutical importance, 
due to its biocompatibility (Cohen et al. 1991; Sennerby et al. 1987), 
hydrophilicity and low cost, and has found many applications in medicine and 
dentistry gaining regulatory approval from several bodies including the Food 
& Drugs Administration (FDA) for use as an injectable, a wound dressing and 
a food additive (Godbey and Atala 2002; Mclntire 2003). Controlled porosity 
in alginates has also been explored by forming sponges via gelation, freezing 
and drying by lyophilization (Shapiro and Cohen 1997).
The biggest problem with using alginates as a source of 
scaffold biopolymer is the inability of alginate polysaccharides or their 
hydrogels to promote protein adsorption for anchorage dependent 
mammalian cells due to its hydrophilic nature and lack of cell surface 
receptors to interact with cells (Smetana 1993). Encapsulation of cells within
(a)
-OOC OH
G G
-OOC
£  OHj
M
O '
M
23
(b) (c)
Figure 1.1 (a) Chemical (Drury and Mooney 2003) and (b)-(c) molecular structures (Vij
et al, 2007) of naturally derived alginate polymer molecule.
Pre-mix cells 
and matrix
Prefabricate 
3D scaffold
TE ORGAN
CELLS
MATRIX
MATERIAL
BIOREACTOR
Figure 1.2 Flow diagram of generic tissue engineering. Cells and matrix material is 
combined via one of three methods -  pre-mixing cells with matrix; 
simultaneous mixing of cells with matrix and formation of TE organ; or 
prefabricating a cell-free TE “scaffold” and populating this with cells after. 
This TE organ is then put into a Bioreactor, cells proliferate and the scaffold 
should dissolve. The resultant TE organ should consist of cells only.
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beads in the past has cultured multicellular aggregates (Yagi et al. 1993). To 
this end, certain groups have covalently modified alginate with peptides 
containing RGD (Rowley and Mooney 2002). Alginate is also not resorbable 
(not absorbed by the body) limiting its usage to in vitro development if used 
to develop autologous transplantable organs, although this has been used to 
deliver protein-producing cells in allogenic and xenogenic situations (see 
1 .2 .1).
In summary the advantages outweigh the issues. Other than those 
above mentioned, alginate is above all non-toxic, low cost and abundant.
1.2 USES OF ALGINATE STRUCTURES
1.2.1 Cell Encapsulation
Historically, alginate has been one of the most important proven materials 
involved in cell and tissue encapsulation (Leinfelder et al. 2003). Cell 
encapsulation falls into two main categories: micro-encapsulation, involving 
materials such as alginate to create cell-populated micro-beads; and macro­
encapsulation, which typically involves much larger preformed thermoplastic 
materials in planar or hollow-fiber geometries (Uludag et al.2000).
Essentially cell encapsulation provides a permeable barrier isolating cells 
from, although allowing interaction with, the outside environment -  which 
could be the homeostatic conditions of an animal host or a synthetic 
bioreactor -  thus enabling transplantation of cells, for end uses such as cell 
therapy, without the need for immunosuppression. This allows control of pH, 
metabolic waste removal, electrolytes and nutrient exchange via diffusion. A 
common problem for encapsulated cells however, is variable cell viability 
depending on specimen thickness (Shelton 1966), which limits access to 
nutrients such as oxygen. Tubular constructs have been used either as an 
intravascular or extravascular encapsulation devices: the former with islet 
cells embedded in the walls of the tube acting as a surrogate pancreas in
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diabetic rats (Tze et al. 1976; Chick et al. 1977; Sun et al. 1977); and the 
latter with the open ends of the tube heat-crimped to act as an envelope 
containing cells, a method able to restore growth hormone in animals for up 
to 3 months (Altman et al. 1981; Altman et al. 1982). In recent years 
mammalian cell encapsulation especially using alginate has seen great 
advances. Presently focus has concentrated not only on host response to 
the transplanted vehicle, but also interaction between the encapsulated cells 
and biological material.
However, despite progress, reports indicate that reproducibility of 
encapsulated products -  both during manufacture and in pre-clinical animal 
studies -  is lacking. Scaleup of standardised technology is also a barrier -  
especially with secrecy surrounding encapsulation information and protocols 
amongst groups. Choice of clinically proven material and final material 
properties remains two of many unanswered questions. An obvious material 
is alginate, but due to its natural source, batch on batch property consistency 
is lacking. Uniformity of beads (size, shape, morphology) remains a problem 
-  but new automated devices may improve this in the future. With constant 
policy adjustments from regulatory authorities -  cell-populated products now 
fall under a new category. Agencies such as the US Food and Drug 
Administration (FDA) have taken particular interest to protocols and 
procedures that demonstrate biosafety to patients (Orive et al. 2003).
Future aims of the field will include finding a method that offers more 
direct contact between the vehicle and the host’s bloodstream in order to 
increase the long-term survival rate of encapsulated cells and tissues. Also 
greater understanding of biomaterial effects to vehicle properties and control 
of vehicle properties during fabrication is required to speed the transition of 
this technology to the real world (Uludag et al. 2000).
1.2.2 Tissue Engineering
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Tissue Engineering (TE) is the combining of cells, scaffold and bio-signals 
(fig. 1.2) to create a transplantable human organ meant as a replacement 
(Bottaro et al. 2002; Chapekar 2000; Godbey and Atala 2002).
Cells can be from three main sources -  autologous (own patient cells), 
allogenic (from another patient), or xenogenic (from an animal). An 
autologous source has the advantages of immune acceptance and safety 
from pathogens. This tissue must be obtained from a biopsy from the 
patient, for each patient. Because of the different types of cells needed for a 
tissue engineered organ, partially differentiated stem cells from a patient’s 
bone marrow would be a likely future cell source (Faustman et al. 2002; 
Germain et al. 2002; Parker 2002). Historically, advances in tissue 
engineering have been mostly acellular due to the complexities of 
mammalian cells (Metzger 2002; Parenteau and Hardin-Young 2002). 
Biomaterial scaffolds influence cell function and response. Cellular scaffolds 
have also encountered physical consistency, maintenance of phenotype and 
host immune response problems (Sipe 2002). Cell expansion and 
differentiation knowledge is limited. Major problems have included 
monitoring cells on a scale and metabolic level (Kapur 2002). Limited 
success has been achieved with in vivo studies of cell expansion and 
differentiation (Sefton 2002; Taylor 2002), although in vitro studies have 
proven difficult mainly due to oxygen demands to three-dimensional 
constructs (Hirschi et al. 2002; Ratcliffe and Niklason 2002).
The scaffold or matrix can be comprised of many varieties of natural or 
synthetic materials. It serves to act as a three-dimensional guide for the 
proliferating cells to take a pre-designed morphology. It constitutes the 
temporary, surrogate extracellular matrix (ECM) that lends mechanical 
strength, organising and guiding cell growth and differentiation (Sipe 2002). 
Using this technique, one can theoretically fabricate any tissue or organ in 
the human body. It is important that the scaffold possesses some basic 
properties, including: mechanical strength; control of degradability; and, for 
safety reasons, compatibility with the human body -  even though the level of
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scaffold material should be negligible by the time of transplantation, i.e. the 
cells will inhabit this and eventually replaces the scaffold, which dissolves 
away, to form a final tissue-engineered organ. For this last point, a natural 
material is desirable, since residual material will often incur a foreign-body 
response. Usage of the final product could vary from therapeutics to 
cosmetics, and this implies different material properties. As a therapeutic the 
main desirable material properties would include: -
• Non-thrombogenic, toxic nor immunogenic upon transplantation
• Sterile
• Acceptable wound healing response without fibrosis
• Mechanical strength for ultimate use in body and handling purposes
• No propensity for creep which would lead to aneurysm (surrogate 
blood vessel)
• Permeable to solutes and cells
• Scalable
• Long shelf-life
• Control over degradation, either by a biological process within the 
body or passive hydrolytic cleavage via control of material 
composition, surface chemistry and topology
• Absorbable by body, via kidneys metabolism, or other means
• Control of enhanced biocompatibility depending on the end use of the 
product
• Free of pathogens
• High porosity and adequate pore size to accommodate cells
• Physical properties for fabrication limitations
• Compatible with anchorage-dependent cells
• Low cost
• Well characterised to better attain regulatory approval
(Mclntire 2003; Tranquillo 2002)
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Biomaterials can be divided into three subcategories -  synthetic, 
naturally derived or semi-synthetic. Most materials originated from surgical 
procedures such as sutures, hemostatic agents and wound dressings, from a 
regulatory approval perspective. But as we understand more about 
mammalian cells, the direction tends to be more end-user orientated now. 
But there is the added advantage of regulatory approval for well- 
characterised materials (Mclntire 2003).
The signals are the chemical and mechanical interfaces between the 
cells, and the matrix and cells in order to facilitate growth. Signals are 
comprised of extracellular chemical and physical inputs, and these serve to 
influence cellular activities such as: gene expression, cell division, migration, 
differentiation and apoptosis (Sipe 2002). Mechanoregulation via physical 
interactions are consistent and unavoidable, most notably the force of gravity, 
and these can drive important results such as cell morphology and tissue 
patterning, which in-turn affects the response to chemical stimuli (Ingber 
2002). Better understanding and hierarchy of important signals is vital for 
future of tissue engineering. Two-dimensional culture must evolve to three- 
dimensional to study the signals involved (Ducy 2002).
General fabrication of TE products follows two schools of thought: 
seeding of cells onto a preformed matrix; and premixing cells with the matrix 
gel and creating the TE product afterwards (fig. 1.2) (Haverich and Graf 
2002).
1.3 OTHER CELL ENCAPSULATION DEVICES
Several research groups have a well-engineered, automated approach to cell 
encapsulation (Lewinska et al. 2004). One such device was that at the Swiss 
Federal Institute of Technology (Serp et al. 2000). The Swiss group 
developed a highly controlled encapsulation device from a syringe pump, for 
creating precision beads using alginate and CaCI2. The device flowed at 1- 
15ml/min, involving laminar jet break-up from a sinusoidal vibrating nozzle.
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The device was capable of creating beads from 250 -  1000pm diameter 
populated with 1x106 -  1x108 cells/mL. The resulting beads were quality 
controlled using a high-speed video camera to monitor droplet size and a 
temperature-controlled coulter counter to count the number of beads formed. 
The group observed that the device was sensitive to alginate concentration, 
in-turn affecting viscosity. However viscous effects were physical in nature -  
concerning the successful formation of beads upon hitting the CaCI2 bath. 
1.0-2.5% shrinkage was observed to occur within 5-10 mins up to 600pm 
diameter beads. And re-dissolving the beads in trisodium citrate took 
between 20mins to several hours.
In fact, the trend for control via engineering and automation seems to 
be the current inclination. A group from Northwestern University have 
developed a device that aims to reproducibly create beads (fig. 1.3a-d) for 
cell encapsulation purposes (Vij et al. 2007).
Another alginate group, a joint effort consisting of Clemson University 
(USA) led by Dr. Phil Brown and small biotech firm -  BioSurfaces, are 
currently working creation of < 100pm thick hollow fibres (fig. 1.4a-b) lined 
with a layer of genetically modified endothelial cells (Wagner et al. 2006). 
The aim of this work is to create a lining within synthetic implanted materials 
to help direct wound healing by increasing the release of certain native 
biological factors (fig. 1.4c). This work is also envisaged to eventually 
encompass genetically modified bacteria or other cells to create commercial 
textiles with anti-fungal, anti-microbial or anti-soiling properties. Their 
process is based on a modified wet/dry spinneret system spinning degassed 
sodium 6% w/v alginate solutions through an air gap of 0-20cm and then 
dowsing in a coagulant bath of salt such as 1% calcium chloride solution (fig. 
1.4d-e). Fibre morphology is fine-tuned using a mixture of salts, such as 
calcium and zinc, as-well-as further additives such as glycerol and ethanol. 
Endothelial cells are injected in the bore fluid at a rate of 1-100ml/hour. Cells 
were obtained commercially by ATCC and concentrations of 2x104 -  2x105 
cells/ml were used. Cellular activity was monitored using Alamar Blue and 
Western Blotting. Fibre geometry was monitored using graticule/optical
(a) (b)
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Figure 1.3 (a) Bead formation; (b) bead harvesting; (c) bead stability; (d) cell viability
assessment.
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Figure 1.4 (a) Photograph of actual device and spinneret
(b) Stereomicroscopic photograph of a hollow alginate tube (Wagner et al)
(c) How the Clemson/BioSurfaces group aim to use the alginate/endothelial 
construct to line transplantable materials in order to make them more 
biocompatible.
(d) The modified spinneret system used by the Clemson/BioSurfaces group 
to create cell-populated hollow fibres.
(e) Spinneret schematic
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microscope and scanning electron microscopy (SEM). The system is 
designed to operate in a laminar flow hood (i.e. sterile) after undergoing 
autoclaving.
Although it can be easy to dismiss shape-forming devices to just those 
that encapsulate cells, one must point out that even a tube can have many 
different end-uses. From bandages and membranes to envelopes for cell 
therapy usage (Altman et al. 1981; Altman et al. 1982).
1.4 OPTICAL COHERENCE TOMOGRAPHY (OCT)
1.4.1 Understanding OCT
Optical Coherence Tomography (OCT) is a non-invasive, newly emerging 
technique utilising novel imaging technology to produce high-resolution 
cross-sectional images of a sample in situ and in real time. First 
demonstrated in 1991 (Huang et al. 1991), it operates on a principle similar to 
conventional B-mode pulse-echo imaging of clinical ultrasound scanning 
(USS), except using light backscatter instead of sound backscatter, to create 
an image. The time for reflected light to travel, or “echo time delay” , together 
with intensity data, is then used to create an image (Schmitt J.M. 1997).
Advantages over other medical imaging techniques such as USS, 
magnetic resonance imaging (MRI) and confocal microscopy (CM) are 
superior resolution over the former two -  OCT has a resolving power of 1- 
15pm compared to the 100-200pm resolution of USS -  and greater 
penetration depth over CM (Drexler et al. 2001; Kaufman et al. 2004). OCT 
can only however penetrate samples up to a depth of 2-3mm, whereas USS 
can penetrate in vivo up to 10cm (Fujimoto 2003).
The heart of the device is a Michelson interferometer (fig. 1.5). It is 
composed of a light source that is both “low-coherence”, i.e. interference of 
light occurs over a distance of micrometers, and “broadband”, i.e. light
Figure 1.5
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Schematic of a simple OCT scanner. The SLD output is coupled into a 
single mode fiber and split at 50/50 coupler into sample and reference arms. 
Reflections from the two arms are combined at the coupler and detected by 
the photo diode. Longitudinal scanning is performed by translating the 
reference mirror with the stepper motor stage at 1.6mm s'1, generating a 3.8 
kHz Doppler shift. The piezoelectric transducer (PZT) in the sample arm 
further provides 21.2 kHz phase modulation to the interferometric signal. 
Interferometric modulation of the output intensity is detected by the 
photodetector when the reference and sample arm delays are nearly 
matched. The detector output is demodulated at the sum modulation 
frequency of 25 kHz to produce the envelope of the interferometric signal, 
which is then digitised (AD) and stored on a computer. A series of 
longitudinal scans are performed. The lateral beam position is translated 
after each longitudinal scan (Huang et al. 1991).
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emitting sources over a broad range of frequencies. Typical light sources 
would include superluminescent diodes (super bright LEDs) or femtosecond 
lasers, i.e. lasers capable of pulsing extremely rapidly. The light is split via a 
beam-splitter and channelled to two arms: a “reference arm” (usually to a 
mirror) of a known reference path length and time delay; and a “sample arm” 
(investigated item), of unknown path length. The two arms of reflected near 
infrared light are combined to give an interference pattern but only when they 
are nearly matched “in group-delay”, i.e. if the light from both arms have 
travelled the same optical distance. The intensity of the reflected light from 
the sample creates greater interference. Any light outside of the coherence 
length does not interfere. This “A-scan” gives information regarding spatial 
dimensions and structures within the sample, detected by changes in 
refraction index as light crosses the boundary between different materials. A- 
scans can be compiled to give a “B-scan” cross-sectional tomograph (Huang 
et al. 1991).
1.4.2 OCT and Tissue Characterisation
OCT has been used as an imaging tool in many diverse fields including 
clinical medicine, life science research, material science research and 
manufacture. In clinical medicine, the role of the pathology department is to 
analyse patient tissue from a biopsy, in order to diagnose and treat the 
patient. Other than the invasive nature of obtaining a biopsy or whole 
sample, this is also very labour intensive, and typically takes a few days to 
achieve a result, or even longer for a more complex specimen. The initial 
capital investment and training required for OCT is far outweighed by the cost 
of maintaining a histopathology department. OCT offers an alternative, non- 
invasive approach to achieve diagnosis in vivo and in real time. Furthermore, 
the use of optical fibres allows it to be used in conjunction with many medical 
devices such as keyhole surgery cameras, gastrointestinal tract endoscopes 
and coronary artery catheters (Mason et al. 2004).
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OCT was first applied to Ophthalmology and imaging of the human 
eye (Hee et al. 1995). Figure 1.6 shows an OCT image of a human retina, 
measured with a device of lOpm resolution. Even at a modest resolution in 
OCT terms, this cross-sectional image allows differentiation of detailed 
structures. The retina is an almost transparent structure, but despite the low 
optical backscattering, OCT is sensitive enough to detect structures such as 
the vitreal-retinal junction, optic disc and the fovea and give an approximate 
retinal thickness. Such studies have contributed towards diagnosis and 
monitoring of retinal diseases such as glaucoma, macular edema and age 
related macular degeneration, as well as monitor dynamic response after 
retinal operations such as laser eye surgery.
Rapid advances in OCT research has utilised longer wavelengths 
enabling non-transparent tissues to be imaged, where optical scattering is 
reduced. At 1300nm wavelength, typically 2-3mm depth penetration can be 
achieved. Due to its optical nature to scan in situ and in real time, OCT is 
suited to cases where excisional biopsy is dangerous or impossible -  such as 
determination of atherosclerotic plaque morphology in coronary artery 
disease. It is the rupture of unstable plaque formations -  those with a 
structurally weak fibrous cap -  that cause thrombosis and vessel occlusion, 
the most common cause of myocardial infarction. Figure 1.7 shows such a 
plaque formation (Brezinski et al. 1996) with corresponding histological 
analysis, obtained after autopsy. At a ~16pm resolution, the OCT image is 
able to show a small intimal layer covering a heavily calcified atherosclerotic 
plaque with low lipid content. As one can imagine, this analysis is only 
conventionally possible upon post-mortem (Fujimoto et al. 2000).
Furthermore OCT can be coupled with Doppler Flow Velocimetry to 
form DOCT, a method useful for capturing moving images or movies. Such 
techniques have been applied to monitoring liquid flow profiles (fig. 1.8) 
within a capillary (Proskurin et al. 2003). From this profile, one can ascertain 
information such as liquid viscosity and drag resistance due to the micro­
vessel walls. Obviously changes such as vessel geometry will impact
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Figure 1.6 Ophthalmic OCT imaging and its development, (a) The first demonstration 
of OCT imaging showing imaging of a human retina ex vivo acquired at 
800nm with 10-pm resolution, (b) Example of a current OCT clinical retinal 
image produced by StratusOCT instrument (Carl Zeiss Meditec) showing the 
papillary-macular axis of the retina between the fovea and optic disc, (c) 
Image of the fovea showing normal architectural morphology of the retina. 
Visible features include NFL, nerve fiber layer; GCL, ganglion cell layer; IPL, 
inner plexiform layer; OPL, outer plexiform layer; and INL, inner nuclear 
layer, (d) Topographic map of the macula constructed by segmenting 
multiple OCT images and showing thicknesses using a false colour scheme. 
Image processing methods such as these enable quantitative analysis of 
images to aid disease diagnosis (Fujimoto 2003).
Figure 1.7 Intravascular OCT imaging and its development, (a) OCT image ex vivo and 
histology showing unstable plaque with a thin intimal cap layer, (b) 
Prototype fiber-optic OCT catheter consisting of a rotating fiber and
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microlens assembly encased in a transparent sheath, (c) OCT catheter- 
based image of a stented rabbit aorta in vivo. (d) Clinical OCT image of 
right coronary artery of a human subject in vivo, from a follow-up study of 
drug-eluting stents (Fujimoto 2003).
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Figure 1.8 Velocity profile (a) obtained with an averaging over five A-scans. Least 
squares fitting (b) gives an excellent agreement with the parabola / 0 = - 
49.751^ + 7.11 (the inset formula shows round-off values) with uncertainty 
AV/V ~ 2.0%.
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dramatically on DOCT liquid velocity profiles. The suitability of the technique 
to measure blood flow is also discussed. It would be an excellent technique 
to monitor fabricated tube consistency.
1.4.3 OCT and Tube Monitoring
The characteristics of OCT make it an ideal tool for monitoring tubes created 
via our tube-forming device. Undoubtedly, one potential use of our alginate 
tubes is to create tissue-engineered products, which could contain 
mammalian cells. The need for a growing tissue-engineered organ is sterility 
and non-destructive testing at an acceptable cost. For any pharmaceutical or 
medical device, safety is paramount. There has as yet been no proof that 
low-powered near-infrared light used in OCT is harmful to tissue as opposed 
to high-powered near infrared, which does permanently damage cellular DNA 
(Boppart and Fujimoto 2002; Nishioka et al. 2002). Data remains to be 
generated for internal organs such as blood vessels and arteries that do not 
have protective melanin deposits such as those in the skin, and do not 
normally see any light. For years medical endoscopes have been used in the 
body without any documented adversity (Mason et al. 2004).
OCT has been used in vitro with human aorta and coronary artery 
sections obtained post-mortem. The high resolution allowed differentiation of 
different morphologies including fatty, fibrous, and water based tissue, as 
well as distinction between different tissues, such as adipose, skeletal 
muscle and tendon. The results have been compared to histological results 
and OCT hailed as promising new technology for high resolution “optical 
biopsy” (Brezinski et al. 1995).
Several features make OCT an ideal biomedical imaging tool 
(Fujimoto et al. 2000):
i. The resolution of OCT typically ranges from 1-15pm, compared to the 
100pm resolution of USS, which has the added advantage -  that 
scanning can be conducted through air. This resolution is more
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comparative to histology, allowing architectural morphology and some 
cellular features to be imaged.
ii. Imaging can be performed in situ without specimen preparation (i.e.
excision and fixing), which also minimises sampling errors involved in
treating the sample.
iii. Imaging can also be performed in real time. This allows on-screen 
monitoring and simultaneous digital recording -  an excellent surgical 
tool.
iv. OCT can be coupled with any existing fiber optical device, e.g. surgical
probes for imaging from within the subject of study.
v. OCT is compact and portable.
1.5 MALVERN PARTICLE SIZER
1.5.1 Understanding Laser Diffraction
A particle sizer measures particle size based on the technique of laser 
diffraction. The principle is that particles passing through a laser will scatter 
the beam in different angles, and that this angle is particle size dependant. 
This relationship of particle size to scattering angle is logarithmic. However, 
intensity is inversely proportional to scattering angle -  i.e. the larger the 
particle, the narrower the scattering angle, but at high intensity due to large 
surface area, and vice versa.
A typical particle sizer (fig. 1.9) consists of the following parts: a laser 
of fixed wavelength; a sample presentation system to ensure a homogenous 
stream of sample particles pass through the laser beam; and a series of 
detectors to measure the diffracted light at different scattering angles 
(www.malvern.co.uk). Range varies from device to device determined by the 
angular range of scattering measurement. Modern devices make 
measurements from 0.02 -  130.00 degrees with a logarithmic detector
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Figure 1.9 An illustration depicting the separate parts of a typical particle sizer system, 
which consists of laser beam, presentation system and detectors.
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Figure. 1.10 An illustration to explain Mie Theory.
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Figure 1.11 An illustration to help explain the equivalent sphere approximation on the 
basis of length, weight, volume, surface area, sieve aperture, sedimentation 
rate and maximum length.
41
sequence, i.e. detectors spaced increasingly far apart as the angle increases, 
to give optimum sensitivity.
Scattering patterns are compared to one of two mathematical models: 
the Fraunhofer Approximation and the Mie Theory (fig. 1.10). Mie Theory 
(used by Malvern particle sizers) is based on Maxwell’s electromagnetic field 
equations. The following assumptions are used for any type of particle size 
and transparency: particles are assumed spherical; the suspension is dilute -  
i.e. light is scattered once only before detection; the optical properties of the 
particle and the medium is known; and finally all particles are homogeneous. 
The Theory predicts from the scattering data and the intensity taking into 
account the refractive index difference between the sample particle and 
medium materials. It also factors in adsorption from the sample particle -  
extremely important for particles below 50pm in diameter and those that are 
transparent (IS013320-1, 1999).
But what is “particle size”, especially for particles that are not 
spherical? The aim of any particle sizer is to create a single number for a 
particle based on the assumptions of either of the Mie Theory or the 
Franhofer Approximation. That is, the diameter reported is that of the 
equivalent spherical particle that would give the same measured variable 
(sample particle diameter, average cross-sectional area or volume) (fig. 
1 .1 1 ).
1.5.2 Using Laser Diffraction to Measure Particles
One of the most common biological tests is cell counting and classification. 
Classification can be quickly achieved using cell size to determine different 
types of cells. One such study from Jiaotong University involved using laser 
diffraction to analyse human: red blood cells (6-9pm diameter); white blood 
cells (6-20pm diameter); and blood platelets (2-3pm diameter). Of the four 
cell counting methods: haemocytometer (a manual counting method using a 
counting grid and a microscope); photoelectric nephelometric method (only 
used for red blood cell counting, and results in large errors); Coulter counter
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or flow cytometry (which both measure a single cell flowing through a 
measured region, but are highly priced). Each have their advantages but 
none of the techniques could measure all three types of cells. This study 
was the first of its kind to utilise Mie Theory and apply it to quantification of 
blood cells. Histograms for red and white blood cells (fig. 1.12) show distinct 
size distributions for each population -  7.69pm mean diameter red blood 
cells, and a white blood cell classification of 25.1% lymphocytes, 73.5% 
neutrocytes and 1.4% middle sized cells (Yang 2004).
Of course laser diffraction is not limited to biological samples. A 
French research group looked at rubber particle coagulation kinetics, a pre­
requisite for latex coagulation and the major limiting factor to yield in rubber 
manufacture (Kongsawadworakul 2003). The study showed that latex cell 
vacuoles contain proteins that cause coagulation, conversely the cytosol of 
latex cells also contains anti-coagulating proteins. Figure 1.13 shows a 
divergence from a Gaussian curve with a peak at 0.8pm denoting (maximum 
initial mode (MIM) prior to addition of any agents. This milky suspension 
remained stable and unchanged for over 3 hours prior to addition of lutoidic 
serum (LS). Seen here is how MIM falls from 14.89% at 0.8pm to 4.37% at 
2.28pm over 20 minutes, with a maximum particle size of 7.72pm (fig. 1.13a). 
The team explored how to manipulate aggregation via breakdown of 
aggregates using shear via a syringe (fig. 1.13b). MIM was decreased 
partially to 0.93pm and particle range from 0.36 to 2.65pm, however this 
returned to previous MIM and range values when left in the LS solution. pH 
and buffer were also explored. Laser diffraction is suggested by this 
research as a way to monitor the kinetics of aggregation of any particles, 
organelles or cells.
1.5.3 Laser Diffraction and Cell Encapsulation
The Jiaotong study of blood cells gave many indications of the advantages of 
using laser diffraction over other particle classification methods (Yang 2004).
(a) (b)
43
35
30
25
20
15
10
5
02 4 6 8 10 12 14 16
D [ p m )
*
10 -
2 4 6 8 10 12 1614
D [ f j m )
Figure 1.12 Size distribution histograms for a sample of (a) red blood cells and (b) white 
blood cells from a human patient.
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Figure 1.13 Size distribution histogram showing LS induction of rubber particle 
coagulation 20 minutes (a) and 35 minutes (b) after adding LS.
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Figure 1.14 A size distribution histogram showing how a non-flowing laser diffraction 
method would compare for accuracy against a flowing method such as a 
Coulter counter or flow cytometry.
44
During the study, the comparison of laser diffraction with the Coulter method 
was compared for measurement of polystyrene latex beads in aqueous 
solution (fig. 1.14). One must ask the nature of particles in the system of 
study. A Coulter counter or flow cytometer is useful for particles in a flowing 
system, but non-flowing measurement approaches such as laser diffraction is 
more suited to study of static particles. Furthermore, Mie Theory assumes 
spherical particles, which is exactly the case for suspended mammalian 
smooth muscle, making this approach very well suited and more accurate.
1.6 THE LEICA QWIN
1.6.1 Introduction
The Leica QWin is an integrated quasi microscope/camera system that is 
designed to capture and quantify microscopic data. The device is composed 
not only of a hardware solution, but also an image analysis and processing 
tool compatible with Microsoft Windows. The system -  comprising the 
sample stage, focus, lamp brightness, filter block and shutter -  is completely 
automated and motorised, so that analysis of multiple positions of the glass 
slide/coverslip can be performed in a systematic fashion and customised by 
the user. The camera is capable of taking digital 736 x 574 pixel images at 
0.83pm/pixel resolution, moving to pre-programmed fields within a sample 
using the motorised stage. Furthermore the Quantitative Interactive 
Programming System (QUIPS) software can also be setup to analyse images 
via a sequence of image analysis operations in a routine manner.
A diverse range of specimens maybe sampled, including: cell 
monolayers; plant sections and seeds; tissue sections; natural and 
processed food products; in-situ hybridization of stained tissue sections; 
protein crystals; synthetic and forensic fibres; polished and etched metals; 
embedded and sectioned minerals; semiconductor water defects; abrasive 
powders and carbon black components (fig. 1.15).
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(a) (b) (c)
Figure 1.15 Digital images from an array of different sample materials captured on the 
Leica QWin system: (a) electronics -  quality control of compact discs (CD); 
(b) artery cross-section -  calculation of percentage restriction; (c) botany -  
seed germination and characteristics.
Measure epidermal area stained
Calculate eLC/mni& eLC/mm2
Draw epidermis
Fxclude objects outside of the epidermis
Classify epidermal objects as LC. 
if size is > 10 pm2 and < 900 pm2
Grab microimage of stained section
Count epidermal LC (eLC)
Detection of stained objects 
based on hue, saturation and intensity
Measure epidermal length & surface
Figure 1.16 Flowsheet of Leica QWin image 
analysis routines
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The Leica system can automatically analyse images by colour, 
contrast, size, number, shape, position or orientation. Selection can also be 
semi-automated via use of the mouse as a drawing aid. A range of 
illumination forms such as: incident, transmitted, polarised, Normarski, 
fluorescent, dark field, or interference contrast may be used. Furthermore, 
any digital image, imported, scanned, or negative may be taken and 
analysed on the Leica software making it a versatile piece of apparatus 
(www.leica-microsystems.com).
1.6.2 Using the Leica QWin to Measure Particles
One Dutch group has successfully utilised the Leica QWin to quantify 
Langerhans cells, thus reducing intra and inter-personal variations in 
sequential cell counts -  a much-needed in vitro alternative to controversial 
vivisectional methods (Jacobs et al. 2001). Langerhans cell migration as a 
result of contact sensitisers is an indicator of allergic contact dermatitis -  an 
increasing health issue in humans. When immature dendritic cells such as 
Langerhans cells in the epidermis come into contact with a contact allergen, 
they migrate to the draining lymph node and mature. Once mature, these 
cells stimulate the development of hapten-specific naive T-cells leading to 
antigen-specific sensitisation. Subsequent exposure to the allergen on the 
skin results in a contact dermitic response. By obtaining several human skin 
explants from multiple donors (n=50), staining with MGP (containing 0.5% 
methyl green and 0.1% pyronine) for CD1a or Lag in epidermal Langerhans 
cells and then analysing the 10 images using the Leica QWin (see fig. 1.16 
for protocol) as-well-as manual counting (6 fields counted per biopsy) by 
three operators and triplicate counts for each image, a comparison between 
automated and manual counting was established (fig. 1.17). As can be seen, 
the results correlated well between methods. The study highlighted several 
factors of importance. Firstly, the success of manual counting was a function 
of staining method -  aiding visualisation and contrast. The Leica QWin was
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Figure 1.17 Manual vs. Leica QWin generated counts of epidermal Langerhans cells 
from skin explants of human donors.
Figure 1.18 A microscopic image of histologically prepared oesophageal squamous cell 
carcinoma MIB-1 stained brown and then counterstained blue to show the 
positive and negative tumourous cells, respectively.
Table 1.1 A comparison of quantitative (manual) versus semi-automated 
counting using “method A” QUIPS routine
Method A
Categories 1 + 2+ 3 +
Quantitative counting 1 + 20 1 0
2 + 4 32 0
3 + 0 6 10
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reported to reduce this variability between counts and operators to a 1 and 
2% variation, respectively. Secondly, distribution of Langerhans cells per 
biopsy and patient is not uniform and differs from field to field even from the 
same biopsy, i.e. the quality of the sample can influence results. Thirdly, 
staining intensities arising from immunohistochemistry can impact results. 
Even at when this effect was minimised, inter-experimental variation was 
21%.
Another group have used the Leica QWin system to automate cell 
counting of antibody MIB-1 positively stained nuclei to aid in oesophageal 
cancer prognosis (Law et al. 2003). This group proved the reliability and 
consistency of the Leica QWin system, bringing analysis times down to 15 
minutes and eliminating overlapped or missed counting by human operators. 
In order to achieve accurate results, counting in excess of 15,000 MIB-1 
stained nuclei from a tumour sample must be carried out per case. The team 
histologically prepared oesophageal squamous cell carcinoma. Of the 
stained, 3pm thick, paraffin mounted samples brown nuclear stain was 
positive whereas blue nuclear stain was negative. Counting was performed 
in manually (by light microscope, at least 1000 nuclei counted) and semi­
automated fashions (using the Leica QWin). Where operator counted brown 
and blue stained nuclei, the Leica QWin used RGB (red, green, blue) 
breakdown, primarily focusing on red and blue pigmentation to isolate and 
quantify positive and negative tumour cells, respectively (fig. 1.18). Manual 
counting was performed for 73 cases, the time for each case being 
approximately 30 minutes. 123 slides were analysed in total. Table 1.1 
shows how the manual and Leica QWin methods compared. Both methods 
assessed for three categories: less than 0.40 of positive tumour cells; 0.40 to 
0.70 of positive tumour cells; and over 0.70 of positive tumour cells. A strong 
correlation between the two methods is shown. The comparison between 
manual and automated counting highlighted several areas of importance. 
Firstly operator errors will obviously include the “inter” and “intra” variety -  
and for this study inter-operator error was minimised by using one operator 
only. Where manual counting of many nuclei are involved, there will be a 
degree of over and missed counting, and obviously it is very time consuming.
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Also digital image capture has distinct advantages over keeping microscopic 
slides for future analysis -  such as no need to recapture the images, no 
fading colour of the specimen, and therefore less errors upon re-analysing a 
sample.
1.6.3 The Leica QWin and Cell Encapsulation
Clearly the studies outlined in section 1.7.3 have shown that this system is 
compatible with biological cells and is capable of detecting and quantifying 
cells discriminating on colour difference. The ability to build automated 
routines, not just for image capture, but also image processing and analysis 
making the Leica QWin an invaluable tool to help automate and standardise 
cell quantification. However, since the technique is very much dependent on 
images, the quality of images i.e. staining can influence results. This point 
must be borne in mind when the Leica is being used.
1.7 CURRENT TISSUE ENGINEERING INDUSTRY
Tissue Engineering is a new and rapidly growing multidisciplinary industry 
(fig. 1.19). Its borderline status between medicines and devices has 
prompted the merger of the Medicines Control Agency and the Medical 
Devices Agency into the Medicines and Healthcare products Regulatory 
Agency (MHRA) in the UK in 2003. Applications include: skin patches, 
cartilage, bone, pancreatic, and corneal and vascular implants to date. There 
is as yet no procedure for market approval in many European countries 
including the UK. It is likely that European legislation will follow (Faulkner et 
al. 2003).
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Figure 1.19 Diagram illustrating the multi-disciplinarity of tissue engineering (Pangarkar 
and Hutmacher 2003).
Table 1.2 Annual Organ and Tissue Deficiencies
Indication Procedures or patients per year
Skin 4 750000
Bone 1 340000
Cartilage I 150000
Tendon and ligament repair 123 000
Blood vessels 1 360000
Pancreas 725 000
Urological 82000
Dental 10000000
(Langer and Vacanti 1993)
Table 1.3 FDA-Approved Tissue-Engineered Products
Product Launch Description 2002 annual sales
Apligraf (Organogenesis) 1998 Living skin equivalent for 
diabetic and venous ulcers
S23 million; 
25.000 units
Carticel tGenzyme Biosurgery) 1999 Autologous chondrocytes for 
cartilage repair
$25 million: 
2.500 units
Dermagraft (ATS) 2001 Living skin equivalent for diabetic 
and venous ulcers
S4.5 million 
4,500 units
OrCel (Ortec) 2001 Living skin equivalent for burn 
patients
<$100,000
•Note: Bolh Organogenesis and Advanced Tissue Sciences have discontinued operations. Smith & Nephew has taken over 
production, marketing, and sales of Dermagraft. The future of Apligraf is unclear
(Lysaght and Hazlehurst 2004)
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Tissue Engineering is promoted by the Government, Industry and Academia 
and investment in this sector is heavy. It is estimated that in 2001, there 
were 3500 scientists in 70 companies working in this field, with a combined 
annual spend of $600 million (Lysaght and Reyes 2001). In 2004, 
accumulated investment since 1990 in Tissue Engineering exceeds $4.5 
billion and investment is still growing by 22.5% annually (Langer and Vacanti
1999). This seems sound since organ replacement therapies prolong the life 
of 20 million patients worldwide (see table 1.2). In the US, it is estimated that 
20% of people reaching 65 will receive organ-replacement therapy during 
their remaining life span. Worldwide, organ-replacement therapy accounts 
for 8% of medical spending or $350 billion annually (Lysaght and O'Loughlin
2000).
Despite the positive investment and drive from all stakeholders 
commercialisation of the products seems the largest barrier (Nerem 2000). 
Of the four pioneering Tissue Engineering firms with FDA approved products: 
Organogenesis has filed for bankruptcy; Advanced Tissue Sciences has 
been taken over by Smith and Nephew; Ortec is operating under a “going 
financial concern warning”; and Genzyme has downsized and been 
assimilated into a larger division of its parent company (table 1.3). The 
problem seems to be a combination of several factors: disappointing initial 
sales due to limited targeted market; lack of engineering and automation to 
produce low cost products; high regulatory costs and approval processes 
creating financial strain; lack of experience by start-up companies; and lack 
of end-user support acceptance (Bouchie 2002; Lysaght and Hazlehurst 
2004). Regulatory factors cannot be controlled, but in order for a product to 
be successful, a well-engineered process is essential if market approval is to 
be achieved.
1.8 VALIDATION, QC AND GMP
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Process validation is establishing documented evidence, which provides a 
high degree of assurance that a specific process will consistently produce a 
product meeting its pre-determined specifications and quality characteristics.
Under the current Good Manufacturing Practices (GMP) Regulations 
for Finished Pharmaceuticals, 21 CFR Parts 210 and 211 and the Good 
Manufacturing Practice Regulations for Medical Devices, 21 CFR Part 820, it 
is a legal requirement to be able to validate a process before mass producing 
a pharmaceutical or medical device. Our process could potentially create a 
tissue-engineered organ that is implanted into the human body. Although it 
should be classed as a medical device we must also address the stringent 
issues associated with an ingested pharmaceutical since it is not inert.
In order to validate our tube-forming device, we must show:
• Quality of parts and materials
• Adequate product and process design
• Control of the process
• In process and end-product testing -  destructive, variations of product 
on safety and effectiveness
Clinical/pharmaceutical grade materials and well-documented research helps 
towards assurance of quality. All variables must be controllable to within a 
margin of error. Since there are no mass-produced blood vessels on the 
market, which variables will be monitored and the FDA-governed margin of 
acceptable error for TE products remains to be seen in the future. Certain 
processes of the blood vessel manufacture relies upon lab techniques, and it
is essential that biochemical engineering principles are incorporated at an
early stage to ensure adequate scale up/out with control of process variables. 
Pier reviewed research papers will contribute towards proof of principle for 
the device. End product testing may not be essential (although pre-clinical 
studies will be necessary) if we can monitor product development in vitro and 
ensure safety. That is:
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• Quality, safety and effectiveness must be inbuilt in the product
• Quality cannot be inspected or tested into the finished product
• Each step must be controlled in the manufacturing process to 
maximise probability finished product meets all quality and design 
specifications
These are quality assurance (QA) steps. QA ensures products are fit for 
intended use. It is through careful design and validation of both the process 
and process controls that a manufacturer can establish a high degree of 
confidence that all manufactured units from successive lots will be 
acceptable. Successfully validating a process may reduce the dependence 
upon intensive in-process and finished product testing. The latter plays a 
huge part in QA. Where in-process or finished product testing cannot 
adequately measure certain attributes, process validation should be derived 
primarily from qualification of each system used in production and from 
consideration or the interaction of the various systems. Validation and end 
product testing are not mutually exclusive.
It is Good Laboratory Practice (GLP) to establish protocols for all 
procedures. These will enable rapid construction of the written validation 
protocol that specifies the procedures (and tests) to be conducted and the 
data to be collected. Data collection must be accurate with a good measure 
of variability between successive runs. From these should be established 
upper and lower limits (worst case or most appropriate challenge conditions) 
within which the product will not fail. Documentation should also include 
evidence of suitability of materials and reliability of equipment and systems.
Key process variables should be monitored and documented, 
including any process changes to help pinpoint process problems. Analysis 
of data collected from monitoring will determine variability of process 
parameters for individual runs and will establish whether or not the 
equipment and process controls are adequate to assure that product 
specifications are met. This may include: component specification, air and 
water handling systems, environmental controls, equipment functions, and 
process control operations (FDA 1993).
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In order for an engineered vessel to satisfy requirements as a clinically 
useful conduit, histological, ultrastructural, biochemical,
immunocytochemical, pharmacological, mechanical and in vivo analyses 
must be performed. Histological and ultrastructural analyses reveal
information regarding extracellular matrix (ECM) proteins. Biochemical 
analyses, includes assays that quantify cellular DNA and collagen content, so 
that the properties of native and engineered tissues may be compared. 
Immunocytochemical staining for SM a-actin, calponin, and myosin will 
determine the differentiation state of smooth muscle cells (SMC) present.
Information regarding SMC hyperplasia, by staining for proliferating cell
nuclear antigen (PCNA), may also be obtained and subsequent risk to 
luminal occlusion upon implantation. Pharmacological testing will test SMC 
response to vasoconstrictive and vasodilatory agents. Endothelial cells may 
also be tested for platelet endothelial cell adhesion molecule (PECAM) for 
identity, or thrombomodulin/prostacyclin for prothrombotic state. Mechanical 
testing assesses the graft’s ability to withstand long-term exposure to 
physiological pressures and forces, such as stress-strain analysis to 
determine the elastic modulus and compliance data and suture retention 
strength (Atala and Lanza 2002).
Other product variables that may require justification include sterility, 
purity from animal products and toxic entities, homogeneity of material, and 
wall thickness. It is likely that since our product is a bioactive tissue for 
implantation, that most validation parameters will be control of biological 
pathways. Sampling will play a large part in process validation, in our case, 
the sterile sampling of dissolved oxygen tension (D0T)/C02, glucose/lactate, 
pH and temperature levels. Protocols for sterilisation are also a key variable. 
However for our process, most parts will be disposable to ensure sterility is 
maintained.
1.9 RESEARCH QUESTIONS
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The literature shows us the properties of working with an alginate system, 
commercially available in powdered or liquid form as sodium alginate, this 
can quickly be solidified into any shape using a wide array of multivalent 
cations, each offering a way of controlling reaction speed. Such structures 
have the added benefit of resolubilisation upon high concentration of 
monovalent ions. Alginate has a rich literature in pharmaceutical research, 
due to availability, price, biocompatibility and non-toxicity.
The porosity of solidified structures allows nutrient exchange as long 
as wall thickness/diameter of structures are controlled. The hydrophilicity of 
alginate means that cells will cluster together as aggregates when the two 
are introduced together, historically to encapsulate cells in a protective 
material for transplantation in a non-immunosuppressed host. This could be 
both beneficial or detrimental depending on the object of the structure being 
created. When cells aggregate, they proliferate and mature to become 
tissues and eventually organs. Where single cells are required, i.e. where 
matured cells are encapsulated to produce protein for the host, aggregation 
may mean cell death in the centre of large cell aggregates that have been cut 
off from supply of nutrients (Sen et al. 2002). In the latter case aggregation is 
not desirable and a homogeneous distribution of cells is more appropriate.
Clearly cell encapsulation is highly researched area due to the 
benefits of immuno-shielding of allogenic or xenogenic cells from a host, 
especially useful for cell therapy purposes when the host is unable to 
produce a protein, e.g. in diabetes. And this can be achieved either by lining 
a sheet of alginate or embedding the cells within the structure’s walls. Such 
alginate structures could also extend to becoming a matrix or scaffold for 
tissue engineering purposes, rarely seen to involve alginate despite its many 
beneficial properties.
The research with respect to cell/alginate interaction and clinical 
effectiveness upon transplantation is extensive. However, it seems that 
despite the promise of this technology, there are few well-engineered 
processes able to reproducibly create structures with a degree of geometrical
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control. If such a fabrication device could be developed, then scaleup or 
scale-out of this technology would ensure a mass production capable 
possibility and subsequent FDA approval for therapeutic use. Serp’s work 
was one of many well-developed processes for the creation of beads using 
vibration frequency to control droplet break-up, but the other useful structure 
for macro-encapsulation purposes -  a tube -  has seen less success. No 
publications to date exists, the results of the two groups outlined were work in 
progress.
A well-engineered process would not just involve creation of a well- 
formed tube, but also the monitoring methods to accompany it. A technique 
such as OCT could firstly help qualify the quality of alginate structures 
produced, and secondly form an integral part of the process monitoring 
quality of subsequent mass-produced tubes. The non-destructive ability of 
OCT to analyse samples in real time through air make it an ideal tool for 
monitoring walls of semi-transparent macro-encapsulation structures upto a 
thickness of 2-3mm. Furthermore the resolution of such a device gives it the 
ability to capture information on a cellular level. Techniques such as laser 
diffraction, proven to be just as accurate yet more versatile than a Coulter 
Counter or flow cytometry, could be useful to qualify the types of cells used, 
presence of any cellular aggregates, or the size of cell-encapsulated beads 
formed. The use of Mie Theory based on the equivalent spherical particle 
makes laser diffraction all the more suited to mammalian cells, which are 
spherical when in suspension. Finally the Leica QWin is another tool that 
could be exploited to automate cell counting, eliminating inter and intra­
operator error and help control cell quantification. The QUIPS software 
aspect makes it all the more suited to other digital image capture techniques 
such as OCT, and brings current technology to this well-engineered process, 
ensuring no loss of information when viewing past analysed samples.
Thus it is the aim of this thesis to address the engineering design 
involved in a creating a cell-populated tube. Clearly there are many end uses 
of such a tube, and therefore specifics (such as cell type and alginate 
properties) will be left open to future development. Cell-alginate literature is 
abundant, and therefore it is not the intention of this research to add to this
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work. Moreover the intention here is to focus on a well-designed process 
that could create a tube of alginate -  an alginate shape lacking publications 
in the current literature. It is also the intention to create a system capable of 
scaleup, working towards FDA approval. Such research will focus in three 
areas. Firstly, reproducibility of tubes formed based on geometrical control -  
primarily wall thickness due to the direct relationship between wall thickness 
and nutrient availability to encapsulated cells. Secondly, monitoring methods 
to qualify the quality of the system and its components, offering a means of 
real-time monitoring and QA of cellular components in a final working system. 
As part of this second focus: cells naturally aggregate in alginate structures, 
therefore we look at creating a homogeneously distributed single cell 
population to ensure even growth on cell-embedded structures, thus lending 
to the versatility of this research. Rat aortic mammalian smooth muscle cells 
will be used as a model, although characterisation of such cells are deemed 
unnecessary due to the adaptable end use of such tubes. We will also look 
at placing controls on mammalian cell control using automation methods. 
Thirdly and finally, we look at integrating the alginate tube forming, the 
monitoring methods and the homogeneous cell suspension together and look 
at alginate and processing impacts on biological cell viability, cellular effect to 
wall thickness consistency, and spatial distribution of single biological cells 
within the alginate walls.
To be specific, we can expand on each of these points -  how can we 
reoroduciblv create well-engineered cell-populated tubes? -  This question 
could be broken down into: what is the current status of the tube forming 
technology at UCL?; is the design of the current fabrication design the most 
effective?; is there any mathematical Theory that supports wall thickness?; 
what is the current protocol and how can it be improved?; what needs to be 
developed to make it work?; how can we measure wall thickness?; how can 
this be improved?
How do we ensure quality of the system and the tubes formed? When 
we explore this question exhaustively, one might ask: how do we monitor 
tubes non-destructively?; which variables should we monitor to ensure QA?;
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what methods are there available to collect this information?; what controls 
should we use?; how can we prove we have controlled all the variables?
So how do we effectively mix cells with polymer?: what are the 
common ways of mixing cells?; are there more appropriate, more effective 
ways of mixing?; what are the important variables to consider when mixing 
cells?; what are the effects of mixing cells using different ways on cell 
viability?; can we prove that we can control or optimise conditions such that 
viability is not compromised?; what are the important variables of tube 
formation?; how do cells impact these important controlled variables during 
formation?; how can we control or minimise this impact?; how can we 
monitor it?
2 Operations, Materials And Methods
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2.1 OPERATIONS
2.1.1 THE UCL TUBE-FORMING DEVICE
2.1.1.1 Evolution of the Base Unit
The experimental chapters will make references to the “mark 1” and “mark 2” 
tube-forming device. It is therefore important to understand the subtle 
differences between the two. At the heart of the device is a twin-port plastic 
base unit, which brings the side port for the matrix fluid, and the base port for the 
propelling fluid together. The difference between the two is solely a change of 
the base unit design -  specifically the injector nozzle design. The mark 1 base 
unit (fig. 2.1, 2.3a) consists of a 6.5mm tall, cylindrical injector nozzle of 1.8mm 
diameter; and the mark 2 base unit (fig. 2.2) is comprised of a 2.9mm tall, 
flanged injector nozzle of 1.8mm diameter at the base expanding to 3.6mm at 
the crown. The mark 1 base unit were used in experimental sections 3.2.1, 
3.2.2, and 4.1.1 only. All other experiments involving the tube-forming device 
were performed using design mark 2.
The reasons behind this change are: firstly because the tip of the injector 
nozzle doubles as a seat for the spherical regulator at the start of tube 
formation; and secondly we are able to reduce dead space within the device 
from 112pl to 89jnl, which means less volume of primer is needed -  a critical 
factor should the matrix fluid consist of expensive or scarce materials. It was 
observed that a tighter fit around the spherical regulator was required to prevent 
seepage of air bubbles into the propelling fluid during tube formation. These 
bubbles disrupted the successful formation of a tube, and its quality was also 
questionable. It was theorised that the flanged design also offered greater
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Figure 2.1 The heart of the Mark 1 tube-forming device -  the “base unit” - cross-sectioned:
(a) longitudinally; and (b) laterally.
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Figure 2.2 The heart of the Mark 2 tube-forming device -  the “base unit” - cross-sectioned:
(a) longitudinally; and (b) laterally.
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stability to the lift-off of the regulator from the injector nozzle forming a tube 
where the first ~7cm were of greater quality.
2.1.1.2 Tube-Forming Device Design
The basic design for the device used in this thesis has been described by 
Mason & Town (Mason and Town 2002). The borosilicate precision-bore glass 
barrel (Glass Precision Engineering, Bedfordshire, UK) is mounted on the plastic 
base unit, with dual injector ports (fig. 2.3b). A smaller cylindrical stub allows 
tight attachment of the glass barrel. At the base of the glass barrel and 
protruding from the plastic base unit sits a metal collar or injector nozzle upon 
which rests the plastic spherical regulator. The dual injector base unit sits on a 
100ml glass syringe (Samco, CA) lubricated with silicon grease (ICI, Cheshire, 
UK) that is steadily driven by a modified syringe driver (Harvard Apparatus, UK). 
1.825 and 2.000mm glass barrels are used in conjunction with 1.587mm and 
1.700mm radii plastic spheres (table 2.1) used as regulators to extrude alginate 
tubes creating 3 different gap widths.
2.1.1.3 Operating the Device
Firstly the device is assembled (fig. 2.4a). The base unit is attached to a well- 
lubricated glass syringe filled with CaCl2 . The 1ml syringe (and later the static 
mixer) containing matrix fluid is attached to the side port. The spherical 
regulator is dropped into place on top of the injector nozzle and the dead space 
is primed with propelling fluid. A finite volume (300pl - 10OOjal) of matrix fluid is 
introduced via a side port into the glass barrel, which surrounds and rests above 
the regulator (fig. 2.4b). Propelling fluid travels through the polypropylene base 
via the base port and is expelled via the injector nozzle into the glass barrel. A
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(a) (b)
Figure 2.3 Digital photographs of (a) the Mark 1 design plastic twin-port base unit, and (b) 
the setup of the glass barrel fitted with the Mark 1 base unit, with a 1ml glass 
syringe attached to the side port (matrix fluid) and a 100ml glass syringe 
attached to the base port (propelling fluid).
Table 2.1 Matrix of wall gap configurations ‘8o\ showing the wall gaps and nominal 
for different sized glass cylinders and spherical regulators
Cylinder Radius, a (mm) 1.825 2.000 2.000
Regulator Sphere Radius, r0 (mm) 1.587 1.700 1.587
Gap Width, 50 (pm) 238 300 413
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Figure 2.4
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Matrix
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Fluid
Schematic to illustrate setup procedure of the tube-forming device.
(a) Device assembly.
(b) The matrix fluid is loaded using the side port.
(c) The propelling fluid is injected from the base port.
(d) The tube length calculated as the length when the regulator sphere 
penetrates the meniscus of the alginate.
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regulator that would sit on the injector nozzle is thus pushed up the glass barrel. 
This propelling fluid pushes the regulator through the matrix fluid, which drags 
the matrix fluid up the inner walls of the glass barrel (fig. 2.4c), and wall 
thickness is determined by the regulator and cylinder size. The syringe driver is 
stopped at the point the spherical regulator breaks through the meniscus of the 
matrix fluid.
The two fluids are then left in contact with each other. A suitable choice 
of fluids would cause the deposited layer to solidify. After approx. 10 mins, the 
deposited fluid on the wall of the cylinder would have formed a patent, cross- 
linked tube (fig. 2.4cf). Cells could be premixed with the matrix fluid to produce a 
hydrogel tube containing embedded cells, or cells could be incubated with the 
tube post tube-formation to line the surface with cells.
Using sodium alginate as the matrix fluid and a propelling fluid containing 
divalent cations, such as CaCI2, the tubular structure would cross-link and 
solidify. The device was specifically designed to produce patent, cross-linked 
alginate tubes.
High G alginates at high concentrations are required to produce viable 
tubes that can be easily delivered from the glass barrel. To improve 
visualisation, small quantities of glycerol based food colouring (Supercook 
Leeds, UK) were added to the alginate solution. All components must also be 
pre-washed in 4M sodium citrate solution and dried using compressed air prior 
to commencement of a study. The sodium citrate solution contains excess 
monovalent ions that replace the calcium ions and revert the hydrogel back to 
an aqueous form.
At one time the tube-forming device was manually powered, but by the 
time of this thesis, the device was already adapted to automated-fluid-drive, to 
maintain reproducible results with respect to wall thickness. Control of timing, 
rate and volume of cross-linking agent was essential.
Overall wall thickness is not only a result of regulator and barrel 
diameters, but also alginate shrinkage and swelling due to cross-linking time 
(Saitoh et al. 2000). Irregularities due to inconsistent regulator travel are usually
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due to calcium chloride “escape” from the central stainless steel barrel to the 
bulk alginate fluid. Air bubbles, imperfect regulators and poor alignment are also 
causes.
Thorough mixing for extended periods of time using a roller bottle mixer 
ensured alginate homogeneity. Elimination of trapped air bubbles was achieved 
using sound technique i.e. good handling of the syringes used both to inject 
calcium chloride and alginate. Precise machining of the polypropylene base, 
glass barrels and regulators ensure perfect alignment. Frequent assembly/ 
disassembly of the cylindrical stub that secures the glass barrel causes wear 
and tear and hence cylinder base material is an important consideration. 
Rigorous cleaning of the device between runs was also absolutely essential.
The syringe driver is a Harvard Apparatus PHD2000 lead screw system. 
It is capable of driving two syringes in parallel (ranging from 0.5 pi to 140 ml), 
which can be coupled with a T-piece. Its infusion rate can be set ranging from
0.0001 pl/hr to 13.2 L/hr. Its accuracy is claimed to be ±0.1%.
Perspex and stainless steel were used for the coupling between the 
syringe and the device, in order to prevent wall distortion. Luer lock fittings were 
used throughout. Straight couplings over 2-3cm, length seemed better possibly 
due to turbulent/laminar regimes. The stainless steel injector was machined 
such that the regulator sits upon it with minimum friction.
2.1.2 The Malvern Particle Sizer
The particle sizer is a laser-based technique, which involves the beam shining 
through a metal block containing a sight-glass on front and back (fig. 2.5a). 
Within the block lies a small plastic impeller that is agitated via a magnetic rotor. 
This impeller keeps particles suspended. As particles pass through the beam, 
the size information is captured, and this is used to formulate a particle size 
distribution.
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The model used was a Malvern 3600Ec. Operation is very simple: the 
metal sampling block must first be cleaned using saline, and then filled with 
10ml of sampling fluid. For our experiments involving cells, sampling fluid would 
be complete medium. The impeller would then be dropped into the metal block. 
This would then be clamped into place within the particle sizer, slid to the end 
and the lever pulled to lock (fig. 2.5b). The laser is then adjusted to shine 
through the sight-glasses. Cover on the detector is removed. Then following 
instructions on the PC unit, the sample is first zeroed, and then the sampling can 
commence. The first time this experiment was carried out, the exact 
concentration of cells needed was not clear, therefore concentrated cell 
suspension was pipetted into the sampling block 200pl at a time until detection 
was within parameters. Range was found to lie between 1x105 and 2x106 
cells/ml concentration. At the end of each sampling session, results must be 
printed.
2.1.3 The Leica QWin
The Leica QWin is a microscopic technique. It is composed of an advanced 
digital microscope that is connected to a computer system (fig. 2.6). The 
mechanised sampling base upon which the glass slide sits can be set to 
measure pin-pointed locations of the sample -  termed “fields”. All images can 
be saved directly to the computer and the software package provided by Leica is 
a powerful tool, which can enhance images and analyse using a vast array of 
techniques.
The model used was the Leica Q5501W. Physical setup involved 
taking a glass slide and placing ~17.5pl of sample under the coverslip with or 
without staining to enhance the image (Trypan Blue stain was used in 
experiments).
Plastic Impeller
Figure 2.5 Digital photographs taken of the Malvern Particle Sizer 3600Ec. (a) Metal
sampling block with sight-glass, (b) Shows the laser, detector and sampling 
block setup.
Figure 2.6 Digital photograph taken of the Leica QWin
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Focusing was achieved at 1-1.5cm between lens and glass slide. Magnification 
was set at 10 x 0.30 Ph1. Stage was set to take 4 fields in a square pattern (fig. 
2.7) 1cm2 between fields.
On screen calibration of local sample (Measure -» Calibration) was
performed. Feature frame was set to x:0, y:0 (Measure -» Frames), width =
500pm, height = 500pm, i.e. 2.5pm2. Resolution was set to 1pm = 1 pixel. 
QUIPS software protocol was as follows:
1. Acquire button.
2. Image - » Image Transform Fill White -» B Sharpen
3. Detect Change band for black cells and blue background
Check adjust (black) radio button
4. Measure Feature -» Flags checkbox
5. Stage
6. Repeat x4
Results can then be saved as jpeg/gif files to a folder on the computer.
2.1.4 The NAC High Speed Camera
The NAC high speed, high-resolution camera was an additional 
experiment made when it was learned that the camera was in the department, 
on loan from the EPSRC. The model of the camera was an NAC HSV-500C3 
and came complete with a digital recording unit (fig. 2.8a) with wired remote, a 
tripod, twin halogen lighting lamps, a GXMZ MonoZoom 7 microscopic lens (fig. 
2.8b) with x0.5 and x0.75 CCD magnification (giving an overall magnification of 
x40), adapter/stepping rings, an additional Sony VCR SLV-SE230, a Panasonic 
14” BT-H1490Y monitor, and a Viglin Genie Pentium 4 Computer with National
STEP 1 STEP 2
( ) 
STEP 4 STEP 3
Hemocytometer
2
1
Figure 2.7 Mechanised stage setup for the Leica QWin.
Figure 2.8 Digital photographs taken of (a) the digital recording unit, and (b) the NAC HSV- 
500C3 camera with GXMZ MonoZoom 7 microscopic lens.
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Instruments LabVIEW software AVI file reader/writer and VirtualDub 1.5.2 for 
editing AVI files. The camera features high light sensitivity, making it ideal for 
low-light environments.
Operation involved firstly setting up the equipment -  the Sony VCR was 
used as a backup source to record digital images (which could in-turn be 
transferred to the PC) onto VCR. Frame-rate was set to maximum of 500 
frames/second (125, 250 & 500fps options). Shutter open to 1/10000 sec. The 
lens would be focussed manually. The experiment could then run. The wired 
remote could then be used to record, stop, play, FF or rewind just like any 
conventional recording equipment. The images could then be transferred to the 
PC via LabVIEW (record whilst playing back on NAC HSV-500) and edited using 
VirtualDub.
2.1.5 The Static Mixer
A further adaptation was made to the device during this thesis allowing the 
integration of cells into the tubes. Current research standard protocols for 
mixing cells with polymer to enable cell bead encapsulation involve hand mixing. 
This is irreproducible, subjective and clearly not the way to engineer a good 
process.
However, traditional chemical engineering methods of mixing become 
increasingly inefficient approaching smaller scale. At the micro-scale, mixing is 
generally accomplished in the industry via diffusion only. Static mixing is a 
viable alternative approach. The static mixer has no moving parts, and 
accomplished mixing via the natural flow of fluids through the mixing elements. 
We used one of the two types of static mixer generally available from Kenics 
(TAH, Northamptonshire, UK) (fig. 2.9), which contains helical shaped elements 
that separate, twist and folds the fluids to achieve mixing (Bertsch et al. 2001). 
This can achieve cellular level mixing by 10 static mixing elements (fig. 2.10).
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Figure 2.9 (a) Cut-out view of the micrometer structures/connector obtained by a CAD step 
with AutoCAD 2000 for a micromixer made of helical elements (Bertsch et al. 
2001). (b) Reconstruction of Kenix design static mixing elements drawn using 
SolidWorks 2004. (c) Digital photographs taken of Kenics design static micro­
mixer elements, and (d) the entire micro-mixer assembled (www.tah.com).
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(a) (b)
12-element micromixer
20mm
Figure 2.10 (a) Cross-sectional representation of static mixer setup (syringe coupler, static
micro-mixer and plastic dual-port base unit), and (b) a digital photograph taken 
of the static mixer driver complete with twin syringes, syringe coupler and 12- 
element Kenics static micro-mixer.
Table 2.2 Series 190 Spiral Bayonet Mixer Specifications
PART NO MIXING ELEMENTS ELEMENT DIA (INCH / MM) ELEMENT LENGTH .INCH /  CM) I HOUSING OUTLET RETAINED VOLUME (ML)
190-206 8 0.093 /  236 I.I/2 .8  SSpbuer 0.07
I90-2I2 12 0.093 /  236 1.5/3.8 I Sip Luer 0.I0
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There are several advantages of this technology. Firstly each static mixer is a 
one off disposable piece of plastic, fitting well to the aseptic requirements we 
require for a tissue-engineered implant. Secondly, it functions in laminar flow, 
so there is negligible shear damage. Thirdly the elements are cheap making it 
perfect for one-use applications.
Series 190 disposable spiral bayonet dental mixers were used throughout 
experiments. Referred throughout this thesis as 8-element (part no. 190-208) 
and 12-element (part no. 190-212), both came with luer-lock fittings so that they 
easily adapted to our process (table 2.2). These were purchased in bulk and 
disposed of after each use. They were adapted to a specially made syringe 
coupler and used in conjunction with a Razel Scientific Instruments Inc. A-99 
Syringe Pump (Razel Scientific Instruments Inc., St Albans CT, USA) always set 
at 1.8ml/min flowrate (highest setting). This could then be coupled to the side 
injection port of the tube-forming device (Mason and Town 2002) to integrate 
cells into alginate tubes.
Operation of the static mixer assembly was as follows: fill disposable 
syringe with alginate and precision glass syringe with cell suspension; assemble 
all parts together; at 1.8 ml/min setting infuse through to prime the static micro­
mixer; stop when all air bubbles are expelled; run experiment.
2.1.6 The Gauva EasyCyte Mini Capillary Cytometer
The Gauva EasyCyte GR1 is a flow cytometer equipped with a 480nm blue 
laser. The device can detect forward and side scatter with 3 channels for 
fluorescence. The package also includes a laptop PC loaded with CytoSoft
3.1.2 modular software, which acts as the control unit. As well as standard 
functions such as maintenance and basic operations, optional modules can be 
added for specific assays such as cell cycle analyses, cell tracking, 
mitochondrial potential and caspase activity measurements, TUN EL and 
Annexin V staining (www. guavatechnologies.com).
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Analysis utilises 96 microwell plates, with a cell concentration range of 
1x104 -  5x105 cells/ml giving a sampling intensity of 2000-5000 events. Gauva 
Viacount Flex reagent and standard protocol was used for cell enumeration and 
Gauva Nexin and standard protocol was followed for apoptosis studies. All 
other analysis stages, e.g. configuration, microwell plate mixing, etc. are 
automated and easy to execute on the CytoSoft system.
2.1.7 The Brookfield Viscometer
The Brookfield DV-II+ Pro is a rheometer with a speed capability of 0.01- 
200rpm. The device has a built-in temperature probe and by varying torque to 
the sample place on the spindle (via range of spindle speeds), the sample’s 
viscosity characteristics can be measured, recorded, and printed. The 
rheometer was used alongside a Watson Marlow Pump 503U and Grant Y22 
water bath to measure sample alginate at varying temperatures. Operating 
procedure was as follows:
1. Check viscometer alignment (via the sight bubble)
2. Remove and wash spindle, eliminating any trapped air
3. Turn on pump and wait for temperature to equilibrate
4. Set % torque between 10-90/100
5. Rotate bezel to lie between C840 and CP42
6. Select: Display Set Speed -> Options -> Setup -> Custom Speeds -> 
(de-select unwanted speeds using “Set Speed” to select)
7. Motor Off -> Options -> Setup -> Custom Speeds ->1.1
8. Spread sample on spindle, reattach and run device.
2.2 MATERIALS
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2.2.1 Reagents
0.9% wt/vol saline was prepared from water for injection, WFI (Sigma, Dorset, 
UK) and NaCI (Sigma, Dorset, UK) and buffered to pH 7.3-7.4 -  using NaOH 
1.0N (Sigma, Dorset, UK) diluted to 0.1 N. This was then used to prepare 0.50, 
0.75 and 1.00% alginate solution from Manugel DB (ISP Alginates, Strathclyde, 
UK) on a roller mixer (Stuart Scientific, Surrey, UK). The mixture was covered 
using aluminium (light free) and kept at room temperature. For all alginate 
experiments, solutions were used same day as preparation. Alginate was 
sterilised by autoclaving at 121°C for 20 minutes.
0.9% wt/vol saline was used to prepare 0.09M CaCI2 (Sigma, Dorset, 
UK), and 0.05M BaCI2 (Sigma, Dorset, UK). Saline and WFI were used as 
infusion agents in certain experiments to look at infusing without cross-linking 
effects.
54% glycerol (VWR, Poole, UK) was diluted using WFI, coloured with 
food colouring and used as the matrix fluid to verify the Theory for a 
homogeneous case of Newtonian fluids. It was also used as the propelling fluid 
without colouring.
For visualisation enhancement purposes in all tube forming experiments 
except those testing cellular viability, small quantities of glycerol based food 
colouring (Supercook Leeds, UK) were added to the alginate solution containing 
cells, and 3-10pm glass beads (Polysciences Inc., PA 18976 USA) were added 
to model cells and provide light scatter in pure alginate solutions.
2.2.2 Infused Fluids
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Alginate concentrations ranged from 0.5 -  1.0% w/v, but defaults were fixed at
1.0% with temperature controlled at 10°C by controlling lab temperature, 
although temperature effect was explored using lab temperature of ~20°C. 
Temperature and pH are said to be important factors affecting viability (Gao et 
al. 2005), but pH is carefully monitored when making up N-Saline and lab 
temperature held constant by thermostat.
Viscosities were measured using a viscometer (Brookfield Engineering 
Laboratories Inc., MA) and a water bath (Grant, Cambridge, UK) to vary water 
temperature. Alginate has a viscosity of 6.71g/cm.s and a density of 1.01g/cm3. 
WFI has a viscosity of 0.0131g/cm.s and a density of 1.00g/cm3. CaCI2 and 
BaCI2 have similar viscosities of 0.0140g/cm.s and densities of 1.04g/cm3. 
Saline has a viscosity of 0.0131g/cm.s and a density 1.03g/cm3. 55% glycerol 
has a viscosity of 8.19g/cm.s and a density of 1.01g/cm3.
2.2.3 Cell Culture
A7r5 aortic rat smooth muscle cells (ATCC CRL-1444) between passage 10 and 
21 were used. The cells were expanded, as described in (Mason et al. 2004), 
from a cell bank in T-150 tissue culture flasks (Fisher, Loughborough, UK), using 
Dulbecco’s Modified Eagle’s Medium (Cambrex, Berkshire, UK) supplemented 
with L-glutamine (Cambrex, Berkshire, UK), penicillin/streptomycin (Cambrex, 
Berkshire, UK) and fetal bovine serum 10% (Cambrex, Berkshire, UK) at 37°C 
temperature under a C02 10% environment for 96hrs. All pipette tips used were 
disposable (Fisher, Loughborough, UK) Trypan Blue stain (Cambrex, Berkshire, 
UK) was used for cell enumeration.
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Centrifuge work was carried out using 15 and 50ml centrifuge tubes 
(Fisher, Loughborough, UK) and a tabletop centrifuge (Eppendorf AG, Hamburg, 
Germany).
2.3 METHODS
2.3.1 CHAPTER 3
2.3.1.1 Robustness Testing: Temperature was controlled at 15°C. A wall 
gap thickness of 300(im was configured, using a 3.4mm diameter regulator and 
a 4.0mm (inner diameter) glass capillary. Mark 1 base unit and 0.09M CaCI2 
was used throughout.
Variables tested were: alginate concentration and CaCI2 infusion rate. As 
a guideline, alginate concentration was kept between 0.5-1.0% in order to stay 
within physiological sodium and calcium salt levels, i.e. those found within a 
mammalian host, and CaCI2 infusion rates of 20-50ml/min were those that gave 
a good compromise between efficient speed and controllability. Temperature 
controlled conditions (15°C) were upheld, to avoid alginate breakdown and 
uncertainties in tube geometry due to viscosity changes.
The setup procedure shown in figure 2.4 was used for the experiment. 
The standard-line experiment used midrange variable conditions of 0.5% 
alginate solution concentration, and 30ml/min infusion rate. Different alginate 
volumes ranging from 300-700pl were assessed at 10Opil increments and the 
length of tube measured using a steel rule. In order to test the effect of alginate 
concentration on tube length, three alginate solutions of different concentration 
were prepared: 0.5, 0.75 & 1.0% were used for the experiment. A total of 11 
tubes were made, 5 at 0.5%, 3 at 0.75% and 3 at 1.0% alginate. Infusion rates 
of 20, 30, 40 and 50ml/min were also tested. Different volumes of alginate
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solution were used in 10O^ tl increments and the length of the tube formed was 
recorded using a steel rule, accurate to ± 0.05mm. The predicted residual 
volume of alginate, i.e. the dead space within the reactor, was measured from 
the weight of water injected up to the top of the injector nozzle of the base unit. 
Results obtained were plotted as length of tube formed vs. volume of sample 
used (pL).
2.3.1.2 Development of New Protocol: A protocol was developed for 
device assembly prior to tube formation:
Standard conditions:
0.9% wt/vol saline, pH 7.3-7.4 
0.09M CaCI2 (propelling fluid)
0.50-1.00% ISP Manugel DB (matrix fluid, unless otherwise stated)
1. Lubricate 100ml syringe using silicon gel and load using propelling fluid.
2. Fit loaded syringe into syringe driver.
3. Fit dual port base unit onto 100ml syringe.
4. Prime device using propelling fluid to the top of the injector nozzle of the 
plastic base unit at 1ml/min.
5. Prime 1ml luer-lock syringe (Fisher, Loughborough, UK) with desired 
volume (300-1000pl) of matrix fluid.
6. Fit 1 ml syringe to side port of dual port base unit.
7. Remove excess propelling fluid from injector nozzle.
8. Position spherical regulator on top of injector nozzle.
9. Fit glass barrel onto stub of dual port base unit.
10. Inject entire volume of matrix fluid.
11. Infuse propelling fluid from syringe driver at 20ml/min*.
12. Leave tube to set for 10 min before removal.
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Further:
1. Any run with air bubbles present, either during setup or during run, should 
be discarded.
2. Triplicates to be performed for each matrix fluid volume (after 3.2.3).
* N.B. Infusion speed was reduced to 20ml/min to increase control on tube 
formation.
A device wall-gap configuration of 300pm was used, with 0.09M CaCI2 as 
the propelled agent, infused at 20ml/min. Mark 1 base unit used throughout. 3 
alginate concentrations were tested: 0.5, 0.75 and 1.0% on volumes ranging 
from 300-900pL. A total of 21 tubes were made in total, 7 per alginate 
concentration at 10Opil increments. These were measured immediately after 
tube formation and the data was then plotted.
2.3.1.3 The Mark 2 Design: A matrix fluid of alginate was loaded via a 
disposable syringe. CaCI2 was then used as the propelling fluid, and injected 
through the plastic base via the central metal port. Temperature was kept at 
10°C by controlling lab temperature to minimise fluctuations in alginate 
properties. A device wall-gap configuration of 300pm and Mark 2 base unit 
used throughout. Volumes of ISP Manugel DB alginate at 0.5, 0.75 and 1.0%, 
ranging from 200-800pL was infused in 100pL increments with cross-linking 
medium, CaCI2 at 0.09M infused at 20ml/min, and the length of the resulting 
alginate-calcium tube was measured from the plastic base using a precision 
steel rule. 19 tubes in total were made, 4 at 0.5%, 8 at 0.75% and 7 at 1.0%.
The predicted residual volume of alginate, i.e. the dead space within the 
reactor, was measured from the weight of water injected up to the top of the 
injector nozzle of the base unit.
2.3.1.4 Wall Thickness Reproducibility: Temperature was controlled at 
10°C. Default settings of 1.0% alginate concentration and 300pm wall gap
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device configuration were used. Mark 2 base unit used throughout. 0.09M 
CaCl2 was infused at 20ml/min. Lab temperature was at a controlled 10°C. 21 
tubes were prepared in total, with 3 replicates of each data point to examine 
consistency of the device. Volumes were ranged from 200-800pL varied in 
100pL increments. Measurements were made with a precision steel rule 
immediately after tube formation.
2.3.1.5 Investigation of Wall Gap Configuration: Lab temperature was 
controlled at 10°C. Alginate concentration was kept constant at 1.0%. Mark 2 
base unit used throughout. 0.09M CaC^ was infused at 20ml/min to maintain 
reasonable control. Effect of sphere reduction was explored reducing the 
sphere radii from 1.700mm to 1.587mm, keeping capillary radius at 2.000mm. 
In essence, 300pm wall gap configuration was compared with a 413pm wall gap 
configuration. Volumes were ranged from 200-1 OOOpL varied in 100pL 
increments. 23 tubes were prepared in total, with several repeats of each data 
point to examine consistency of the device.
After this capillary radius effects were measured by decreasing radii of 
the capillary from 2.000mm to 1.825mm whilst keeping sphere radius at 
1.587mm. I.e. a 413pm wall gap configuration was compared with a 238pm wall 
gap configuration. Volumes were ranged from 200-700pL varied in 100pL 
increments. Tubes were immediately measured after formation with a precision 
steel rule.
2.3.1.6 Effect of Altering Propelling Fluids: The experiment was 
temperature controlled at 10°C. Propelled liquid was infused at 20ml/min 
throughout conditions. Mark 2 base unit used throughout. A default wall gap 
configuration of 300pm for all experiments was used. Matrix fluid was 1.0% 
alginate in all cases. Propelling fluids tested included: 0.05M BaCL (4 tubes 
made); 1.0% alginate (8 tubes made); WFI (7 tubes made); and 0.9% wt/vol 
saline (9 tubes made). And the trend for 1.0% alginate matrix with 0.09M CaCI2
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propelled fluid was included for comparison (section 3.2.4). All tubes were 
measured immediately after formation using a precision metal rule.
In a separate experiment, 54% glycerol was infused with 54% glycerol, 
and WFI infused with WFI for Theory verification purposes (data not shown). 
Both involved standard conditions: mark 2 base unit; 238, 300 and 413pm gap 
widths (4 tubes, 4 tubes, 4 tubes for glycerol; 5 tubes, 6 tubes, 7 tubes for WFI, 
respectively); infusion rate 20ml/min; and propelling fluids were coloured to aid 
visualisation. Volumes 200 to 800pm (100pm intervals) were tested for all 
configurations and both sets reacting and non-reacting fluids.
2.3.1.7 Alginate Viscosity Data: Alginate was made up using Manugel 
DMB and N-saline, and this was placed on the spindle of the viscometer 
(Brookfield, Massachusetts, USA). This was set up to run water from a water 
bath through the spindle to simulate conditions at different temperatures. 
Viscosities were tested for: 1.00% alginate for temperatures of: 15, 20, 25, 30 
and 35°C.
2.3.2 CHAPTER 4
2.3.2.1 Primary Tube Scans: 8 tubes (4 at 0.50% alginate, 2 at 0.75% 
alginate, 2 at 1.0% alginate) were prepared a day in advance using the mark 1 
device. All tubes made were 15cm in length, 4mm in diameter and 300pm wall 
gap configuration. Conditions tested were: 0.5, 0.75 and 1.0% alginate with 
0.0005g/ml glass beads and 0.5% alginate with 0.005g/ml glass beads, meant to 
represent cells and also induce light scattering, so as to aid visualisation of 
OCT. Pure alginate control tubes contained glass beads at 0.14% volume 
fraction. All tubes were formed using 0.09M CaCl2 at 20ml/min infusion rate. All 
tubes contained blue dye for visualisation purposes and to ensure tubes formed
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were not failed tubes. Tubes were refrigerated and scanned next day using a 
motorised platform and real-time measurements were made using an 820nm 
wavelength near infrared light-source and a resolution of 10pm. 20 (300 for 
cross-sectional scans) A-scans at 27,680 points, averaged every 20 points were 
made. 6 points were scanned per tube (fig. 2.11) and one cross-sectional point. 
Images were then produced using Matlab (Mathworks, MA, USA) to analyse 
collected OCT data, which takes into account the refraction index of the 
borosilicate glass (Mason et al. 2004).
2.3.2.2 Mark 2 Tube Scans: 3 tubes prepared a day in advance 20cm in 
length, 4mm in diameter and using 238pm, 300pm and 413pm gap width. Mark 
2 base unit used throughout. Conditions used throughout were: 1.0% alginate 
with 0.0005g/ml glass beads; and 0.09M CaC^ concentration; 20ml/min infusion 
rate; and 20pl/ml alginate of blue food colouring. Tubes were refrigerated and 
scanned next day together with the glass barrels. Tubes were horizontally 
mounted on a motorised platform and real-time measurements were made using 
a 820nm wavelength near infrared light-source and a resolution of 10pm. 20 A- 
scans at 30,000 points, averaged every 20 points were made. 5 points were 
scanned per tube (figure 2.12). Images were then produced using Matlab to 
analyse collected OCT data, which takes into account the refraction index of the 
borosilicate glass.
2.3.2.3 Shrinkage Effects: A tube containing glass beads at 0.0005g/ml 
approximately 4cm in diameter and 16cm in length was formed using in the 
device using a 300pm configuration, 0.09M CaCfe concentration at room 
temperature (~18°C). Mark 2 base unit used throughout. For control purposes, 
a pure alginate tube (at 1.0% alginate concentration) was also formed. Upon 
formation these tubes were sequentially OCT analysed at a fixed point using an 
820nm wavelength near infrared light-source and a resolution of 10pm. 1600
Figure 2.11
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f
A B C
Ocm 2 ,5 c m  5 .0 c m
T
D
T
F
G 2
G 1 /D
Experimental scanning setup and nomenclature used for Mark 1 primary OCT 
experiment. Point A is 180° from D on the opposite face of the glass capillary 
and so on. Points A, B and C are 2.5cm apart, point B lying in the centre of the 
glass capillary. Scan G was a half cross-section taken from a random point in 
the tube. The table was constructed using G1, 2 and 3 terminologies, taken 
from set points from the cross-section. G3 corresponds to point A, and G1 to 
point D.
12
Figure 2.12 Experimental scanning setup and nomenclature used for Mark 2 OCT tube 
scans. Points A, C and E are 180° from B and D on the opposite face of the 
glass capillary. Points A to E are 4cm apart, point C lying in the centre of the 
glass capillary.
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point-scans, averaged every 20 points were made, to give 80 points, one per 30 
seconds. This data was then used to produce graphs with corresponding 
images using Matlab to analyse collected OCT data, which takes into account 
the refraction index of the borosilicate glass.
2.3.2.4 High Speed Camera Monitoring: The camera used was an NAC
V-142 digital high-speed colour video camera with a multitude of lenses allowing 
high magnification. This camera was connected to a NAC HSV-500 compact 
cassette recorder which allowed transfer of data to PC, a VHS to convert all data 
to video cassette and a colour monitor to observe everything as it occurs. Using 
this setup it was possible to study tube formation at 500 frames/sec and x40 
magnification to obtain video clips over a large section of tube.
5 x T150 rat SMCs were harvested, pooled then concentrated using a 
centrifuge and resuspended to 4X107 cells/ml using 1% N-Saline. 20ml of 1% 
and 1.33% alginate was also prepared with 0.09M CaCI2. Cells were embedded 
1:3 ratio cells to alginate to make up 1X107 cells/ml and 1% alginate 
concentration overall. Default settings (unless otherwise stated) included: 
20ml/min infusion rate, 300pm device configuration, 0.09M CaCI2 as infusion 
medium, and 1.0% alginate concentration. Mark 2 base unit used throughout. 
In order to improve visualisation, potassium permanganate dye was added to 
the infusion medium. All tubes were formed at 15°C constant room temperature. 
In order to eradicate glass distortion effects, a sealed Perspex box was filled 
with optical fluid (Cargill, Minneapolis, US) at the same refractive index as the 
borosilicate glass (1.473), and this housed the glass barrel that was used to 
make to the alginate tube. The following camera settings were used: 500 
frames/second; F (full) screen size, 0.2g/ml permanganate dye in CaCI2; and 
uncoloured alginate.
The following variables and their subsequent impact on tube formation 
were studied: the effect of infusion rate; the effect of gap-width configuration; the 
effect of setting and non-setting infusion medium; the effect of alginate
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concentration; the effect of cell presence in alginate; and “lift-off” effects -  i.e. 
tube formation at the device metal collar. This was achieved using the following 
variables: infusion rate 50 ml/min; gap-width configuration of 300 and 413pm; 
infusion medium of 0.09M CaCI2 (setting) and WFI (non-setting); alginate 
concentration of 0.05 and 0.09M; cell concentration of 0 and 1X107 cells/ml. 
Regulator rotation and “lift-off” effects were also explored. The conditions are 
summarised in table 2.3.
The tube was filmed at 2.5cm from the base unit/regulator interface to 
analyse “lift off” and at 10cm up from the plastic base unit to obtain a 
representation of the tube formation process at ‘lull flow”. For ball spin 
experiments, a spot was put onto a plastic regulator using permanent marker 
pen and all fluids were left uncoloured, so that the effect of ball spin could be 
clearly analysed. This data was then processed using the Leica QUIPS 
software, breaking down the dye colour data into red, green and blue profiles.
2.3.2.5 Particle Size Detection and Particle Enumeration: 5 x T-150 
flasks of rat SMCs were expanded and harvested using standard procedures 
(Appendix A, protocol 2) at 20°C. The quenched cell suspensions were 
collected into one T-150 using a 25ml pipette tip to limit shear to cells. This 
suspension was not passed up and down the pipette in the ordinary manner to 
break up aggregates. A cell count was performed at this stage. The suspension 
was transferred into 50ml centrifuge tubes and centrifuged at 250xg for 5 min. 
The supernatant was decanted and the pellet resuspended via addition of 0.5ml 
per tube complete culture medium and vortexing to dispel clumps. 2ml was 
used to wash out residual cells per tube. Serial dilutions were then made to 
create the following final concentrations: 1X105, 5X105, 1X106, 1.5X106, and 
2X106 cell/ml. Replicates were then counted using a haemocytometer and 
Trypan Blue (fig. 2.13), and the samples were also analysed using the Leica 
QWin (Leica Microsystems AG, Wetzlar, Germany) and a particle sizer (Malvern 
Instruments Ltd, Worcester, UK). Samples analysed in the particle sizer were 
loaded into 15ml of complete culture medium.
Table 2.3
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Combinations of variables used to study effects upon tube formation 
using high-speed, high-resolution camera.
Infusion Rate (ml/min) WFI CaCI2 0.5% Alginate
20 X X X
50 X X X
Lift-off X X X
Infusion Rate (ml/min) 413pm
20 X
50 X
Lift-off X
Wall Gap Config. WFI CaCI2 0.5% Alginate
413pm X X X
Hemocvtometer
0.1 cm
0.1 cm
Liquid Vol. = 1.0mm2x 0.1mm = 0.1mm3
Figure 2.13 Grid setup of the haemocytometer.
87
Samples analysed by the Leica QWin were placed on a glass slide, with a 
cover slip placed over the top, and 8 x 500pm squares were snapped at 10x 
magnification (same as light microscope used for haemocytometer). The Leica 
QWin generates data by counting particles of different preset size ranges. 
Calibrating the number of cells with those counted using the haemocytometer an 
area size of 80-279 pm2 per cell was estimated assuming perfectly round cells. 
This was then used to estimate the amount of cells per particle. The y-axis was 
also converted into % of the total number of particles counted. This information 
was then used to create comparative profiles (fig. 4.10) to the particle sizer data.
2.3.2.6 Enumeration Using the Capillary Cytometer: Two cell- 
integrated tubes were made. Both tubes were made using Kenix 12-element 
static mixers, 300pm wall-gap configuration, 1.0% overall alginate concentration, 
0.09M CaCb concentration, 1X107 cells/ml, 20ml/min CaCI2 infusion rate, and 
1.87ml/min sample injection rate into the device. Mark 2 base unit used 
throughout. Each tube was cross-sectioned into 6 equal pieces, and each piece 
was weighed then re-dissolved in 1.0% sodium tricitrate (Sigma, Dorset, UK) 
made up in 1ml PBS (Sigma, Dorset, UK). The resultant mixture was placed on 
a roller mixer (Stuart Scientific, Surrey, UK) for 30 min. Then cell enumeration 
was performed for each section using Trypan Blue and Guava ViaCount Flex 
Reagent (Guava Technologies, Haywood CA, USA), a nuclear, fluorescent 
viability stain for cell enumeration. 200pl of cell sample was mixed with 4pl of 
reagent (1:50 dilution) in a well of a 90 micro-well plate (Fisher, Loughborough, 
UK) by pipetting up and down 3 times. Cells were incubated in foil-wrapped 
conditions for 5 min at room temperature. A number balance was then 
calculated for each tube, i.e. the number of cells per section of tube, assuming 
that the cells are evenly distributed throughout.
Similarly samples were prepared for apoptosis analysis adding 50pl 1X 
Nexin Reagent (Guava Technologies, Haywood CA, USA) to 150pl of cell 
sample and incubating for 20 min.
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2.3.2.7 Effect of Pipetting to Breakup Cell Aggregates: 3 x T-150 flasks 
of rat SMCs were expanded and harvested using standard protocol. The 
suspensions were pooled together using a 25ml pipette to limit the shear on 
aggregates that maybe present and a cell count was performed. This pooled 
suspension was then split into 50ml centrifuge tubes and centrifuged at 100xg 
for 10 min. The supernatant was then decanted, and the pellets resuspended 
via addition of 0.5ml per tube complete culture medium and vortexing to dispel 
clumps. 2ml was used to wash out residual cells per tube. The timer was 
started at this stage. Concentrated aliquots were made and added one by one 
to the particle sizer to give a final cell concentration of 1X106 cells/ml in 10ml of 
complete culture medium. 10Optl micropipettes (yellow tips) were used for 
passes and the following passes were used to create shear on the samples: 0, 
5, and 20. The time at analysis of each sample was also noted. Calibration 
profile used 0.001 g of 3-10pm glass beads in 10ml of WFI. The particle sizer 
requires a minimum number of 100 counts for accuracy -  for the purpose, a 
concentration of 1X105 cells/ml was used throughout experiments.
2.3.2.8 Effect of Holding Time and Gauze Filtration on Cell 
Aggregation: 4 x T-150 flasks of rat SMCs were expanded and harvested using 
standard protocol. The suspensions were pooled together using a 25ml pipette 
to limit the shear on aggregates that maybe present and a cell count was 
performed. This pooled suspension was then split into 50ml centrifuge tubes 
and centrifuged at 100xg for 10 min. The supernatant was then decanted, and 
the pellets resuspended via addition of 0.5ml per tube complete culture medium 
and vortexing to dispel clumps. 2ml was used to wash out residual cells per 
tube. Complete culture medium was then added to make up a cell concentration 
of 1X106cells/ml. The timer was then started and a 1ml syringe used to place 
400pl of sample into the particle sizer with 10ml complete culture medium. 
Using a 1ml pipette with a modified adapter to house an autoclaved membrane 
of 20pm pore size gauze, a 400pl sample of filtered cells were then placed into
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the particle sizer 10 min after the non-filtered sample was analysed, this allowed 
for analysis and cleaning of the particle-sizer sampling unit. This second set of 
repeat experiments was performed in parallel intended as a control experiment -  
the gauze filter would be used just prior to analysing the sample for aggregates. 
This process was repeated every hour for 3 hours.
2.3.2.9 Effect of Centrifugation and Passage Number on Cell 
Aggregation: 3 x T-150 flasks of rat SMCs were expanded, and harvested. The 
suspensions were then pooled together and a cell count was performed 
manually using Trypan Blue stain. 10ml of complete culture medium was then 
placed into the particle sizer and the device zeroed. 10ml of un-centrifuged 
sample was then placed into the particle sizer and analysed. The remaining cell 
suspension was subjected to 100xg and 500xg via the centrifuge in separate 
treatments. The supernatant was then discarded, and the pellets were 
resuspended in complete culture medium to make up a concentration of 1X106 
cells/ml. 400|il of each sample was added to 10ml of complete culture medium 
in the particle sizer separately and analysed.
2.3.3.1 Effect of Biological Cell Addition On Tube Wall Thickness: The
cell-alginate was hand-mixed (i.e. cells were injected by micropipette, stirred and 
then put on the roller mixer for 30 min) using 1.0% alginate concentration and 
1X107 cells/ml. Mark 2 base unit used throughout. This mixture was infused 
into three different gap width configurations 238, 300 and 413 pm. Cell-free 
(pure alginate) control tubes corresponding to each tube-forming device 
configuration were prepared in parallel. A tube was formed per data point. A 
total of 20 tubes were formed using set volumes ranging from 200-800pL. The 
length of each tube was measured at time, t=0s (i.e. immediately after tube 
formation) and the relationship between the two plotted.
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2.3.3.2 Static Mixers and Impact on Wall Thickness: Six tubes in total 
were made. Tubes were prepared a day before OCT scanning. Three 
conditions were used to make the tubes: a control experiment of cell-free 
alginate tubes (mixed with inert glass beads for visualisation); a cell-integrated 
tube mixed using a 12-element static mixer arrangement; and a cell-integrated 
tube mixed by hand. Two tubes were made per condition. Tubes were 
prepared a day before OCT scanning, so were fully set and all shrinkage effects 
had taken place (Saitoh et al. 2000; Zhang et al. 2000). All tubes were made 
using 300|im wall-gap configuration, 1.0% overall alginate concentration, 0.09M 
CaCb concentration, 1X107 cells/ml and 20ml/min CaC^ infusion rate. All 
statically mixed tubes were injected at 1.87ml/min max infusion rate into the 
Device. OCT was then used to scan each tube at 18 points per tube (fig. 2.14) 
in order to determine tube wall thickness. The radial repeats (A, B, C) was to 
ensure at least one usable image was taken at each sampling location (1 -  6). 
Representative cross-sectional OCT images (longitudinally through the tube) of 
cell-free alginate tubes (n=2) and manually mixed cell/alginate cell-integrated 
tubes (n=2) are shown in figure 5.4, one for each sampling location.
2.3.3.3 Effect of Processing on Viability: 20ml of 2% alginate and 0.09M 
CaCl2 was prepared using N-saline. 40ml 0.1 M sodium citrate was also 
prepared in PBS. Alginate was autoclaved at 121°C for 20 minutes. 7 x T-150 
flasks were expanded, harvested and pooled together. A cell count was carried 
out. The cell suspension was then split into 50ml centrifuge tubes and 
centrifuged at 100xg for 5 min.
The supernatant was discarded and the pellet resuspended using 
complete culture medium and manually mixed with alginate via pipetting into the 
alginate and stirring with the pipette tip to give a final mixture of 1% alginate with 
1X107 cells/ml, as in Appendix A, protocol 5. Two tubes were then formed using 
the device. Mark 2 base unit used throughout. They were each left to set for 10
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Figure 2.14
Figure 2.15
11cm
7.5cm 
1 3
4cm
2pm 2pm
15cm
Schematic diagram (not to scale) showing experimental setup used for Optical 
Coherence Tomography (OCT) scanning of cell-integrated tubes. The 
longitudinal (numbers 1-6) and radial (letters A-C) locations correspond to 
images seen in figure 5.4.
7 \
Experimental scanning setup and nomenclature used for initial cell OCT tube 
scans. Points 1 and 3 are 180° from 2 on the opposite face of the glass 
capillary. Points 1 and 3 are on either end of the tube, with point 2 lying in the 
centre of the glass capillary. The cross-sectional scan was taken at a random 
point along the tube.
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min, before being dissolved in 0.1 M sodium citrate to give 1X105 cells/ml 
concentration. Cell counts were performed again at this stage. This was 
replicated for the second tube.
2.3.3.4 Effect of Processing on Viability Repeat: 20ml of 2% alginate 
and 0.09M CaCfe was prepared using N-saline. Alginate was autoclaved at 
121°C for 20 minutes. 40ml 0.1 M sodium citrate was also prepared in PBS. 7 x 
T-150 flasks were expanded, harvested and pooled together. A cell count was 
performed. The cell suspension was then split into 50ml centrifuge tubes and 
centrifuged at 100xg for 5 min. The supernatant was discarded and the pellet 
resuspended in 10ml volume to obtain a suspension of 4x107cells/ml. This was 
then mixed with alginate to give a final mixture of 1% alginate with 1X107 
cells/ml, as in protocol 5. This mixture was rolled on a roller-mixer for 30 min for 
alginate to be mixed thoroughly with cells after pipetting of cell suspension into 
the alginate and initial stirring. A 0.4ml sample was drawn, diluted in citrate to 
give 1X105 cells/ml concentration and a control cell count was taken. Two tubes 
were then formed using the device. Mark 2 base unit used throughout. They 
were each left to set for 20 min within the tube-forming device, before being 
dissolved in 0.1 M sodium citrate to give 1X105 cells/ml concentration. Triplicate 
cell counts were performed again at this stage. This was replicated for the 
second tube.
2.3.3.5 Effect of Concentration Steps on Viability: Rat SMCs were 
expanded in 27 x T150 flasks and harvested. The suspensions were pooled 
together. A triplicate cell count was then taken using Trypan Blue and a 
haemocytometer. The suspension was then centrifuged at 100xg for 5 min. 
This was then resuspended to: 1X107, 5X106, 2.5X106, 1X106 and 1X105 
cells/ml in 4ml. Each suspension was then passed through the centrifugation 
process and resuspended back to the original concentration using fresh medium 
5 times. A triplicate cell count for each concentration was performed after each 
pass.
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2.3.3.6 Effect of Media on Cell Viability: For this experiment 5 x T150 
flasks were cultured and harvested. The suspensions from all flasks were 
pooled together. An initial cell count was then taken using Trypan Blue and a 
haemocytometer. The pooled cell suspension was then spun down using 
centrifugation at 100xg at 5 min, and resuspended to 1X105 cells/ml in the 
following media: food colouring at 100pl/ml, N-Saline, complete culture media, 
1.0M sodium citrate, and 0.09M CaCl2 . A 10Opil sample was drawn from each 
condition every 10 min for 1 hour and triplicate cell counts were measured using 
Trypan Blue, light microscopy and a haemocytometer.
2.3.3.7 Effect of Liquid Alginate on Cell Viability: For this experiment 3 
flasks of T-150 A5r7 rat SMCs were cultured, harvested and pooled together. 
An initial cell count was measured. The suspensions were then centrifuged 
twice at 100xg for 5min and resuspended in complete culture media. The final 
concentration was 4X107 cells/ml. The suspension was then mixed 1:3 with 
several different media. Conditions tested included: 0.5% final alginate 
concentration, 1.0% final alginate concentration, and N-Saline control. This was 
kept for 3 hours and samples taken every 1/2  hour for triplicate cell counting. All 
alginate was autoclaved at 121°C for 20 minutes.
2.3.3.8 Effect of Infusion Speeds on Cell Viability: 27 x T150 flasks of 
A5r7 rat SMCs were cultured and harvested. All suspensions were pooled and 
an initial cell-count done. The suspension was then aliquoted into 50ml 
centrifuge tubes and centrifuged at 100xg for 5 min. This was then resuspended 
to 8ml with complete culture medium and centrifuged again. This was finally 
resuspended to 4X107 cells/ml in medium and mixed 1:3 cells:1.33% alginate to 
give final concentrations of 1X107 cells/ml and 1.0% alginate concentration. 
Alginate was autoclaved at 121°C for 20 minutes. This mixture was then used 
to form tubes using 300pm wall-gap configuration and 0.09M CaCI2. In parallel 
(timed experiment), 1ml of the mixture was used to form beads as a control.
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Beads were created manually by dripping cell-alginate mixture into a bath of 
0.09M CaCl2 using a 1ml disposable syringe. Mark 2 base unit used throughout. 
Infusion speeds of: 20, 40, 60, 80, 100ml/min were tested. After 10 min, the 
tubes and beads were simultaneously dissolved in 1.0M trisodium citrate. 
Triplicate cell counts were carried out.
2.3.3.9 Pronova SLG 100 and Static Mixer Impacts on Cell Viability:
This experiment was done in two stages: through the static mixing device and 
through the tube-forming device. Viability experiments through the static-mixer 
involved passing cells through the device with no alginate present. Viability of 
cells through the tube-forming device involved forming cell-alginate tubes, 
instantly dissolving them in 1.0% sodium tricitrate, and performing triplicate cell 
enumeration using Trypan Blue. Alginate source was switched to SLG 100 
(Pronova, Lysaker, Norway). Simultaneously cell/alginate beads were produced 
and dissolved in 1.0% sodium tricitrate, and cell enumeration performed in 
parallel as a control. Cell/alginate beads were prepared by dripping a pre­
prepared cell/alginate mixture into a bath of 0.09M CaCI2 via a 1ml syringe with 
a sterile needle tip. All tubes were made using 300pm wall-gap configuration. 
Beads were created manually by dripping cell-alginate mixture into a bath of 
0.09M CaCI2 using a 1ml disposable syringe. Mark 2 base unit was used 
throughout. Both tubes and beads were made at 1.0% overall alginate 
concentration, 0.09M CaCI2 concentration, and 1X107 cells/ml.
2.3.3.10 Cellular Apoptosis Analysis: Guava Nexin kit was used to study 
cell apoptosis. Two cell-integrated tubes were made using two cell-integration 
methods -  hand-mixing and static mixing (12-element). Each tube was cross­
sectioned into 6 equal sections, and each piece was weighed then re-dissolved 
in 1.0% sodium tricitrate. The analysis was carried out on central and end 
sections of each tube. Samples from each section were potted into wells of a 
96-well plate, incubated for 20min at 20°C with Guava Nexin kit and then
95
analysed on the capillary cytometer. All tubes were made using 300pm wall-gap 
configuration, 1.0% overall alginate concentration, 0.09M CaCI2 concentration, 
1X107 cells/ml, 20ml/min CaCI2 infusion rate, and 1.87ml/min sample injection 
rate into the device. Mark 2 base unit used throughout. Alginate was 
autoclaved at 121°C for 20 minutes.
2.3.3.11 Initial Cell-Integrated Tube OCT Scans: 2 x T-150 flasks of rat 
SMCs were grown and harvested. The pooled mixture was then sampled for a 
cell count using Trypan Blue and the cell suspension was added to alginate via 
hand mixing to alginate using protocol 5. 1X107 cells/ml final concentration was 
used and 1% final alginate concentration in a 1:3 part ratio, respectively. A tube 
approximately 4cm in diameter and 16cm in length was then formed using this 
mixture in the device using a 300pm configuration, 0.09M CaCI2 concentration 
and 10°C temperature. Mark 2 base unit used throughout. This was allowed 10 
min to set before the tube was bunged at either end and wrapped in foil. This 
was OCT analysed at Cranfield University the following morning using a 820nm 
wavelength near infrared light-source and a resolution of 10pm via the set-up in 
figure 2.15. 200 A-scans at 27,700 points, averaged every 20 points were 
made. 4 points were scanned in total including 1 cross-sectional scan (at 500 A- 
scans). Images were then produced using Matlab to analyse collected OCT 
data, which takes into account the refraction index of the borosilicate glass.
2.3.3.12 Effect of Static Mixers on Cellular Distribution: Cell-integrated 
tubes were prepared using an 8-element and 12-element static-mixers and the 
hand-mixed method. Alginate prepared was autoclaved at 121°C for 20 
minutes. These were then each cross-sectioned into six equal pieces. Each 
piece was then weighed and re-dissolved in 1.0% trisodium citrate before cell 
counting using Trypan Blue stain and results obtained were standardised per 
section weight. A total of nine tubes were made. All tubes were made using 
mark 2 base unit, 300pm wall-gap configuration, 1.0% overall alginate
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concentration, 0.09M CaC^ concentration, 1X107 cells/ml, 20ml/min CaCl2 
infusion rate, and 1.87ml/min sample injection rate into the tube-forming device. 
By comparing cell counts per section of tube for cell-integration by hand-mixing, 
8-element static mixer and 12-element static mixer, we were able to obtain 
cellular distribution data.
2.3.3.13 Visual Verification of Cell Distribution Using Light 
Microscopy: Rat SMCs were grown, harvested and pooled. A cell count was 
performed. This mixture was then centrifuged at 100xg for 5 min and 
resuspended in 8ml complete culture medium. This process was repeated once 
and resuspended to 1X104 cells/ml concentration. The suspension was then 
integrated into 1:3 into 1.33% alginate via hand mixing and via 12-element static 
mixer to give a resultant mixture of 1.0% alginate concentration at 1X107 
cells/ml. All alginate was autoclaved at 121°C for 20 minutes prior to cell 
integration. These mixtures were then used to form a tube using the tube- 
forming device. A control tube of alginate, containing glass beads was also 
made. Conditions maintained throughout include: a 300pm wall-gap 
configuration, 0.09M CaCk, 20ml/min infusion rate and 20°C. Mark 2 base unit 
used throughout. A control tube of 1.0% alginate, containing 1x1 O'3 g/ml glass 
beads was also made. The tubes were then each sectioned into 6 equal pieces 
using a scalpel and each piece was then viewed under a light microscope at x20 
magnification in the presence of a graticule. Digital photographs were then 
taken.
2.3.3.14 Visual Verification of Cell Distribution Using CLSM: Two tubes 
were made in total. Cell/alginate tubes approximately 20cm in length, 4mm in 
diameter and of 300pm in wall thickness were prepared on the same day of 
confocal analysis. Mark 2 base unit used throughout. Alginate was prepared 
and autoclaved at 121°C for 20 minutes. Cell-integrated tubes made via hand- 
mixing and 12-element static mixing were created. These were then
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fluorescently stained to allow visualisation using CLSM. Fluorescent staining of 
nuclei was achieved using Guava ViaCount Flex Reagent (Guava Technologies, 
Haywood CA, USA). Tubes were washed before and after staining using buffer 
and thoroughly dried. The tubes were then directly analysed using liquid 
immersion techniques, a 558-656-emission band prism, and x40 magnification. 
Each tube was scanned at 3 fixed points along the tube length -  top and bottom 
walls of the tube were simultaneously scanned. Both tubes were made using 
300pm wall-gap configuration, 1.0% overall alginate concentration, 0.09M CaCb 
concentration, 1X107 cells/ml, 20ml/min CaC^ infusion rate, and 1.87ml/min 
sample injection rate into the Device. CLSM was then used to scan each tube 
at 3 points, through both walls of a collapsed tube to obtain cellular distribution 
verification data. Raw data was analysed using LCS Lite (Leica Microsystems 
AG, Wetzlar, Germany) to produce snapshots and profiles. The area under 
these profiles were then analysed using curve analysis software (Cyber 
Solutions, Dundee, Scotland).
3 Tube Formation
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This chapter follows the progression of design of the tube-forming device, its 
protocols and reliability testing of the device. At the beginning of this thesis 
the tube-forming device was an untested prototype, perhaps capable of 
forming tubes, but not of high precision and not very robust, i.e. tubes could 
be formed but had inconsistent length with the same volumes. No standard 
protocol existed and there was much room for design improvements.
The aims of this chapter were therefore: to establish the tube-making 
ability of the device, which variables should be measured, how much 
variation existed and what is an acceptable error; what are the optimum 
settings for tube formation in order to limit variations in tube consistency and 
what is the protocol to do so; what improvements could be made to reduce 
these variations, and what is the new variance; and what other variables 
could influence tube formation and how do they influence tube geometry.
3.1 INTERPRETATION OF THE FLUID DYNAMICS THEORY
Although the Theory for this thesis was developed during work from this 
chapter, it is more logical to explain it at an early stage, in order to better 
grasp how tubes are formed and how the findings of the results relate to the 
fluid dynamics.
It is necessary firstly to point out that the Theory was developed 
entirely by the Department of Mechanical Engineering, UCL and no claim to 
its development is made by this thesis. The raw equations and non-standard 
derivations can be found in Appendix B. The Theory was, however, verified 
experimentally by results taken from this thesis, which also adds several 
interesting discussion points due to the cross-linking nature of the alginate- 
calcium system.
In this sub-section the Theory will be explained in “laymen’s terms” 
and although the explanation will not follow Appendix B equation by equation,
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the key equations underpinning the fluid dynamics will be described, as well 
as some key figures.
The starting point is figure 2.4. After assembly of the tube-formation 
device, a finite volume of liquid alginate is injected as the matrix fluid into the 
system via the side injection port of the dual port base unit. The propelling 
fluid -  CaCI2 is then infused, pushing the spherical regulator upwards through 
the matrix fluid. The first key concept is that the matrix fluid flows upwards 
throughout tube formation -  i.e. it is dragged upwards with the rising 
spherical regulator. Therefore the gap width (distance between the regulator 
and the glass barrel walls) is not the thickness of the alginate layer deposited 
-  in fact the nominal wall thickness of the alginate tube is considerably 
thinner than the gap width, the question is how thin?
The Lubrication Theory mentioned in Appendix B can be explained 
with the help of figure 3.1. Basic fluid dynamics states that any moving fluid 
has a velocity profile. The parabolic profile on the bottom of figure 3.1 
resembles a standard velocity profile for a Newtonian fluid, flowing in a 
laminar regime within a cylindrical pipe i.e. fluid at different points flows at 
different velocities much like sheets. The fluid moves with velocity zero at 
the wall of the glass barrel; and velocity v at point P (any point around the 
wall of the spherical regulator). Next we concentrate on the Navier Stokes 
Equation. The equation basically states that: the forces acting on a fluid = 
pressure gradient + resistance due to viscous forces, or:
We assume steady state conditions -  therefore no acceleration occurs 
eliminating the left-hand part of equation (A). This gives us equation (1) from 
Appendix B:
pDu/Dt = -Vp + |iV2u (A)
(1)
(a)
Figure 2.4
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HI
Propelling
Fluid
Schematic to illustrate setup procedure of the tube-forming device.
(a) Device assembly.
(b) The matrix fluid is loaded using the side port.
(c) The propelling fluid is injected from the base port.
(d) The tube length calculated as the length when the regulator sphere
penetrates the meniscus of the alginate.
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v x
Velocity profile of the 
vertical component of flow 
across the cylinder
Figure 3.1 Schematic to show the arrangement of the spherical regulator in a cylinder 
propelled upwards by a flow at the inlet.
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The pressure gradient term from equation (1) can be split into vertical and 
radial pressure gradients exerted on the spherical regulator during tube- 
formation. Because radial pressure gradients are negligible compared to 
vertical pressure gradients, we disregard radial pressure gradients in the 
Theory. Rearranging equation (1):
<B>jU dx
We know from this type of equation that the solution will take the format:
Ux = K(Ar2 + Br + C), (C)
By substituting the limits previously identified:
ux = V when r = (a - 5x) 
ux = 0 when r = (a)
And solving equation (C) we obtain equation (13) from Appendix B, a solution 
for the Lubrication Theory, which gives us velocities v and u during tube 
formation.
v -  u 4 ( I -  8 SQ / 3 r0 
1 “  4^0 / 3r0 j3 r0
(13)
This is however not what we want. We need an equation relating to 
tube wall thickness, in particular at the end of tube formation. If we look at 
figure 3.2, we can see that the initial height of the matrix fluid is ‘V and after 
travelling with velocity ‘G’ at time ‘t’ (at the end of tube formation) the total 
height of the matrix fluid is ‘ut + X. If the spherical regulator travels with
103
Before Tube Formation
HI
After Tube Formation
ut + A. vt
Figure 3.2 Diagram showing the distances travelled before and after tube formation by 
both the matrix fluid and the spherical regulator.
Figure 3.3 Diagram of a cylinder or hollow tube, similar to the open tubes formed using 
the tube-forming device.
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velocity V  (it will travel faster than the average speed of matrix fluid flow), 
and it also reaches the end of tube formation at time ‘t\ then the distance 
travelled is ‘vt\
Since the distance is equal for both the spherical regulator and the 
matrix fluid at the end of tube formation, then:
And if we substitute equation (13) into equation (G) we finally have an 
equation whereby we can extract geometry information from the theoretical 
prediction of tube formation -  equation (14).
This can be approximated to the right-hand side part of the equation. ‘TB’ is 
the predicted wall thickness of the tube formed. And if ‘8o’ is the gap width 
between the spherical regulator and the glass barrel wall then ‘502’ is an 
extremely small number and can be considered negligible. It therefore
vt = ut + X (D)
Rearranging we get:
vt = <v% .o , (E)
Finally by taking equations for the volume of a tube, V (fig. 3.3):
V = d x n[a2 -  (a -  TB)2] (F)
And substituting from equation (E):
V = vt = [(v% .o )M a2- ( a - T B)2] (G)
(14)
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follows that overall, the predicted wall thickness of the deposited layer is 
approximately equal to 2/3 of the gap width, i.e.:
T b = 2/3 5o (H)
as ‘a’ (glass barrel radius) approaches ‘r0’ the radius of the spherical 
regulator.
That is to say that this 2/3 rule of thumb does not always apply, but 
only for very small gap widths. Figure 3.4 was a joint effort between the 
Mechanical Engineering, UCL and Biochemical Engineering, UCL 
departments. The lines on the diagram represent limits predicted by CFD 
based on the Theory. The data points show experimental results for the 
alginate-CaCI2 system (collated data from Chapter 3 is shown in table 3.1). 
We can see in figure 3.4 how the experimental results verify the 2/3 
Approximation that the fluid dynamics Theory predicts, by falling into the pre­
defined range.
This Theory was developed not just for alginate-CaCI2 systems, but 
any two fluids (even the same matrix and propelling fluid), reacting or non­
reacting.
3.2 TUBE-FORMING DEVICE
3.2.1 Robustness Testing
Initial experiments were carried out using the mark 1 device. The aim was to 
evaluate the robustness of the device to generate tubes of reproducible 
length (for fixed volume) and hence thickness -  the governing variable -  as 
thickness directly relates to the effectiveness of nutrient exchange (Glickis et 
al. 2004) and therefore the viability of using the alginate tube as a macro­
encapsulation structure.
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Thickness (Vs volume)
Final Thickness (tracking) 
Mean Thickness (tracking) 
Alginate with CaCI2 (setting)
0.05 0.1 0.15 0.2
So/a
Figure 3.4 Tube wall thickness, T  as a fraction of gap width, ‘5o’ versus 
gap width as a fraction of cylinder radius ‘a’. Alginate infused 
with CaCI2 wall thickness data, T0 is marked as (X) .  The 
predicted wall thickness (TB) (14) is plotted as a green line.
Table 3.1 Summary of Raw Data For All Alginate-CaCI2 Experiments
Spherical
Regulator
Glass
Barrel Slope of Nominal Wall
Predicted
Wall
Gap Width,Radius, r0 Radius, a Graph Thickness, T0 Thickness, TB
(mm) (mm) /m m » 3 \ \  'm m  / (mm) (mm) 5o (mm) 5o/a To/So
1.700 2.000 0.447 0.187 0.206 0.187 0.150 0.622
1.700 2.000 0.441 0.189 0.206 0.189 0.150 0.631
1.700 2.000 0.418 0.201 0.206 0.201 0.150 0.669
1.588 2.000 0.310 0.275 0.283 0.275 0.206 0.667
1.588 2.000 0.315 0.271 0.283 0.271 0.206 0.658
1.588 1.825 0.584 0.156 0.158 0.156 0.130 0.657
1.588 1.825 0.567 0.161 0.158 0.161 0.130 0.677
0.9
0.8
0.7
0.6
T/So
0.5
0.4
0.3
0.2
0.1
0.0
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An initial standard-line experiment, using mid-range variable values for 
a combination of safe physiological conditions and process control was used 
to establish the reproducibility of the device (fig. 3.5). The dead-space, i.e. 
the residual alginate lost in the device was measured to be 112pl using 
water. Data was fitted by linear regression giving an R2 = 0.9814 hence 
indicating that the relationship between the variables was linear. The 
coefficient of variation (CV) of 3.56% shows fluctuation across replicates.
The first variable to test was the effect of alginate concentration on 
tube length and hence geometry. The aim was to establish the effect of 
fluctuations brought about by alginate concentration. Three conditions were 
evaluated: 0.5, 0.75 and 1.0% alginate. The results of the lengths of tubes 
were plotted and compared. We can see from figure 3.6 that there seems to 
be a gradient of the slope from incremental increases in alginate 
concentration -  i.e. the greater the concentration the steeper the slope. This 
is of concern if small changes affect trends, and hence wall thickness so 
greatly. However the data points do not always fit very tightly to their 
corresponding regression lines especially seen for 0.75% alginate 
concentration falling below R2 = 0.9, perhaps due to the lack of data points to 
regress to a linear trend.
The analysis of infusion speeds (fig. 3.7) shows little variation between 
different trends. The slopes are almost inseparable and there is no pattern to 
the gradient of the slopes, perhaps suggesting that this variation is due to the 
error of data and not due to device sensitivity.
Overall the data shows highly linear trends of length of tube against 
volume of alginate used, as indicated by high R2 values. When compared to 
other well-engineered devices, such as the bead formation device of Serp 
(Serp et al. 2000) -  who quote a CV of 5% - then a CV of 3.56% across data 
points for the standard line experiment indicates a level of precision within 
the device. However, the range of tube lengths (and therefore tube wall 
thicknesses) with varying alginate concentrations indicates a very sensitive 
system. We know from the theoretical fluid dynamics that fluid properties 
play no part in determining tube wall thickness. Even though viscosity is an
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Figure 3.5 Standard-line experiment, showing relationship between volume of sample 
(pL) against length of tube formed. Conditions used throughout: 300pm wall 
gap configuration; 0.5% alginate concentration; 0.09M CaCI2 concentration; 
30m I/m in infusion rate; and 15°C. Symbols represent the average length of 
n=2 replicate tubes per set volume. Dotted line represents line of best fit. 
Error bars represent CV across data points. R2 = 0.9814. Mark 1 device 
was used.
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Figure 3.6 Effect of alginate concentration on tube length. Alginate concentrations of 
0.5% (■); 0.75% (•); and 1.0% (A ) were tested and compared. Conditions 
used throughout: 300pm wall gap configuration; 0.09M CaCI2 concentration; 
30ml/min CaCI2 infusion rate; and 15°C. Symbols represent the length of 
n=1 tubes per set volume. The solid, dotted and broken lines represent
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average lines of best fit for 0.5%, 0.75% and 1.0% alginate, respectively. R2 
= 0.9796, 0.8952, and 0.9845, respectively. Mark 1 device was used.
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Figure 3.7 Effect of infusion speed on tube length. Infusion speeds of 20ml/min (■); 30 
ml/min (A); 40ml/min (•); and 50 ml/min (□) were tested and compared. 
Conditions used throughout: 300pm wall gap configuration; 15°C; 0.5% 
alginate concentration; and 0.09M CaCI2 concentration. Symbols represent 
the length of n=1 tubes per set volume. The bold, solid, dotted and broken 
lines represent lines of best fit for 20, 30, 40 and 50m I/m in, respectively. R2 
= 0.9612, 0.9990, 0.9951, and 0.9992, respectively. Mark 1 device used.
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initial term in (A) and (1), it does not form part of the final equations -  (14) 
and (H). We must therefore assume that the trends observed in figure 3.6 
are down to data error. Infusion speed, V is also a term that appeared in the 
equations up to (14). However, despite its presence in the final equation, it 
appeared that infusion speed, V was a variable we could control accurately 
via the syringe driver within the range tested and it seemed to play no 
substantial part to influence tube length and therefore tube wall thickness.
3.2.2 Development of New Protocol
The previous experiment showed significant impact to tube length from small 
changes in alginate concentration. These data errors of the mark 1 device 
could have been due to either: a lack of data points, i.e. short range of 
sample volumes tested; or due to data collection. On a practical front, it was 
also noticed that during tube formation, bubbles would creep into the system 
during setup, and the size of the bubble would determine the disruption to the 
geometry of the tube. It was unclear which of the two causes was more 
substantial at this stage. Therefore a new protocol was devised (fig. 3.8) to 
counter any disruption to measurement and simultaneously more data points 
were measured across a wider range of volumes. Any run where a bubble 
had crept into the system was discarded. Furthermore, the standard infusion 
rate was lowered to 20ml/min to gain more control since it was learned from 
the previous experiment that the infusion rate did not affect the length of tube 
formed (and therefore thickness).
This new SOP was tested via a repeat experiment, again measuring 
tube length against the effect of alginate concentration. Data points over a 
larger range of sample volumes were taken on this experiment to ensure 
more precise results.
Figure 3.9 shows the effect of optimised settings on tube length. It is 
immediately apparent that there was a marked improvement with linear trend 
consistency -  all R2 values are now above 0.99 -  also shown by the data
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Figure 3.8 Flow diagram of experimental decisions for section 3.2.2.
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Figure 3.9 The effect of optimised device settings to tube length. Alginate 
concentrations of 0.5% (■); 0.75% (A); and 1.0% (•) were tested and 
compared. Conditions used throughout: 300pm wall gap configuration; 
20ml/min; 15°C; and 0.09M CaCI2 concentration. Symbols represent the 
length of n=1 tubes per set volume. Broken, dotted and solid lines represent 
average lines of best fit for 0.5, 0.75 and 1.0% alginate concentrations, 
respectively. R2 = 0.9958, 0.9912 and 0.9972, respectively. Mark 1 device 
used.
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points being closer to the linear regression line. There are still two very 
different trends, but this time the 0.75 and 1.0% alginate concentration trends 
are overlapping.
The new protocol tightens the data errors previously found from 
section 3.2.1, however alginate concentration (within range of 0.50-1.00%) 
still plays a significant factor to tube length and tube wall thickness 
determination. Using optimised settings and a data points across a wider 
range taken reduced the variability of data points from the linear regression 
line. However physical limitations of the current device design may have 
introduced these large data variations despite improvements to protocols and 
techniques. From parallel OCT studies (see section 4.1.1), it was observed 
that the initial third of 20cm tubes (~7cm) were poor quality compared to the 
rest of the tube. It was therefore hypothesised that the initial lift-off of the 
spherical regulator may have caused poor uniformity tubes, affecting tube 
thickness and therefore tube length. After the initial ~7cm, the tube forming 
process is thought to stabilise. I.e. the variability may arise from the initial 
part of the tube formation process due to the design of the injector nozzle 
upon which the plastic spherical regulator sits.
3.2.3 The Mark 2 Design
The design of the device was altered to take into account the results 
from section 3.2.2 (fig. 3.10). The metal collar upon which the spherical 
regulator sat was modified to an ‘eggcup’ geometry (fig. 2.2). It was 
predicted that this design would enable a smoother initial lift-off from the 
device right from the start of tube formation, leading to more consistent tube 
wall thicknesses throughout, and hence more reliable tube lengths. The tight 
fit of the regulator sphere to the metal collar was also expected to eradicate 
the problems of air bubbles seeping into the process. Furthermore, the 
shortening of the injector nozzle reduced the dead space prior to tube 
formation from 112pl to 89jxl. Triplicates per matrix fluid volume were also 
introduced to the protocol to reinforce reduction to inherent sampling errors.
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Figure 3.10 Flow diagram of experimental decisions for section 3.2.3.
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Figure 3.11 Effect of alginate concentration on tube length using the mark 2 device.
Alginate concentrations of 0.5% (•); 0.75% (A); and 1.0% (■) were tested 
and compared. Conditions used throughout: 300pm wall gap configuration; 
20ml/min; 10°C; and 0.09M CaCI2 concentration. Symbols represent the 
average length of replicate tubes of set volume. Number of replicates for: 
0.50% (n=1), 0.75% (n=2), 1.00% (n=1). Dotted line represents line of best 
fit. Error bars represent CV across data points. R2 = 0.9995.
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With the mark 2 base unit in place, effect of alginate concentration was 
retested by a repeat experiment. It was hypothesised that the combination of 
improved protocol with the new mark 2 device would improve robustness of 
tube formation, manifested by a reduction in tube length CV for different 
alginate volumes.
Figure 3.11 shows the effect of alginate concentration with the mark 2 
tube-forming device. Immediately obvious is the lack of variation between all 
3 sets of data. This improvement could only be due to improvements in tube 
making protocol and the mark 2 base unit design -  a fact verified by parallel 
OCT studies showing that the entire tube was now of reproducible quality 
including the first ~7cm (see 4.1.2). The CV remained small at 
an average of 2.4% throughout all 3 sets of differing alginate concentration 
data. An extremely important factor was the reduction in dead space within 
the device, mostly due to the shortening of the injector nozzle, which reduces 
tube “end effects” (fig. B2(ii) taken from Appendix B). This figure shows a 
more realistic view of tube formation for the mark 1 device. The fluid 
dynamics Theory assumes that the system is in steady state, but we know 
that the spherical regulator starts at 0 and quickly accelerates to speed, V. 
Alginate also flows upwards throughout tube formation, and hence thinning at 
the ends is inevitable. The extra material that should have formed tube wall 
of predicted thickness TB is therefore applied to the rest of the tube, and 
therefore nominal tube thickness is T0, which is marginally thicker than TB. 
What must be noted however are the scales of the diagram -  the vertical 
being 0-60 and the horizontal 0.8-1.0 -  the vertical axis is therefore 
massively compressed to exaggerate the tube end effects. Due to the 
injection nozzle shape of the mark 2 base unit, it is theorised that these end 
effects are much reduced and therefore T0 is closer to TB than for the mark 1 
device.
This experiment showed that the design of the device was finally 
robust enough to withstand changes to alginate concentration within the 
tested range.
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Figure B2 (ii) Calculated interface from tracking a number of particles distributed 
across the sphere-cylinder wall gap.
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Figure 3.12 Flow diagram of experimental decisions for section 3.2.4.
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3.2.4 Wall Thickness Reproducibility
The focus of this study was to demonstrate a high degree of reproducibility 
using only one alginate concentration (1.0%) in the tube forming process and 
the robustness of the experimental techniques, via repeated tube formation 
and measuring for any variation in tube length (fig. 3.12).
Figure 3.13 shows the reproducibility of tube formation for fixed 
reactor geometry. The R2 value of 0.9995 shows the high linear correlation 
of volume with length of tube formed, as anticipated. This shows high “inter­
tube” and “intra-tube” reproducibility -  i.e. it was easy to predict the length of 
consistent thickness tube formed from any given volume of alginate, and this 
given value varies within a controlled margin of error from tube to tube. The 
CV from point to point on three replicates of data varied from 0.4 -  3.0% (as 
a % of tube length) and was 1.9% on average. At this stage, it would seem 
that control of tube length based on alginate volume within acceptable CV 
limits (Serp et al. 2000), and coupled with the high R2 value, we could say 
these sets of data were highly reproducible.
With the assurance that the mark 2 device is no longer sensitive to 
data errors arising from fluctuations in alginate concentration, figure 3.13 
shows a theoretical line (broken line) of tube lengths were there no 
contraction effects of fluid dynamics at play. As we can see, a ~340mm 
length tube would be equivalent to a 200mm tube with much thicker tube 
walls. As we know, such effects brought about by the drag of the spherical 
regulator on the matrix fluid do exist and therefore we must be able to predict 
tube wall thicknesses and compensate to achieve desired thickness tubes.
3.2.5 Investigation of Wall Gap Configuration
With reliable results now achievable from the mark 2 base unit design, 
we turn our attention back to the Theory and the end uses of the alginate 
tube. As we have discussed in Chapter 1, this thesis will not make
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Figure 3.13 The reproducibility of tube using the Mark 2 tube formation device. Alginate 
volume, number of measurements and CV were: 200pl, (n=3, CV 1.9%); 
300fjJ, (n=2, CV 3.0%); 400pl, (n=4, CV 3.0%); 500|il, (n=2, CV 0.4%); 
600|il, n=4, (CV 2.6%); 700pl, (n=2, CV 1.3%); 800pl, (n=4, CV 1.1%). Line 
of best fit is shown (solid line), 0.443mm/pl (R2 = 0.9995). Conditions used: 
capillary radius 2.0mm; sphere radius 1.7mm; wall gap thickness (per side) 
0.3mm (300pm); 1% w/v alginate concentration; infusion rate 20 ml/min. 1% 
CaCI2 infused. Symbols represent the average length of replicate tubes of 
set volume. Line (.._.._) is tube length assuming no contraction due to fluid 
flow effects.
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Figure 3.14 Flow diagram of experimental decisions for section 3.2.5.
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prescribed end uses of the tubes created, but moreso, it will make 
suggestions as to the multiple uses of alginate tubes. Undoubtedly, end use 
will involve some type of cells integrated with the tube -  either embedded in 
the tube walls, or lining the tube surface. With any cells, be them bacterial, 
mammalian or fungal, suspended or anchorage dependant, all require 
nutrients to survive and to grow. Nutrients such as oxygen, a food source 
and waste exchange is essential for any cell, and such nutrient exchange in 
our tubes will be proportionally limited by tube wall thickness (Glickis et al. 
2004).
But how do we physically manipulate tube wall thickness? As we 
have described in section 3.1 regarding tube formation, the speed of the 
device and the ratio of gap-width (wall gap) to regulator diameter can subtly 
alter the tube wall thickness from a maximum thickness of 2/ 3 gap width. 
However, since the deposited matrix layer is a direct result of the gap width 
created by the spherical regulator and the glass barrel wall, we can 
manipulate wall thickness by altering either glass barrel diameter, or 
spherical regulator diameter (or both). Therefore, we pose the question -  is 
the system still reproducible when we alter glass barrel diameter and 
spherical regulator diameter (fig. 3.12)?
Tube formation robustness by the device was investigated 
experimentally using a combination of capillary and regulator dimensions 
(table 2.1). Device performance was again characterised by measurement of 
length of tube formed using different alginate volumes for each of the gap- 
width configurations studied. In all cases the alginate volumes reported were 
corrected for the dead volume of the system (89.0pl). The slopes of these 
graphs were then used to derive the tube thickness.
The ‘average’ thickness of the tube wall, T, was related to how the 
length of the tube formed varied with the volume of injected fluid:
(i)
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Table 2.1 Matrix of wall gap configurations ‘8o\ showing the wall gaps for 
different sized glass cylinders and spherical regulators
Cylinder Radius, a (mm) 1.825 2.000 2.000
Regulator Sphere Radius, r0 (mm) 1.587 1.700 1.587
Gap Width, §o (pm) 238 300 413
600 i
500
rO = 1.700mm
■§400
rO = 1.587mm
200 600 10000 400 800
Volume of Matrix Fluid (pL)
Figure 3.15 Effect of regulator sphere radius. Alginate volume, number of 
measurements and CV were: 200pl, (n=1); 300pl, (n=3, CV 5.5%); 400pl, 
(n=3, CV 4.9%); 500pl, (n=3, CV 0.8%); 600pl, (n=3, CV 1.6%); 700pl, (n=3, 
CV 1.1%); 800|il, (n=3, CV 2.4%); 900pl, (n=2, CV 0.3%); 1000pl, (n=2, CV 
0%). Line of best fit is plotted as a solid line, slope 0.308mm/pl (R2 = 
0.9998). Capillary radius 2.000mm; sphere radius 1.587mm; wall gap 
thickness (per side) 0.413mm (413pm); 1% w/v alginate concentration; 1% 
CaCI2; infusion rate 20 ml/min. Symbols represent the average length of 
replicate tubes of set volume. Data for line obtained using sphere radius of 
1.700mm (------ ) see figure 3.13.
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Where;
a is the capillary radius and,
dL/dv is the experimentally measured relation between length of tube 
formed (L) and volume of alginate used.
Figure 3.15 demonstrates the effect of altering the regulator sphere 
radius, for a fixed glass capillary radius. The dashed line shows the data 
from figure 3.13 and the new data for a sphere radius of 1.587mm. The 
resulting gap width of 413jnm was wider and hence the same volume of
alginate yielded much shorter tubes. Again the R2 value of 0.9998 was
extremely high and an average CV of 1.8% showed reproducible results 
despite this configuration change. Tube wall thickness for gap width of 
300pm was back calculated to be 188.4pm ± 3.6pm (CV) using equation (I). 
The ratio of nominal tube wall thickness (T0) and gap width (50), To/5o is 
shown to be 0.628 (close to the % rule). Wall thickness for 413pm gap width 
was 277.3pm ± 5.0pm, giving a To/5o ratio of 0.671.
Similarly, figure 3.16 shows the effect of altering the glass barrel
radius for a fixed sphere radius. A smaller glass barrel for the same sphere 
means a gap width of 238pm and hence the same volume of alginate yielded 
much longer tubes with thinner walls. R2 was found to be 0.9996, and 
average CV was 1.4%.
Therefore for a wall thickness for 238pm gap width, the back- 
calculated nominal wall thickness was 143.4pm ± 2.0pm, giving a To/5o ratio 
of 0.603. A summary of the configurations, back-calculated tube thicknesses 
and T0 /8 0  ratios has been constructed in table 3.2 (based on table 2.1).
This set of experiments shows that by altering either the glass barrel 
or spherical regulator diameters we can obtain different sized tubes with 
different wall thicknesses. These results also show how thicknesses 
obtained relate with the % Approximation derived from the fluid dynamics 
Theory. The coefficient of variation for each of the gap width configurations 
were within peer-acceptable limits (Serp et al. 2000) indicating reproducibility
121
400
350
a = 1.825mm300
250
200
a = 2.00mmh  150 £
100
50 :
0 1 00 200 300 400 500 600 700
Volume of Matrix Fluid (|xL)
Figure 3.16 Change in capillary radius. Alginate volume, number of measurements and 
CV: 200pl, (n=1); 300pl, (n=3, CV 5.0%); 400pl, (n=3, CV 1.5%); 500|il, 
(n=3, CV 1.3%); 600pl, (n=3, CV 0.3%); 700pl, (n=1). Line of best fit is 
0.580mm/pl (R2 = 0.9996). Capillary radius 1.825mm; sphere radius 
1.587mm; wall gap thickness (per side) 0.238mm; 1% w/v alginate 
concentration; 1% CaCI2; infusion rate 20 ml/min. Symbols represent the 
average length of replicate tubes of set volume. Data obtained using a 
capillary of radius 1.825mm (------ ) see figure 3.15.
Table 3.2 Matrix of wall gap configurations ‘8o\ showing the wall gaps and 
nominal wall thicknesses ‘T0’ of tubes for different sized glass 
cylinders and spherical regulators used in this thesis
Cylinder Radius, a (mm) 1.825 2.000 2.000
Regulator Sphere Radius, r0 (mm) 1.587 1.700 1.587
Gap Width, 50 (pm) 238 300 413
Derived Tube Thickness, T0 (pm) 143.4 188.4 277.3
To / So 0.603 0.628 0.671
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of the device despite changes in gap width size. This robust level of control, 
alongside the Theory to predict resultant wall thickness allows reliable control 
of tube wall thickness, and thus control of nutrient and waste exchange of 
any cells present in the alginate structure used as either a macro­
encapsulation device or tissue engineering product.
3.2.6 Effect of Altering Propelling Fluids
As a final experiment to conclude these studies of wall thickness, robustness 
and how they relate back to the fluid dynamics Theory, we consider the 
extension of the Theory outside of the alginate-CaCl2 system. Nowhere in 
section 3.1 is it mentioned that there are limitations to the theoretical 
prediction of tube wall thickness, or that even a reaction need occur and a 
tube needs to be formed. We therefore tested the robustness of the Theory 
and the system applied to different propelling fluids -  both reacting and non­
reacting and see how they compared to the 2/ 3 Approximation derived from 
equation (14) of the Theory (fig. 3.17).
The effect of changing propelling fluids is shown in figure 3.18. The 
range of fluids looked at included alginate, N-saline, WFI, 0.09M CaCI2 and 
0.05M BaCI2. Each fluid combination gave a slightly different slope, each 
graph’s gradient equating to a different wall-thickness. The graphs appear 3 
distinct groups formed -  the reacting systems (BaCI2 and CaCI2), the non­
reacting systems (WFI and N-saline), and the viscous systems (alginate). It 
would appear that this range of gradients showed a trend of increasing 
tendency to react and cross-link -  the alginate giving a less steep slope, i.e. 
BaCI2 is a stronger linking agent than CaCI2, and these two reacting infusing 
agents had similar trends at much less-steep gradients than all other infusion 
materials. The other propelling fluids all had steeper slopes indicating longer 
tubes and thinner deposited layers (tube walls).
A further experiment involving all 3 gap width configurations using 54% 
glycerol matrix fluid infused with 54% glycerol propelling fluid and WFI
Le
ng
th
 
Tu
be
 
Fo
rm
ed
 
(m
m
)
123
( START
San W e \  
C reate  Different 
Thickness  
\W a ls ? /
YESYES Do L iq u ic P v  
Toperties Affect Tu&  
\  Form ation?
'''Are Results^  
Reproducible?
Is the Device 
. Robust? /
NO NO NO
Remove 
Data Errors Repeat Tests END
Improve Device 
Design
Figure 3.17 Flow diagram of experimental decisions for section 3.2.6.
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Figure 3.18 Effect of changing propelling fluids. Each data point represents the average 
of a number of measurements and the range of values observed. All 
combinations involved 1.0% alginate as a matrix fluid. Measurements using 
0.09M CaCI2 are denoted ( - - - - )  see figure 3.13. Alginate volume, number 
of measurements and CV of the results for:
0.05M BaCI2 data was: 200pl, (n=1); 400pl, (n=1); 600pl, (n=1800pl, (n=1). 
Line of best fit was 0.421 mm/pl (R2 = 0.9998).
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0.9% N-saline data was: 200|il, (n=2, CV 14.9%); 300fil, (n=1); 400fil, (n=2, 
CV 2.8%); 500|il, (n=1); 600p.l, (n=2, CV 1.3%); 700|il, (n=2, CV 2.7%). Line 
of best fit was 0.529mm/fil (R2 = 0.9989).
WFI data was: 200|xl, (n=2, CV 0.6%); 400^il, (n=2, CV 2.7%); 600^il, (n=2, 
CV 7.3%); 800|il, (n=1). Line of best fit was 0.506mm/fil (R2 = 0.9972).
1.0% w/v alginate was: 200(il, (n=2, CV 4.4%); 400[il, (n=2, CV 0.8%); 
500|il, (n=2, CV 3.8%); 600^1, (n=2, CV 5.0%). Line of best-fit was 
0.644mm/|il (R2 = 0.9971).
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infused with WFI was carried out to further ascertain what was occurring in 
the system (summary table 3.3). These results were then plugged back into 
figure 3.4 to see how they all compared with the Theory. Figure 3.19 shows 
the collated results. This time the % Approximation has been added, 
represented by a bold green line. It is clear that there are only two groups of 
data, ‘reacting systems’ and ‘non-reacting systems’. Whilst first thought that 
the reacting systems, having a To/5o close to 2/ 3 was a good indication of 
results falling within thicknesses theoretically predicted by equation (14) 
(original thin green line), it now appears that these results are in fact in error. 
By plotting equation (H) (bold green line) we can see that in fact the non­
reacting systems are closer to the theoretical predicted wall thickness than 
the reacting systems. But did we not say a To/5o of 2/ 3 was the Theory? No, 
because it is dependent on the ratio 5o/a, i.e. the gap width with the cylinder 
radius. As gap width becomes very small, we approach a maximum To/5o of 
2/3. So what is happening inside the system?
What is now thought is that the reacting systems freeze the thickness 
of the deposited alginate layer immediately upon contact, and therefore flow 
contraction effects created by drag of the matrix fluid up the glass barrel walls 
are rendered negligable. This resulted in thicker walls of solidified alginate 
much closer to 80, hence shorter tubes and a less steep gradient in figure 
3.18. We know from literature that CaCk is a fast cross-linker and BaCk is 
yet faster (Kuo and Ma 2001). The systems closest to the Theory in fact 
were alginate infused by WFI, alginate infused by saline and WFI infused 
with WFI. The other two viscous systems -  glycerol infused with glycerol and 
alginate with alginate were thought not to form tubes due to the high viscosity 
of the fluids used being beyond the handling capacity of the syringe pump. 
Theoretically, viscosity should not affect results, but when it physically retards 
the formation process creating non-linear infusion rates, then this may go to 
explain why results did not fit. It was observed that the fluid flow for these 
viscous propelling fluids would continue after pressing stop on the syringe 
driver, due to the vaccuum of pressure formed. However, the interpretation 
of the findings from figure 3.19 is the subject of some debate within the 
department.
Table 3.3 Summary Table for All Alternate Propelling Fluid Experiments
Matrix Fluid 
Propelling Fluid 
Cylinder Radius, a 
Sphere Radius, r0
Gap Width, 60 (pm)
Nominal Thickness, T0 (pm)
To/50
Bead Density (g/cm3)
Matrix Density (g/cm3) 
Propeller Density (g/cm3) 
Matrix Viscosity (g/cm.s) 
Propeller Viscosity (g/cm.s)
1% Alginate 1% Alginate
1% CaCI2 1% CaCI2
1.825 2.000
1.587 1.700
238 300
143.4 188.4
0.603 0.628
0.960 0.920
1.01 1.01
1.04 1.04
6.71 6.71
0.0140 0.0140
1% Alginate 1% Alginate
1% CaCI2 1% BaCI2
2.000 2.000
1.587 1.700
413 300
277.3 198.9
0.671 0.663
0.960 0.920
1.01 1.01
1.04 1.04
6.71 6.71
0.0140 0.0140
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1% Alginate 1% Alginate 1% Alginate 98% Glycerol WFI
(0.9% w/v) Saline WFI 1% Alginate 98% Glycerol WFI
2.000 2.000 2.000 2.000 2.000
1.700 1.700 1.700 1.700 1.700
300 300 300 300 300
156.6 164.0 127.7 125.6 140.2
0.522 0.547 0.426 0.419 0.467
0.920 0.920 0.920 0.920 0.920
1.01 1.01 1.01 1.26 1.00
1.03 1.00 1.01 1.26 1.00
6.71 6.71 6.71 14.9 0.0131
0.0140 0.0131 6.71 14.9 0.0131
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F ig u re  3 .1 9  Tube wall thickness, T  as a fraction of gap width, ‘50’ versus gap width as a 
fraction of cylinder radius ‘a’. Symbols indicate: alginate infused with CaCI2 
(A); alginate infused with BaCI2 (■); alginate infused with N-saline (A); 
alginate infused with WFI (x); alginate infused with alginate (o ); 54% glycerol 
infused with 54% glycerol (•); and WFI infused with WFI (+). The predicted 
wall thickness (TB) based on the % Approximation (H) is plotted as the bold 
green line, whereas the bold black line represents T/5q = 0.66.
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In summary, we have taken a tube-forming device, created a robust 
protocol and redesigned the base unit to create more reproducible results. 
We have shown that the data is reproducible, time after time, and unaffected 
by fluctuations in alginate concentration within the range of 0.5-1.0%, nor by 
fluctuations in constant infusion speeds ranging from 20ml/min to 50ml/min. 
We have shown that we can create tubes of varying wall thicknesses by 
changing gap widths, either by using a different diameter glass barrel or a 
different diameter spherical regulator, and that the device is robust enough to 
withstand these changes to gap width configuration. Finally we have shown 
that the developed Theory can be applied to any system, although non­
reacting systems that do form a tube successfully are best described by the 
2/ 3 Approximation. Due to the cross-linking reaction involved in any alginate- 
multivalent ion system, the resultant thickness of the tube walls will depend 
on two things: 1. the speed of the reactant (Kuo and Ma 2001) at the time of 
tube formation, and 2 . shrinkage effects that occur over time after tube 
formation (Quong et al. 1998).
A final point to add is that all tube thickness were back-calculated by 
equation (I) only, and not measured directly -  it was assumed in all cases 
that all sides of the tube were uniform. Indirectly measuring wall thickness 
via tube length is clearly not the way forward, especially as we’ve just 
discussed the thickness of alginate tube walls are subject to more factors 
than just the wall gap configuration of the device alone.
3.3 SUPPLEMENTARY EXPERIMENTS
3.3.1 Alginate Viscosity Data
Impact of alginate viscosity to tube length (brought about by change in 
alginate concentration) is a more complex variable. Alginate viscosity can be 
affected by large changes in temperature, autoclaving and time-degradation
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-  these are variables we cannot easily control. Although the Theory clearly 
states that viscosity does not affect the fluid mechanics of tube formation, 
huge shifts to viscosity beyond the physical capabilities of the pump handling 
capacity could affect tube formation as we have seen in section 3.2.6, and 
this could be reflected in the tube length. Although the Theory predicts that 
viscosity changes cause no change to tube wall thicknesses, it would be a 
good idea to gain some insight on the change of viscosity with temperature. 
It must also be noted that temperature was controlled at 10-15°C in all 
experiments. In order to collect viscosity information, a viscometer was used.
Figure 3.20 shows the impact of temperature and alginate 
concentration on viscosity. This graph suggests that the viscosity (cP) to 
alginate concentration (%) relationship become less linear with changing 
temperature, a well-known fact that alginate is pseudo-plastic as opposed to 
Newtonian (Manojlovic et al. 2006), i.e. it is a shear-thinning fluid. However, 
since alginate concentrations are fixed at 1 .0 % throughout late experiments 
and room temperatures are controlled, then any large changes to viscosity 
should be minimal. A summary of results can be seen in table 3.4.
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Figure 3.20 Effect of temperature and alginate concentration on alginate viscosity.
Symbols represent n=1 viscosity measurements per set alginate 
concentrations. Solid lines represent trends through data sets. 
Temperatures tested were: 15°C (A), 20°C (A), 25°C (•), 30°C (o ) and 35°C 
(■). Alginate concentration tested at 1.00%. Temperature changes were 
manipulated using ice and a water bath, and all readings were taken using a 
viscometer (Brookfield, Massachusetts, USA).
Table 3.4 Effect of varying alginate concentration, temperature and hence 
viscosity with respect to nominal wall thickness (T0)
Alginate 
Cone. (%)
Temp.
(°C)
Nominal Wall Thickness, T0 (|im)
Viscosity (CP)
8o = 238 5o = 300 5o = 413
0.50 1 0 . 0 0.188 58.2
0.75 1 0 . 0 0.188 302.4
1 . 0 0 1 0 . 0 0.158 0.189 0.273 671.2
1 . 0 0 2 0 . 0 0.159 0.187 0.285 597.6
4 Monitoring Methods
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Chapter 3 left one huge question unanswered -  can we measure tube wall 
thickness? Although we have a seemingly robust system design and 
protocol, and even a mathematical model to predict tube wall thickness, we 
did not once verify actual tube wall thickness directly. Instead we resorted to 
back-calculation based on tube length and geometry of a cylinder. In this 
chapter we will not only look at methods to directly measure tube wall 
thickness at the time of tube formation, but also tube wall thickness after tube 
formation, that is, we will consider the added complexity of tube wall 
shrinkage (Kuo and Ma 2001). In addition we will look at other methods to 
quantify the size and number of any particle component that maybe 
introduced to the tubular constructs, since large particles may disrupt the wall 
thickness consistency of tubes made. Furthermore, we will look at 
introducing controls where possible to minimise variations introduced during 
mammalian cell culture.
Therefore the aims of this chapter were: to establish a direct method 
of measuring tube wall thickness immediately during and after tube formation 
to capture quality and shrinkage information of alginate tubes; to institute a 
method to capture particle size data; to find a way of improving consistency 
in particle quantification; to determine the impact of adding biological cells to 
the system; and to ascertain factors to help control cell aggregate size.
4.1 OPTICAL COHERENCE TOMOGRAPHY (OCT)
4.1.1 Primary Tube Scans
Up until this stage, tube geometry was measured as a function of tube length 
only. Wall thickness was back calculated using tube length and equation (I) 
from Chapter 3. There had been no direct way of measuring the walls of the 
alginate tube formed to verify the validity of the results (fig. 4.1). For this
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Figure 4.1 Flow diagram of experimental decisions for section 4.1.1.
133
task, we incorporated a technique known as Optical Coherence Tomography 
(OCT), which allows high-resolution, real-time imaging in situ. Due to section
4.1 being run parallel to Chapter 3, at the time the latest device version was 
the mark 1 base unit, which was used for this initial experiment.
OCT yielded the brown and orange scans shown in figure 4.2. Firstly, 
it must be discussed how this figure is read. Because OCT is a light source 
based technique, the signals used to construct these images are based on 
changes in refraction index as the laser beam passes from one medium to 
another. Therefore, although certain segments of the diagram are similar in 
shade of colour, this does not mean they are the same material. From 
knowledge of the experimental setup and taking the labelled cross-sectional 
scan, we know that the initial segment of all OCT scans must be part of the 
glass wall of the barrel. As we cross from glass to CaCl2 , we see the first 
bright orange line. Then as we cross from CaCfe back into alginate, we see a 
thick orange band that represents the alginate tube wall. Because this wall is 
embedded with glass beads, the light beam constants crosses in and out of 
glass-alginate boundaries, clarifying the alginate tube walls so precisely. In 
the centre of the alginate tube wall is CaCI2 fluid.
As we can see from figure 4.2, taking 3 points along either side of the 
tube formed and a cross-sectional scan (greyed area on the tube schematic), 
the OCT image clearly shows the general uniformity of the tube formed. To 
aid spatial visualisation, the bottom three images have been turned 180°. 
From these images, table 4.1 was constructed (fig. 2.11 has been reiterated 
for convenience). Several key findings can be deduced from this table. It 
can be seen from the table, that it was characteristic of a formed tube to have 
walls of the same thickness on one side, i.e. taking tube 3 for example, points 
A, B and C on one tube face give an average wall thickness of 189pm, whilst 
points D, E and F on the other face give an average wall thickness of 129pm. 
That is, if a tube is formed with a thicker wall on one side, this trait will 
continue to run throughout the length of the tube (we will see this in more 
depth in sub-section 4.2.1). The table verifies that tubes are generally well 
formed, with relatively low CV ranging from 3-7%. Tube 3 however has a CV
urn u.1 u .n  u.2 u.2:> U.U) U.1 U.1) U.il U.Z) U.U) U.1 U.1) U.2 U.ZS
Figure 4.2 OCT tube scans of a pure alginate tube containing glass beads. Positions 
of images are indicated in relation to their position on the tube. Tubes were 
formed using base unit design mark 1.
B C
i
Ocm  2 .5 c m  5 .0 c m
i
D
i
F
Figure 2.11 Experimental scanning setup and nomenclature used for Mark 1 primary 
OCT experiment. Point A is 180° from D on the opposite face of the glass 
capillary and so on. Points A, B and C are 2.5cm apart, point B lying in the 
centre of the glass capillary. Scan G was a half cross-section taken from a 
random point in the tube. The table was constructed using G1, 2 and 3 
terminologies, taken from set points from the cross-section. G3 corresponds 
to point A, and G1 to point D.
G3/A
G1/D
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Table 4.1 Thickness measurements taken from alginate tubes with glass beads.
% Cone. A B C D E F Average SD CV
1.00% 157 157 157 166 157 148 157.00 5.20 3.31
0.75% 139 148 166 157 157 157 154.00 8.49 5.51
0.50% 189 189 189 123 132 132 159.00 30.15 18.96
0.50% * 170 189 189 160 160 170 173.00 12.03 6.95
Units o measurement (pm derived from Matlab images from scan of tube (figure 4.1). 
* Denotes 0.50% alginate with 0.005g/ml glass beads.
Figure 2.12 Experimental scanning setup and nomenclature used for Mark 2 OCT tube 
scans. Points A, C and E were 180° from B and D on the opposite face of 
the glass capillary. Points A to E are 4cm apart, point C lying in the centre 
of the glass capillary.
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of over 18%. This proves OCT is a good tool, with it in place we can instantly 
differentiate good from bad tubes by setting a level of tolerance based on 
wall thickness variation -  tubes were all checked visually prior to OCT 
scanning via blue dye and deemed sufficient quality before transporting to 
Cranfield for OCT analysis. Visibly, measuring tube length and assuming 
uniformity to back-calculate wall thickness has a blind spot that OCT cures. 
Interestingly, tubes 1-3 have a decreasing level of alginate concentration, 
and tube 3 has the lowest concentration of 0.50%. From Chapter 3, we 
discussed the sensitivity of the mark 1 design to alginate fluctuations that 
prompted the mark 2 design. Additionally, we see an average tube thickness 
of ~157pm for the first 3 tubes at 0.0005g/ml glass beads, yet a 173pm wall 
thickness for tube 4 at 0.005g/ml glass beads (x10 concentration) -  clearly 
the concentration of the glass beads has altered the thickness of the tube 
formed. One also maybe wondering why the thickness of 157pm differs 
greatly from the 188.4pm (for gap width configuration, 5o of 300pm) seen 
from table 3.2 from Chapter 3. The explanation to both these observations is 
simple -  final thickness of the alginate tube walls is dependent on two macro­
factors: (1 ) the gap width configuration, 5o during tube formation; and (2 ) 
shrinkage (Kuo and Ma. 2001) after tube formation. In Chapter 3, we 
measure tube length immediately after tube formation, and here we form 
tubes that shrink and then set before they are scanned at a different site. A 
final point, perhaps not immediately obvious is that only the central third of 
the tube is scanned. The tube is 15cm long, yet from preliminary scans, we 
could see that the first third of the tube was poor quality -  another point 
raised in section 3.2.2.
Whilst it is obvious that OCT is an excellent monitoring tool, due to the 
ability of the device to scan a tube non-destructively, in situ and through air 
(Fujimoto et al. 2000), we must further consider several points. The walls of 
the alginate tubes are in the order of 1 0 0 -2 0 0 pm thickness yet the resolution 
of the OCT scanner is 10pm (i.e. each pixel represents 10pm), meaning an 
accuracy of ±10pm. OCT devices can reach 1pm resolution but such light 
sources are increasingly expensive with increasing resolution. Because OCT 
work is carried out in collaboration with Cranfield University, Silsoe,
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shrinkage -  a unique factor of alginate-CaCI2 structures -  must be taken into 
consideration when predicting tube wall thickness. Finally, this section 
highlighted that the most important stage of tube formation being right at the 
start. Any slight instability in flow would carry through the length of the tube 
and create a thinned wall on one side -  which was the main justification for 
the redesign of the base unit geometry.
4.1.2 Mark 2 Tube Scans
In order to verify the efficiency of the mark 2 design, OCT was performed 
once again on enhanced tubes.
Results have been tabulated (table 4.2) and fig. 2.12 reiterated for 
convenience. At first glance, results seem disappointing considering that 
lower CV values were achieved for the mark 1 device. Here, we see a range 
of CV values from 5.9-16.3%. But it is easy to forget that the initial base unit 
design only produced successful tubes a fraction of the time (data not 
shown). Also, the previous design yielded tubes where only the central third 
was adequate for OCT analysis. Moreover, there appears to be no evidence 
of tube lopsidedness from all 3 gap-width configurations.
A gap width, So of 238pm gave a wall thickness of 115.6; a gap width, 
So of 300pm gave a wall thickness of 144.2; and a gap width, So of 413pm 
gave a final wall thickness of 205.6. In addition to fluid mechanics effects, 
this effect termed “shrinkage” appeared to give a final tube wall thickness in 
the region of Vz of gap width configuration, So for all three tubes.
4.1.3 Shrinkage Effects
Sections 4.1.1 and 4.1.2 show a discrepancy between the tube wall 
thicknesses during tube formation (fluid dynamics contraction effects applied) 
and much later after tube formation. We now know from literature that this
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Table 4.2 Table of verification OCT tube scan results. Thickness measurements 
were taken from alginate tubes with glass beads.
Gap Width, 5o A B C D E Average SD CV % Shrinkage
238pm 107 100 100 150 121 115.6 18.8 16.3 48.6
300pm 171 129 143 114 164 144.2 21.2 14.7 48.1
413pm 186 200 214 207 221 205.6 12.1 5.9 49.8
Units of measurement are pm derived from Matlab images from scan of tube.
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Figure 4.3 Flow diagram of experimental decisions for section 4.1.3.
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discrepancy is due to shrinkage. Shrinkage is a term used to describe water 
loss from cross-linked alginate structures with time. When multivalent ions 
first come into contact with alginate, depending on the speed of gelation, 
structure thickness, G monomer length, and G:M ratio of the alginate 
involved, the reaction plane may solidify before the ions have saturated the 
whole structure. This results in a solid surface but varying degrees of solidity 
in the structure core. As these ions diffuse slowly through the structure, 
water molecules are lost and the remaining alginate G monomers are cross- 
linked resulting in further reduction of structure diameters as whole structure 
solidifies. This process typically lasts -10 mins for alginate beads, but can 
last up to 3 days depending on alginate thickness (Martinson et al. 1989).
Many indirect methods have been used to measure the effects of 
shrinkage, from weight loss as water molecules are shed to tilting blocks of 
alginate and taking the time it no longer flows (Kuo and Ma 2001). In this 
section we aim to use OCT to precisely measure shrinkage effects of our 
alginate tubes (fig. 4.3). It is so far unknown how much shrinkage will occur 
as a result of formation and the time frame involved. In order to better 
understand the relationship between time to set and actual thickness change, 
OCT was used to monitor tube wall thickness in real-time, i.e. during setting, 
once the tube was formed. This was achieved by analysing at a set point 
and measuring tube wall thickness with time. A new part of the Matlab 
programme was developed by Cranfield University especially for this 
purpose, which takes into account situations where the tube is attached or 
not attached to the glass barrel wall.
From the scattergrams seen in figure 4.4, shrinkage can be clearly 
seen occurring. A rapid drop in wall thickness is followed by a plateau, 
roughly occurring during the initial 10-15 minutes. This time is within the 
range expected for the thickness of alginate specimens created (Serp et al. 
2000). Section 4.1.1 experienced differing wall thickness with concentration 
of glass beads added. Here, we see an initial wall thickness of -225pm 
falling to -  180pm within 10 mins for the pure alginate tube (fig. 4.4a). 
Conversely, we see an initial wall thickness of ~270pm dropping to - 2 0 0 pm
140
(a) (b)
« 0.19
Figure 4.4
20
Time (mln)
30 40
0.3
0.28
?
E, 0.26 
<n| °-24 a
 ^ 0.22
0.2 TT
0.18
10 40
OCT scattergrams showing shrinkage of tube wall thickness with time. 2 
conditions studied included: (a) pure alginate tube; (b) alginate tube 
containing inert glass beads at 0.0005g/ml. Red line represents line of best 
least squares fit, based on a polynomial approximation through all data 
points.
(a) (b)
Figure 4.5 OCT images corresponding to scattergrams from figure 4.4 showing 
shrinkage of tube wall (y-axis) with time (x-axis). 2 conditions studied 
included: (a) pure alginate tube; (b) alginate tube containing inert glass 
beads at 0.0005g/ml. Red line represents line of best least squares fit, 
based on a polynomial approximation through all data points.
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for the glass bead encapsulated tube (fig. 4.4b). This firstly confirms that 
solid glass beads are not a good model for biological cells, and that they do 
indeed affect tube thickness. The follow-on question is therefore -  would 
biological cells affect tube wall thickness also (see Chapter 5)? However, 
what we expect to see is a 188|j.m initial thickness, falling to 150pm within 
10-15 mins. This anomaly cannot be isolated, although it could be the result 
of a number of factors. In all previously experiments, alginate was prepared 
and immediately used to create tubes, which were left to set and then 
refrigerated for OCT analysis the following day. Here, due to the timing of 
the experiment, we were required to prepare alginate at UCL, and transport 
all materials and machinery to Cranfield University, Silsoe to carry out the 
experiment. During transit, temperature was not controlled, nor was it 
controlled in the Cranfield lab. The time difference from makeup of alginate 
powder to use of hydrogel could account for this difference in wall thickness. 
Ultimately it could either be due to concentration differences of the CaCI2 
beyond the range of 0.05-0.09M tested at UCL, or due to large viscosity 
differences due to fluctuations in temperature. Figure 4.5 shows us the 
corresponding images for figure 4.4. It must be pointed out that the x-axis is 
not length, as in previous OCT images, but time. This image is a time 
compilation of A-scans at a set point. We can see in figure 4.5a how the tube 
becomes detached from the glass barrel wall as the whole tube shrinks. 
Figure 4.5b shows a perfect tube. The striated pattern is due to no 
disruptions during the timed-experiment. Any vibration to the device during 
scanning would have resulted in a distorted image.
This experiment contains some anomalies with regards to previous 
wall thicknesses. Without UCL’s own OCT team and apparatus, we cannot 
rule out all the factors that may have affected tube wall consistency. 
However, were the process to be commercialised, OCT would certainly be an 
integral, on-site part of it. Nevertheless, this experiment does show 
shrinkage visually in a precise, quantitative way that no previous groups 
studying shrinkage have achieved before. This highlights another potential 
use of the versatile OCT scanner.
4.2 HIGH SPEED CAMERA
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4.2.1 High Speed Camera Monitoring
Although answers to the flow diagram (fig. 4.3) were clearly “yes”, an 
opportunity presented itself when it was learned that a high-speed, high- 
resolution camera was on loan from the EPSRC (fig. 4.6). This would allow 
us to observe the tube formation and further analyse how this occurs.
It is interesting to look at figure 4.7 and see tube formation during 
developed flow, mid-capillary. Although this figure can only give us 
qualitative information regarding tube formation, several important points can 
be discerned. The matrix fluid profiles for all but figure 4 .7 /are parabolic in 
shape, assumed when developing the fluid dynamics Theory. As mentioned, 
for lift-off conditions, i.e. when the spherical regulator first leaves the injector 
nozzle, this profile is not present (fig. 4.7f). This second point is the best 
visual proof of end-effects that the Theory does not account for -  resulting in 
a nominal tube wall thickness T0 being slightly greater than TB.
The 3-colour component translation of the image using Leica QUIPS 
software (fig. 4.8) better facilitates analysis of the effects of changing 
conditions. It breaks down the colour information gained by using 
permanganate (purple) and separates it into blue, green and red profiles. For 
the purpose of analysis of the tube formation, we will concentration on the 
blue, zigzagged line either side of the spherical regulator. Again we traverse 
back into wall thicknesses during tube formation, and these 3-colour profiles 
give us gap-width information, i.e. this can indicate the uniformity of the 
resultant tube formed.
It can be seen that the control experiment, figure 4.8a, a 20ml/min 
infusion rate and 1 .0 % alginate concentration gives a well controlled, well 
formed alginate tube, with both walls equal (~300|im each -  estimated by 
pixels on x-axis) in thickness. When we reduce the alginate concentration to 
0.5% (fig. 4.8b), we see a slight compromise in the quality of tube formed 
(the regulator veers off to one side, and the left-hand wall appears larger than
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Figure 4.6 Experimental setup of the high-speed camera.
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Figure 4.7 High-resolution, high-speed camera images during tube formation. Images 
were enhanced using Adobe Illustrator CS. The following conditions were 
tested: (a) control experiment at 20ml/min; (b) tube formation using 
uncoloured 0.50% alginate concentration; (c) tube formation at 50ml/min; (d) 
tube formation at 413pm wall-gap configuration; (e) tube formation at “lift­
off’; (f) tube formation at “lift-off at 413pm wall-gap configuration; (g) of tube 
formation at 413pm wall-gap configuration infused with WFI; (h) tube at 
formed at 413pm wall-gap configuration and 50ml/min with WFI.
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(c) (d)
Figure 4.8 Leica 3-colour component profiles for tubes formed corresponding to images 
seen in figure 4.4. The graphs show grey level (y-axis) against horizontal 
position. The following conditions were tested: (a) control experiment at 
20ml/min; (b) tube formation using uncoloured 0.50% alginate 
concentration; (c) tube formation at 50ml/min; (d) tube formation at 413pm 
wall-gap configuration; (e) tube formation at “lift-off”; (f) tube formation at 
“lift-off” at 413pm wall-gap configuration; (g) of tube formation at 413pm 
wall-gap configuration infused with WFI; (h) tube at formed at 413pm wall- 
gap configuration and 50ml/min with WFI.
146
the other by about 150pm). Increasing the infusion rate to 50ml/min in figure 
4.8c further reduces the stability of the regulator (that lies further right). 
Changing the device configuration to 413pm wall-gap, 1.0% alginate and 
20ml/min shows an equal spaced regulator. Figure 4.8e-f (300 and 413pm 
configurations) tells us that even at the start of the tube (un-developed flow) 
the gap-width is equally thick and the tube is consistent in thickness to the 
rest of the tube -  this is an indication as to the quality of the tube overall. 
This further strengthens the fact that tubes are now consistent in wall 
thickness throughout the tube length and not just the central section, due to 
the efficiency of the new mark 2 design. Figures 4.8g-h show the effect of 
infusing water through the system instead of CaCI2, i.e. no cross-linking. By 
substituting the linking agent CaCI2 with WFI, there appears to be 
deterioration in gap-width consistency, and therefore tube wall thickness, 
most noticeable for the 413pm device configuration. This seemed to get 
increasingly substantial with increasing infusion rate (fig. 4.8h). This is 
perhaps explained by dilution effects of the permanganate dye by the WFI, 
and hence breakdown in the consistency of the 3-colour profile. Proof of this 
Theory is the blending of the 3-colour profile that indicates the spherical 
regulator blending into the left-hand wall of the glass barrel. It was also 
proven in the previous chapter that tube wall thickness for non-reacting 
propelling fluids ought to be closer to Theory than wall thicknesses for 
reacting propelling fluids. Suffice to say, the high-speed camera gives some 
information, but its accuracy as a monitoring tool is questionable.
Finally, figure 4.9 shows the spherical regulator at 2 positions along 
the tube length, a tenth of a second apart. A marked position on the ball 
showed the effect of ball spin. Surprisingly the ball did not spin in any 
direction at all. This explains the carrying of a wall thickness throughout the 
length of the tube (i.e. a thinned wall on one side would be seen throughout 
the tube length) since no ball spin indicated no ball position correction. This 
is an important finding since ball spin could mean the ball ricocheting 
throughout the glass capillary, which would in turn affect tube wall 
consistency. Furthermore, if all wall characteristics are the same throughout
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Figure 4.9 High-speed camera images of tube formation to observe ball spin in 
developed flow. Two time points are shown at: (a) t=4.268 seconds; and (b) 
t=4.380 seconds.
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Figure 4.10 Flow diagram of experimental decisions for section 4.3.
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the tube, only one point in the tube need be monitored (such as section 
4.1.3) to determine tube consistency in a mass-production scenario.
4.3 MONITORING PARTICLE SIZE
4.3.1 Particle Size Detection
So far within this chapter, we have managed to find a reliable method of 
monitoring tube wall thickness. As we have seen from the previous sections, 
this wall thickness is very much dependent on the particles we embed within 
it. Inert solids such as glass beads will affect wall thickness as a function of 
concentration. Biological cell addition is left unanswered until the Chapter 5. 
Logic dictates that compressibility of the particles introduced is but one 
factor, another would be size and we have also mentioned concentration. 
We therefore require a monitoring method to detect particle size and also 
enumerate the particle concentration. If we can monitor the particle 
suspension prior to addition to the alginate, pre-tube formation, we gain 
another level of control of wall thickness. Figure 4.10 shows how this fits into 
the experimental decisions. To reiterate, glass beads were used as a model, 
but alginate structures -  be it as beads or tubes -  are commonly used for 
biological cell encapsulation. Wall thickness of our tubes would therefore 
determine nutrient and waste product exchange across the alginate walls. 
This would apply to both cells embedded within the walls (those cells furthest 
from the outer wall will have decreasing access to nutrients) or a lining of 
cells on the inner wall of an alginate tube.
Three techniques were evaluated for particle sizing and enumeration 
purposes: the Malvern Particle Sizer, the Leica QWin, and the 
Haemocytometer. For the remainder of this thesis, rat smooth muscle cells 
were used as a model, and particle number and size consistency across the 
suspension was concluded the governing variables. Particle size can be 
interpreted as variation in individual cell sizes or as aggregates of several
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cells. The aim of this experiment was to determine a way of detecting 
particles and differentiating on the basis of particle size and number.
The Particle Sizer is a device used for analysing particle size and size 
distribution. Malvern is just one company of many, each device using 
different technology to obtain the required results. Such techniques can 
include dynamic light scattering, image analysis, laser diffraction, electrozone 
sensing, x-ray sedimentation, sieves methods or centrifugal particle size 
analyser methods. The device from Malvern uses the principle of laser 
diffraction, also known as low angle light scattering, which scatters a beam 
passing through a sample of suspended particles, which in-turn scatters onto 
a detector. The intensity of light is then converted via a mathematical 
algorithm to give a particle size distribution plot. The Leica QWin is a 
hardware/software solution used to quantify microscopic results. It can be 
used with stains and image-enhancing software to obtain absolute 
measurements from 2d images of cell samples under the coverslip on a glass 
slide. The haemocytometer has long been a laboratory standard for manual 
cell counting. Based on a modified glass slide with a grid, a cell sample can 
be injected under a cover slip and counted using a stain and a light 
microscope. However between users and repetitions, the same sample has 
been known to vary by up to 30% (Peebles et al. 1981). Although it is 
possible, with high magnification and a graticule, to obtain size distribution 
information of cells, this would be extremely time-consuming and inaccurate 
and large aggregates may be excluded by coverslip. Therefore, rather than 
for direct detection of aggregates, here the haemocytometer was used for 
cell enumeration, and served as a control for the other two methods.
The particle sizer was firstly calibrated against inert glass beads of 
known size (fig. 4.11). The particle sizer clearly demonstrates a sharp peak 
at 7.2|nm, and the glass beads are stated to be between 3-10pm in diameter. 
As expected since the different concentrations of cells originated from the 
same sample source, a common profile was repeated throughout the 5 sets 
of data (fig. 4.12a). These profiles are further differentiated from one another 
by estimating the number of particles (fig. 4.12b), which was done on a basis
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Figure 4.11 Calibration profile using the Malvern Particle Sizer. Inert, 3-10pm glass 
beads in WFI were used at 20°C. Dotted line is a linear interpolation 
between points taken. Y-axis represents a percentage based on number of 
beads counted.
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Figure 4.12 Particle size distribution plots obtained using the Malvern Particle Sizer by
(a) % band of sample analysed and (b) estimated number of particles on a 
basis of cell area. Profiles were taken for cell concentrations of: 2X106; 
1.5X106; 1X106; 5X105; and 1X105 cells/ml in 15ml complete culture medium 
at 20°C. Coloured lines are linear interpolations between points taken. 
Cells were harvested at passage 19.
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of area for one perfectly round cell. The area differs from experiment to 
experiment based on the initial one-cell peak, which is 32.4pm taken from 
figure 4.12a. The estimated particle number data used to compile figure 
4.12b was then statistically analysed.
In order to establish whether there is any statistical difference (or 
similarity) between the datasets for differing cell concentration, a one-way 
analysis of variance (ANOVA) for a set of correlated samples was performed 
for the estimated particle number data in figure 4.12b. The t-Test is perhaps 
the most widely used statistical tool of all time, as it tells the user whether: 
two independent variables are related to one another; and secondly if we 
alter the level of one variable, would we alter the level of the other. This is 
useful for comparing two sets of data, but where multiple t-Tests are required 
for several sets of data, the ANOVA test is much more suitable since it 
removes the disjunctive probability of any two sets of data being significant at 
the 0.05 level purely by chance. What this means is that if we are comparing 
for significance of a treatment (in this case, cell concentration) and this 
occurs at a 0.05 level (or 5%), then if we have k=5 sets of data, that makes 
the likelihood of significance between any two of the sets of data 25%. The 
ANOVA test removes this addition of disjunctive probabilities. The samples 
are correlated since we compare on the basis of size of particle -  in order for 
two graphs to be similar the % band peaks for both need to occur at the 
same particle sizes. Appendix C summarises the calculations. Using the df 
values of 4, 124, one can obtain critical F values of 2.45 at 5% and 3.48 at 
1%. The F value of 10.6816 lies to the right of the 1% level meaning that the 
differences caused between the 5 sets of data by changing cell concentration 
are highly significant.
Given that this experiment was also intended to explore the 
robustness of the Malvern particle sizer to fluctuations in cell concentration, 
this statistical test is rather alarming. However, one must consider the 
limitations of the ANOVA test. A significant F-ratio tells you whether any of 
the analysed datasets are significantly different to one another, but it does 
not tell you which of the datasets are significantly different and by how much. 
This is where the TUKEY HSD (honestly significant difference) test can
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enrich the information that the ANOVA does not provide. Appendix C tells us 
how dataset 4 (5x105 cells/ml) differs to the 5% level and dataset 5 (1x105 
cells/ml) is significantly different to the 1% level. This is apparent when 
looking at figure 4.12. Figure 4.12a shows a slightly different shape for the 
red profile (5x105 cells/ml) and this is exaggerated when using estimated 
particle number data in figure 4.12b. The abnormal level of large aggregates 
is detected in the red profile. The green profile however, for 1x105 cells/ml in 
fig. 4.12b is relatively flat compared to the other concentration samples. 
There are simply not enough cells in this sample to form any similarities with 
the other concentration profiles. From preliminary statistical tests (data not 
shown), % band information would not be satisfactory to discriminate 
between any of the 5 profiles, and therefore estimated particle number data 
was necessary. As previously stated, we will continue to used % band 
information to establish the one-cell peak and then use this to calculate the 
estimated particle number, and this will differ from experiment to experiment. 
Other than robustness, the analysis also requires sufficient sensitivity to 
detect significant changes to the profile, and this is where estimated particle 
number data is essential for the remainder of the particle size analysis 
experiments.
The figure further establishes the working range of particles needed to 
obtain a signal. The overall profile however did not form the shape 
anticipated for a rat aortic smooth muscle cell. All 5 sets of data show an 
initial peak at 10pm followed by a normal distribution at 30pm, and another at 
60pm. From observing a rat smooth muscle cell under a light microscope at 
x40 magnification using a graticule, and from literature we know that average 
cell size ought to be ~20pm diameter (Alberts et al. 2002). At this stage, it 
was that believed that the 30pm peak represented a population of single 
smooth muscle cells. It was unknown at this stage what the 10pm or the 
60pm peaks were.
The same cell sample was then analysed using the Leica QWin. 
Comparative cell size profiles can be seen in figure 4.13. It is instantly 
apparent that the level of particle size information gained from the Leica
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Figure 4.13 Comparative size distribution plots created from Leica QWin data. Profiles 
correspond to cell concentrations of: 2X106; 1.5X106; 1X106; 5X105; and 
1X105 cells/ml in complete culture medium at 20°C. Coloured lines are 
linear interpolations between points taken. Cells were harvested at passage 
19.
Table 4.3 Summary table of the techniques tested for use in tissue engineering
and the conclusions as to their suitability.
Technique Features Conclusion
Particle sizer Measures particles 0-120 pm, 
operates on the principle of particles 
crossing the path of a beam in a 
sampling cell, 10ml of sample 
required. Minimum number of 
particle counts -  1X105cells/ml.
Only gives % of cells counted and 
does not actually count cells, but 
generally easy to use and generate 
data provided concentration of 
sample is already known. Hence 
suitable for screening of cell 
suspensions prior to use in tissue 
engineering applications.
Leica QWin Measures particles at multiple 
points, range depends on 
magnification, obtains results via 
manipulation of a 2D image from a 
sample under a coverslip, 1ml 
sample volume required. Minimum 
number of 20 cell counts per grid.
Needs calibration with 
haemocytometer for cell counting. 
Preset particle areas, making heavy 
data manipulation necessary. Poor 
level of detail for cell size 
distributions created. Not suitable 
for tissue engineering screening.
Haemocytometer Measures particles via staining and 
light microscopy, range dependent 
on magnification, data must be 
obtained manually, 1ml of sample 
required. Minimum number of 10 
cell counts per grid.
Suitable for tissue engineering but a 
slow technique with much inherent 
error from the operator.
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QWin is not as detailed as the particle size graphs obtained using the 
Malvern particle sizer. The same ANOVA test was run for the raw data used 
to compile figure 4.13 and the tabulated results can be seen in Appendix C. 
Critical 5% and 1% values were 2.82 and 4.26, respectively and the F result 
was 3.319, meaning that the 5 sets of data are not identical but there are 
statistical similarities. The TUKEY HSD test shows that datasets 2 (1.5x106 
cells/ml) and 5 (1x105 cells/ml) are statistically different to the 5% level, which 
accounts for the slightly significant F ratio difference seen in the ANOVA. 
Due to the restricted information gleaned from the Leica QWin, all profiles 
show a peak at 1 cell diameter (~20pm), and there is also a population at 2-3 
cell diameters -  which corresponds to the 60jLim peak observed using the 
Malvern. It can be seen that the 1 cell diameter peak for the pink 1.5x106 
cells/ml profile is abnormally high, given the y-axis is estimated particle 
number. Due to the sensitivity of the Leica, the 10pm peak is not detected. 
A hypothesis that the two techniques show the same data was tested 
statistically. A comparison of the 2x106 cell/ml concentration data for both 
the Malvern and the Leica was analysed by ANOVA. The 5% and 1 % critical 
F values were 7.71 and 21.20, respectively. An F-value result of 9.4263 
means that the differences between the two methods are not strongly 
connected, yet they are not too dissimilar -  a result we expect given the 
datasets are from two different devices. Essentially both monitoring methods 
show two main peaks, now thought to consist of a population of single cells 
at 30pm and a second population of 2-3 cell aggregates creating a 60pm 
peak. From this we can gather two important points. Firstly both devices are 
capable of detecting particle presence, and measure particle size. 
Secondly, the both techniques are not sensitive to fluctuations in particle 
concentration, and the limitations of concentration range -  i.e. comparing 
samples with large concentration differences.
However, it must be noted that the detail of information from the 
Malvern particle sizer was much more useful than the data obtained from the 
Leica QWin, with much less effort. The Leica QWin required a lot of data 
manipulation per image, which was then used to create a size distribution 
plot and the low level of resulting information after analysis was based on
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much fewer cells (due to the area physically analysed by the Leica). The 
particle sizer can tell us the degree of homogeneity of the particle sample. If 
there were a large number of aggregates, the analysis would show this in the 
form of a peak on the size distribution profile. It was deemed that the 
information gathered from the particle sizer was much more valuable and 
convenient than that obtained from the Leica QWin. A summary can be seen 
in table 4.3.
4.3.2 Particle Enumeration
In this experiment we compared the effectiveness of the haemocytometer 
and the Leica QWin for particle enumeration. The particle sizer is only 
capable of giving results as a percentage and not a total count of the 
particles, therefore for enumeration purposes the Malvern was omitted.
Figure 4.14 shows cell images taken by the Leica QWin microscope. The 
image at x40 (fig. 4.14a) was used in preliminary scans for experimental 
setup purposes. The image clearly shows cells at two different diameters. 
The central cell appears to be two times larger in diameter than the other two 
cells. Figure 4.14b shows a cell scan at x10 magnification. Such an image 
was then used to compile graphs such as figure 4.13. This cell image shows 
cells at two different sizes as the previous cell scan, but also two-cell and 
multi-cell aggregates. These images show how the peaks at 30pm and 
60pm could have resulted -  from two cell diameters and cell aggregates.
In figure 4.15, it can be seen how the two techniques compare. The 
haemocytometer gives an accurate representation of cell concentration up 
until 1.0X106 cells/ml, but the last two data points (1.5 and 2.0X106 cells/ml) 
seem to stray away from the perfect fit line. At these higher concentrations 
the data from the Leica QWin fits the perfect-fit line better than the 
hemocytometer. But overall the haemocytometer gives less variable data 
due to a smaller CV (error bars). On this last point, it can be summarised 
that the haemocytometer is more reliable than the Leica QWin for cell
156
(a) (b)
Figure 4.14 Leica images of rat aortic smooth muscle cells at (a) x40 and (b) x10 
magnification.
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Figure 4.15 Trend showing cell enumeration against corresponding cell concentration.
Comparison of cell counts using Trypan Blue and the haemocytometer (■) 
with those from the Leica QWin (A) .  Cell concentrations of: 2X106, 1.5X106, 
1X106, 5X105 and 1X105 cells/ml were tested. The cell count corresponds to 
the number of cells counted in a 10mm2 area. All cells in complete culture 
medium and 20°C. The solid line is the perfect fit line, i.e. the actual cell 
count for any given concentration of cells.
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counting up to 1.0X106 cells/ml. Above this concentration, dilution would 
usually be done, since the count would be too time consuming. The lack of 
good fit of data to the perfect fit line could be due to large aggregates not 
being able to fit under the coverslip -  which applies to both methods.
The particle sizer is an excellent tool sensitive enough to detect 
changes in the distribution of particle sizes, however it is not a tool for cell 
counting. The Leica QWin can analyse a small number of cells of preset size 
ranges, making data manipulation difficult and long-winded. The sampling is 
also only that of a microscopic slide, making data slightly unreliable. So both 
techniques have their limitations.
At this stage it was decided not to pursue the Leica QWin as a form of 
analysis. Granted the Leica QWin is not a particle sizer and the data 
manipulation required in order to achieve particle size information was also 
very time-consuming. It also didn’t perform very well as a cell enumeration 
method. The number of cells counted per area was an estimate that required 
the haemocytometer for calibration in the first place. Also the physical area 
analysed was ~ a fifth of the area analysed by the haemocytometer making 
the errors substantial. In summary, despite the many strengths of the Leica 
QWin found by other groups, particularly for automotive cell enumeration 
(Jacobs et al. 2001; Law et al. 2003), the technique was found unsuitable for 
particle enumeration for our process.
4.3.3 Enumeration Using The Capillary Cytometer
Going back to the experimental thought process (fig. 4.10) we have failed to 
find a monitoring method for cell enumeration. Section 4.3.2 established that 
manual counting via the haemocytometer remains the best method of 
enumeration due to the inconvenience of data manipulation required and the 
assumptions made (for cell area) for the Leica QWin. Biological research 
has conventionally used haemocytometer measurement and staining with 
Trypan Blue as a technique for cell enumeration. Although this is widely 
accepted as the standard, it is well known that variability due to different
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operators can result in errors of up to 30% (Peebles et al. 1981). We 
therefore require another method to enumerate particles -  in our experiments 
these particles were rat aortic smooth muscle cells. Continuing with the 
theme of reproducibility and automation, we evaluated the use of a capillary 
cytometer combined with a fluorescence staining with Guava ViaCount Flex 
reagent. The Guava EasyCyte is a bench top capillary cytometer that can 
automatically count 100 cells per second from a standard 96-microwell plate.
Figure 4.16 shows how two cell-encapsulated tubes compared when 
enumerated using both haemocytometer and Gauva capillary cytometer. 
Both cell enumeration methods pivot about the number balance line, with the 
Trypan Blue and Guava ViaCount Flex giving inter-tubular (fig. 4.16a) cell 
counts with CVs of 29.8 and 17.6%, and intra-tubular CVs of 37.3 and 44.8%, 
respectively. One could comment that the Gauva flow cytometer is similarly 
effective at cell enumeration. Due to the lack of experiment datasets and 
points, statistical analysis could not be performed. However, this experiment 
does show that capillary cytometry can offer an attractive automated 
alternative to conventional manual cell counting methods. The device will be 
further explored in the next chapter.
4.4 CONTROL OF MAMMALIAN CELL CULTURE
4.4.1 Effect of Pipetting to Breakup Cell Aggregates
Having now established the data gathering tools required for both particle 
size and enumeration, we turn to control of cell culture processing (fig. 4.17). 
As we have already discussed, it is likely that a successful process for 
manufacture of alginate tubes could be used for macro-encapsulation of 
biological cells or will contain biological cells for the production of tissue- 
engineered products. From a purely generic perspective, it is favourable in 
the majority of cases to have a homogeneous suspension of biological cells 
of known size, so as not to disrupt wall thickness upon integration into an
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Figure 4.16 Cell quantification analysis by light microscopy and capillary cytometry.
Weighted-average total cell counts for (a) inter and (b) intra-tube cell 
enumeration comparing Trypan Blue cell counting with Guava ViaCount Flex 
reagent. Dashed line represents weighted average cell count expected via 
a calculated number balance. All tubes were made as described in section 
5.3.1.
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alginate-cell tube, since cell wall thickness will determine the ease of flux of 
nutrients and waste products across the tube walls and ultimately the viability 
of the cells dwelling within. Large cell aggregates will also mean necrosis 
within the aggregate centres that have little access to nutritional sources 
(Sen et al. 2002).
In mammalian cell culture, there are three non-controlled variables 
whereby the particle size could be influenced -  the first of these is the degree 
of pipetting. We have previously found a statistically sensitive method of 
detecting changes to particle size profiles. It is therefore the aim of this sub­
section to see whether controlled pipetting induces changes to the “normal” 
distribution of cell sizes previously found and whether the Malvern can detect 
these changes. The experimental thought process is summarised in figure 
4.17.
Pipetting is a commonly used mammalian cell laboratory technique 
used to breakup cell pellets after centrifugation. It is well known that breakup 
of aggregates is due to shear stress (Serra et al. 1997; Serra et al. 2007; 
Colomer et al. 2005). In essence pipetting is a method used to achieve a 
more homogeneous cell suspension. However the degree of pipetting is not 
controlled in manual cell culture. Therefore in this study, it was decided to 
look at the effect of passes using an autopipette. This experiment was 
calibrated against time to keep all variables constant and controlled. Any 
effect of time on aggregation (and the profile of the particle size distribution 
histogram) was assumed negligible at time zero -  i.e. at time of resuspension 
of pelleted cells -  due to the lack of any new aggregates formed with time. 
The results can be seen in figure 4.18. An ANOVA statistical analysis on the 
estimated particle number data gives a F-ratio of 1.6264. 5% and 1 % critical 
values of 2.45 and 3.48 mean that the differences amongst the profiles are 
not significant, i.e. the treatment of pipette passes to create shear to cell 
aggregates is not effective. This negative result can mean one of several 
possibilities: either (1) the shears generated by the autopipette tip is not 
sufficient to breakup any cell aggregates present in the cell suspension; (2) 
breakup does occur, but the Malvern is not sensitive enough to detect it; or
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Figure 4.17 Flow diagram of experimental decisions for section 4.4.
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Figure 4.18 Particle size distribution plots obtained using the Malvern Particle Sizer by
(a) % band of sample analysed and (b) estimated number of particles on a 
basis of cell area. 5 conditions (passes through a pipette) were tested and 
each experiment was timed: 0 passes at time, t=0; 0 passes at time, 
t=24min; 0 passes at time, t=44min; 5 passes at time, t=5min; and 20 
passes at time, t=9min. Coloured lines are linear interpolations between 
points taken. Cells were harvested at passage 28.
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(3) no aggregates are actually present. The 30pm and 60pm peaks seen in 
figure 4.12a correspond to the 20pm and 40pm peaks seen in figure 4.18a as 
a matter of coincidence and these peaks are 2 distinct populations of single 
cells -  a Theory supported by images seen in figure 4.14. This result can be 
interpreted in a positive way -  since degree of micro-pipetting does not 
influence aggregation of cells significantly, it is not a factor we need to control 
in a well-engineered generic process for creation of cell-integrated alginate 
tubes.
4.4.2 Effect of Holding Time and Gauze Filtration on Cell Aggregation
The next non-controlled cell culture variable we will investigate is holding 
time. Holding time is the time a cell spends in suspension, after harvesting 
but prior to processing -  and this can be considerably different between 
batches. The Smoluchowski Theory describes aggregation of suspended 
colloidal particles due to Brownian diffusion via collision and formation of 
intercellular bonds (Longmire and Frojmovic 1990). This can be extended to 
include move of cells on the tissue culture surface (Neelamegham et al. 
1997), although in both cases state of aggregate formation is dependent on 
holding time. Hence the object of this set of experiments is to study the 
effect of holding time and measure the effect on aggregate formation using 
the particle sizer.
Holding times up to 3 hours were tested. As an aggregate free control 
experiment, the cell solution was also passed through an autoclaved filter of 
a 20pm diameter sieve/gauze, intended to reduce the cell suspension to a 
population of single cells only.
Figure 4.19 shows the effect of holding time on particle size distribution at 
hourly intervals. Figure 4.19a does not show any large difference between 
profiles, but figure 4.19b does. The profiles at 2 hours (yellow) and 3 hours 
(blue) clearly are markedly different from early profiles. ANOVA analysis 
gives an F-ratio at 3.1977 with critical 5% and 1% values at
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Figure 4.19 Effect of holding time on unfiltered cell size distributions using the Malvern 
Particle Sizer by (a) % band of sample analysed and (b) estimated number 
of particles on a basis of cell area. Conditions were: 0 hours; 1 hour; 2 
hours; and 3 hours. Holding times were calculated from the moment cells 
were resuspended after centrifugation and vortexed to dispel all aggregates 
formed. Cell concentration throughout was 1X106 cells/ml in 10ml complete 
culture medium at 20°C. Coloured lines are linear interpolations between 
points taken. Cells were harvested at passage 14.
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Figure 4.20 Effect of holding time on filtered cell size distributions using the Malvern 
Particle Sizer by (a) % band of sample analysed and (b) estimated number 
of particles on a basis of cell area. Conditions were: 0 hours; 1 hour; 2 
hours; and 3 hours. Holding times were calculated from the moment cells 
were resuspended after centrifugation and vortexed to dispel all aggregates 
formed. Size filtration was performed using a syringe with a 20(im pore 
gauze membrane. Cell concentration throughout was 1X106 cells/ml in 10ml 
complete culture medium at 20°C. Coloured lines are linear interpolations 
between points taken. Cells were harvested at passage 14.
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2.70 and 4.00 indicating significance at the 5% level. A TUKEY HSD test 
reveals there to be a significant difference between profiles at 0 hours and 3 
hours. This shift of the peaks towards the right is an indication of cell 
aggregation. As time increases, the likelihood of two particles colliding 
increases and aggregate formation results. 3 hours appears to be a 
statistically significant time upon which aggregation effects are noteworthy. 
Figure 4.20 shows the same cell sample processed through the 20pm gauze 
membrane. With an ANOVA result of F at 1.1933 and the same critical 
values, this time the profiles are statistical similar. This means that although 
there might be presence of aggregates, especially significant after 3 hours, 
the gauze filters out presence of particles, be it cells or aggregates of cells, 
any larger than 20pm. The 3-hour (blue) particle size distribution shows a 
peak at 30pm, but certainly no significant peaks any larger than this. This 
would be a good process control measure for cell size homogeneity.
4.4.3 Effect of Centrifugation and Passage Number on Cell
Aggregation
This final study concentrates on the effect of centrifugation on cell size 
distribution. Because centrifugation is a concentration step commonly used 
in any cell culture process, yet the protocols involved (i.e. centrifugation steps 
and speed) will differ from lab to lab. As explained in the previous sub­
section, aggregation is an outcome from collisions of particle and intracellular 
bond formation (Longmire and Frojmovic 1990). Centrifugation speed, which 
hastens cell settlement (Furukawa et al. 2003), and time (see above) will 
impact on cell aggregation. And the intracellular bond strength will determine 
the size of the aggregates after resuspension.
Figure 4.21 shows the results of the experiment. Visibly the graphs for 
% in band and estimated particle number do not show any large differences 
between groups for centrifugation within the range of 0 -  500g. This range 
reflects a realistic centrifugation range that maybe used in cell culture. The
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Figure 4.21 Effect of centrifugation on cell size distributions using the Malvern Particle 
Sizer by (a) % band of sample analysed and (b) estimated number of 
particles on a basis of cell area. Conditions tested were: uncentrifuged 
cells: cells centrifuged at 100xg for 5 min; and cells centrifuged at 500xg for 
5 min. Rat SMCs cells, cell concentration of 1X106 cells/ml, 10ml complete 
culture medium and 20°C were maintained constant throughout. Coloured 
lines are linear interpolations between points taken. All cells harvested at 
passage number 13.
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Figure 4.22 Effect of passage number on cell size distributions using the Malvern 
Particle Sizer by (a) % band of sample analysed and (b) estimated number 
of particles on a basis of cell area. Cell concentration throughout was 1X106 
cells/ml in 10ml complete culture medium at 20°C. Coloured lines are linear 
interpolations between points taken. Cells were harvested at passage 
19,28,14 and 13.
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three sets of data were compared using ANOVA tests. The F result of 
2.5722 falls to the left of the 5 and 1% critical values of 3.15 and 4.96, 
meaning that the treatment had no significant impact on the size distribution 
profile. This result indicates that within the range tested, increased 
centrifugation speed only served to speed the formation of the cell pellet, 
rather than cause any significant cell aggregation, which would be reflected 
by a shift of the 15pm peak to the right. In essence, centrifugation is not a 
variable that will cause batch-to-batch variability in particle size homogeneity 
between cell suspensions.
At this stage we have cell size distributions for cells at passage 19, 28, 
14 and now 13. These were plotted and compared in figure 4.22. In each 
case, the profile generally remains the same, an initial peak (to date 
unidentified), a population of single cells and a second population of two cell 
diameter particles, possibly made up from larger cells or multiple cell 
aggregates. What does seem to change however is the size of the 
populations in each of these peaks. It was hypothesised that this could be a 
result of cell passage number (generation number of the cell), due to 
adaptation of cells to the culture media over several generations (Conlon and 
Raff 2003). Despite there being no sort of pattern emerging from figure 4.22, 
the profiles for 1x106 cells/ml at passage 19, 0 passes at passage 28 and 0 
hours unfiltered at passage 14 were statistically compared. An ANOVA F- 
ratio of 0.7423 falls far to the left of the 5 and 1% critical values at 2.70 and
4.00 respectively, indicating no statistically significant difference between the 
profiles. If there is any difference in average cell size, resulting in a shift of 
the cell size distribution to the right (increasing cell diameter and resulting 
aggregate sizes) then this is not noticeable in the 4 datasets at different 
passage numbers.
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5 Impact of Cellular Integration
This final chapter brings all elements of the cell-integrated tube together -  the 
alginate tube, monitoring methods and the biological cells -  and looks at the 
system in its entirety. What happens when we integrate cells into the alginate 
tube walls? How does this impact on the fluid mechanics? We have already 
witnessed the effects of addition of inert glass beads, and discovered that they 
influence wall thickness as a function of concentration. However, we left the 
question of impact of cellular addition unanswered in Chapter 4 (fig. 5.1), as it 
seemed more appropriate to answer it in this final chapter.
As we have discussed, it is likely that the end use of an alginate tube 
would be either a macro-encapsulation envelope or perhaps it could be 
developed into a tissue-engineered product. Either way, biological cells will be 
either lined on the inner tube walls, or integrated within the walls. Since the 
latter option is more complex, we decided to develop this aspect in this thesis. 
Despite the fact that the tube can be used with any biological cells, rat aortic 
smooth muscle cells were used as a model, therefore other than simple 
mechanical aspects such as viability, no other cell identification steps were 
performed. As we know, cells are not rigid objects, and mammalian cells in 
particular are fragile and prone to lysis by process factors such as shear 
(Serra et al. 1997; Serra et al. 2007; Colomer et al. 2005). In concentrations 
such as those required to create a cell-integrated tube, percentage of cell 
viability could influence viscosity (due to cytosol leakage), which subsequently 
impacts on cell aggregation (Sen et al. 2002), which in turn impacts on wall 
thickness. Alginate wall thickness will control the level of oxygen tension and 
availability to embedded cells, which will cyclically influence cell viability 
(Schneider et al. 2004).
The aims of this chapter are therefore: to control the impact of cell 
addition to tube wall thickness; to introduce reproducible cell-alginate mixing 
method; to monitor biological cell viability as a result of process shears 
through the tube-forming process and as a result of integration with all media; 
and to control and quantify particle spatial distribution in alginate hydrogel.
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5.1 CELL IMPACT TO WALL THICKNESS
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5.1.1 Effect of Biological Cell Addition On Tube Wall Thickness
This first experiment aimed to introduce biological cells to the alginate tube 
and measure impact on tube wall thickness as a result (fig. 5.1). Chapter 3 
demonstrated the reproducibility and consistency of the tube-forming device 
described in (Mason and Town 2002) to produce alginate tubes of pre-defined 
length and wall thickness from well-mixed liquid alginate. As described 
previously -  by measuring length of the tube with a known fixed volume (and 
density) of alginate, one can use the relationship between the two to back- 
calculate an average wall thickness, assuming that the tube walls were formed 
evenly on all sides. This method gave results with CV of ~1.0%. Although this 
measurement technique relies on the said assumptions, it remains one of the 
easiest methods to determine tube quality at time of formation. These results 
were then followed by a full cell-integrated tube OCT scan, post tube- 
shrinkage, at Cranfield University (5.1.2).
By comparing the trends of cell-integrated tubes with cell-free alginate 
tubes at identical concentrations, figure 5.2 demonstrates that the cell- 
integrated alginate tubes also share high correlation to linear trends, ranging 
from R2 0.9972 -  0.9998, indicating good tube quality control. There is also an 
obvious decrease in gradient of the slopes with an addition of mammalian 
cells. This means that the cell-integrated tubes are shorter with thicker walls 
at the same volume of sample used. This result corresponds with that seen in 
table 4.1 from section 4.1.1. A possible theoretical explanation for this 
phenomenon maybe due to the solidity of the matrix fluid -  as we embed solid 
particles into the alginate, it’s ability to flow is impeded, and therefore the 
contraction or thinning effects of the spherical regulator dragging the matrix 
fluid upwards. This results in a thickness much closer to the experimental 
maximum TB « % x 8o. With gap widths of 238, 300 and 413|nm, these values 
would be 159, 200 and 275pm. By back calculating we can crosscheck this
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Figure 5.2 Length of tube formed as a function of injected volume of sample in the 
presence (cell-integrated, solid symbols) or absence (cell-free alginate tubes, 
hollow symbols) of SMCs at 1x107 cells/ml concentration. Wall gaps (space 
between glass capillary and plastic regulator) were (■) 238pm, ( • )  300pm 
and (A) 413pm giving calculated tube wall thicknesses of 164.2pm ± 6.4pm, 
196.6pm ± 8.8pm, and 285.3pm ± 9.2pm as calculated from cell-free tube 
data. Symbols represent single lengths of tube formed measured with a 
precision steel rule (see Materials and Methods). Solid lines represent linear 
regression fittings of the data for each cell-integrated tube whilst dashed lines 
represent linear regression fittings for cell-free alginate tubes under the same 
conditions. R2 values for cell-integrated tubes were 0.9998, 0.9973 and 
0.9996, respectively. Conditions used throughout: 1% w/v alginate 
concentration, CaCI2 infusion rate 20 ml/min, mark 2 device.
Table 5.1 Tabulated wall thicknesses derived from figure 5.2.
Gap Width 
(pm)
Barrel Radius 
(mm)
Cell-Integrated 
Graph Slope 
(mm/pl)
Nominal Wall 
Thickness, T0 
(pm)
Pure Tube 
Graph Slope 
(mm/pl)
Nominal Wall 
Thickness, T0 
(pm) CV (%)
238 1.83 0.556 0.164 0.577 0.158 3.91
300 2.00 0.426 0.197 0.444 0.188 4.48
413 2.00 0.300 0.285 0.309 0.276 3.25
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hypothesis based on the assumption that the tube walls are uniform. Table
5.1 gives a summary of results. Indeed cell-integrated tubes are closer to TB 
than pure alginate tubes.
Since manual cell-integration provides no way to control distribution of 
cells and clumping, this makes the reproducibility of these results 
questionable. CV of lengths of tubes formed using the mark 2 tube-forming 
device generally does not exceed 5%, and we can see that the difference 
between the gradients of the cell-free and cell-integrated alginate tubes comes 
close to this figure. Therefore, cellular additions up to 1x107 cells/ml 
concentration may substantially affect average tube wall thickness under 
worse manual mixing conditions, and hence may compromise tube 
mechanical uniformity and therefore structural integrity, if the cells are not 
introduced in a controlled manner.
5.1.2 Static Mixers and Impact on Wall Thickness
In sub-section 5.1.1 we measured tube length to back-calculate tube wall- 
thickness. This next experiment directly measures wall thickness of cell- 
integrated tubes using OCT. But first we must introduce a new method of 
controlling cell integration with liquid alginate, which figure 5.2 showed in the 
last sub-section is inadequate via manual integration. The aim here was 
therefore to show the uniformity in wall thickness of a control cell-free alginate 
tube, and then to integrate cells into alginate, via hand-mixing and static 
mixing and compare the differences in uniformity.
We have already seen that cells will affect wall thickness, and the lack 
of homogeneity of cell distribution in the previous experiment. It is envisaged 
that the cell integration method will better control this aspect. This method 
should not just evenly distribute cells within liquid alginate, but also limit the 
amount of shear damage to the cells. Although hand mixing is usually 
acceptable in laboratory protocols, an automated method would be required in
Cell suspension 
inlet
Alginate solution 
inlet
Figure 5.3
Figure 2.14
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A scale diagram showing the experimental setup. The tube-forming device 
was modified by addition of a dual-port stainless steel coupling and an 8 to 12 
element static mixer. Diagram shows components aligned but not coupled. 
Dead volumes within the entire static mixer arrangement and tube-forming 
device are -0.31 pi and 89pl, respectively.
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Schematic diagram (not to scale) showing experimental setup used for Optical 
Coherence Tomography (OCT) scanning of cell-integrated tubes. The 
longitudinal (numbers 1-6) and radial (letters A-C) locations correspond to 
images seen in figure 5.5.
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an industrial process. Popular automated methods of mixing cells include 
roller mixing, impeller mixing and static mixing. Roller mixing requires long 
periods of time to achieve homogeneity while impeller mixing is known to 
generate large shear forces and reduce viability of mammalian cells (Abu- 
Reesh and Kargi 1991). Kenics design static mixers offered a cheap, 
negligible shear (Bertsch et al. 2001), and disposable (hence sterile) option. 
Figure 5.3 demonstrates a schematic of how a static mixer was used to 
integrate concentrated cell suspension with liquid alginate to give a resultant 
cell-alginate mixture of 1x107 cells/ml and 1.0% alginate concentration, and 
how this setup was incorporated with the tube-forming device.
The experimental setup is shown in figure 2.14. Figure 5.4 shows the 
OCT scans for tubes of all 3 conditions. Again, since the tube was analysed 
within the glass barrel, we see two lines, the first thin line represents the glass 
to CaCb liquid interface, the second represents the liquid to alginate wall 
interface and the third the alginate to liquid interface. Here we see a 
representation of the results obtained for each of the conditions and each of 
the 6 points along the tube, however there are 18 scans per tube and 2 tubes 
per condition and all results were used to compile figure 5.5. The variation in 
wall thickness along the length of the tube was quantified by calculating the 
coefficient variation (CV) of the wall thickness values obtained (n=18) for each 
tube.
The OCT scans reveal mean wall thicknesses to be 157.2±12.1pm and 
134.3±8.2pm for the pure alginate tubes; 160.4±68.3pm and 349.5±150.5pm 
for hand-mixed cell-integrated tubes; and 160.6 ±10.1pm and 135.6±14.1pm 
for 12-element statically mixed cell-integrated tubes. Clearly the manually 
integrated cell-tubes were less uniform than pure alginate or static-mixer 
integrated cell tubes. Figure 5.5 shows CV data compiled from these OCT 
scans. Wall thickness of cell-free alginate tubes had an average CV of 7% 
along the length of the tube while hand-mixed cell-integrated tubes had a CV 
of 43%. It is hypothesised that the variation in wall thickness observed in cell 
integrated tubes was caused both by heterogeneous mixture of the cells with
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Figure 5.4 Tube wall thicknesses by real-time OCT scanning. Three types of tubes were evaluated: (a) a control tube: cell-free alginate with inert glass 
beads (to aid visualisation); (b) a hand-mixed cell-integrated tube; (c) a cell-integrated tube formed using the 12-element static-mixer in place. 
Images were taken at selected points along the length of tube as shown in Figure 3, the top line in each image represents the glass interface 
while the lower line represents the wall of the tube, respectively.
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Figure 5.5 Uniformity of tube wall thickness by OCT. Three types of constructs were 
tested in duplicate: control tubes formed with 0.7pm glass beads integrated 
via roller mixer, 12-element statically mixed cell-integrated tubes and hand- 
mixed cell-integrated tubes. Wall thickness was measured at 18 points (as 
shown in figure 5.4) and coefficient variation (CV) was calculated. Mean wall 
thickness, (n=18) ± SD was 157.2±12.1pm and 134.3±8.2pm for control 
tubes; 160.6 ±10.1pm and 135.6±14.1pm for 12-element statically mixed cell- 
integrated tubes and 160.4±68.3pm and 349.5±150.5pm for hand-mixed cell- 
integrated tubes. All tubes were made using: Mark 2 device, 300pm wall gap 
tube-forming device configuration, 1.0% alginate concentration, 1.87ml/min 
sample injection rate, 20ml/min calcium chloride infusion rate at 0.09M 
concentration. Tubes with cells contained cells at 1x107 cells/ml.
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Figure 5.6 Flow diagram of experimental decisions for section 5.2.
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the alginate and variation inherent to manual methods. In order to test this 
hypothesis 12-element static mixers were connected upstream the tube- 
forming device as shown in figure 5.3. OCT scanning indicated that wall 
thickness of cell-integrated tubes processed using a 12-element static mixer 
was more uniform than manual mixing with CVs similar to the ones obtained 
with cell-free alginate tubes (-7%). This result shows that the 12-element 
static mixer can help ensure effective mixing, resulting in cell-integrated 
alginate tubes with greater uniformity of wall thickness.
5.2 CELL VIABILITY STUDIES
5.2.1 Effect of Processing on Viability
In this section we investigated the effect of the process on cell viability (fig. 
5.6). Viability is important due to its direct effect to viscosity of mixtures that 
are used produce the cell-alginate tubes -  i.e. badly managed shear 
conditions could increase cell death, and poorly mixed systems have poor 
tube wall thickness consistency. Other groups have conducted similar viability 
testing to their processes (Sakai et al. 2004; Takei et al. 2006). In 
biochemical/pharmaceutical industries, it is conventional to agitate fluids/solids 
using impeller systems. Whilst this is normally acceptable for suspension 
cultures, here impeller mixing is undesirable due to the scale of the volumes 
used and need for high cell viability. Mammalian cells are large in size and 
hence more prone to shear forces than bacterial cells, produced by such 
mixing systems. The main advantage of static mixing is the negligible shear 
during processing. This is vital for biological cell integration.
In this first experiment, the effect of passing smooth muscle cells 
(SMCs) through the process and the impact on the viability of these cells was 
examined. Cells were counted before after harvesting, used in an alginate
177
mixture to form a tube, which was immediately resolubilised using citrate 
(Orive et al. 2003; Markusen et al. 2006), and the cells were recounted.
Results revealed a cell viability count of 93.1% just after harvesting. 
After processing however, averaged viability dropped to 67.7% ± 6.0. Given 
the CV in counting low cell numbers, this is a substantial drop in viability. It is 
critical to understand which factors have affected viability. The factors must 
be isolated and controlled. Factors that could have affected viability included: 
contact of cells with alginate, CaCI2, sodium citrate, food colouring, or any 
component used to make up these fluids; damage due to centrifugation; shear 
via processing using the static mixer (magnitude of shear ~0.0003N/m2 from 
static mixer); and shear via processing within the tube device (magnitude of 
shear -0.0017N/m2 from tube-forming device) and/or a combination of some 
or all. Previous studies have shown that cellular viability should only fall 
between shears of 0.75-1 ON/m2 (Mardikar and Niranjan 2000).
5.2.2 Effect of Processing on Viability Repeat
The previous experiment showed a 25.4% drop in viability as a result of 
processing cells in order to create a cell-alginate tube. However, the lack of 
automation and consistency prompted a repeat experiment to verify the 
reproducibility of the viability drop before beginning a series of experiments to 
identify the underlying causes.
Initial cell viability counts yielded 97.7% ± 4.6 viability after harvesting. 
C cell counts taken after mixing cells with alginate, prior to processing within 
the tube-formation tube-forming device gave only 25.8% ± 3.7 viability. And 
final averaged cell counts were 16.5% ± 3.7 and 26.3% ± 7.2. This indicated a 
73.6% drop in viability over the 60 min period required to prepare the sample 
and form the tubes. These results show that the largest drop in viability occurs 
during mixing of cells in alginate. Given this huge drop in viability any further 
effects from processing within the tube-forming device appeared negligible. It 
was concluded that the stage of mixing with alginate was highly detrimental to
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the viability of the cells introduced to it. There was a mechanism that was 
actively destroying the cells. This could have been due to toxic effect of 
alginate, CaCI2, redisolution step with sodium citrate, or pH. The exact cause 
was yet to be established. A series of experiments were therefore devised to 
isolate which variables were affecting viability.
5.2.3 Effect of Concentration Steps on Viability
In order to better understand the drastic drop in viability during processing, it 
was decided to run a series of exhaustive tests in order to isolate the main 
causes of this decrease. Conditions tested were all those that might affect cell 
viability throughout normal cell processing (see Appendix A). The first 
condition tested was concentration via centrifugation and resuspension. It was 
hypothesised that the forces exerted within the centrifugation device might 
impact negatively on cell viability within certain limits. Other groups have 
reported affects of centrifugal force on human oral cell carcinoma (Chien et al. 
2006) and mouse sperm (Katkov and Mazur 1999).
Figure 5.7 shows the effects of five consecutive concentration cycles at 
100xg on five different cell concentrations. A horizontal line of best least 
squares fit indicates that there is no cumulative effect to cell viability of up to 
five passes of centrifugation and resuspension steps. Although this is not a 
large centrifugal force applied to the cells, this experiment discounts the 
possible negative effects of cumulative concentration steps at 100xg to 
viability of this type of mammalian cell. Concentration steps would not usually 
exceed 3 cycles however.
5.2.4 Effect of Media on Cell Viability
The next tested condition was possible toxic effect of prolonged exposure to
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Figure 5.7 Viability as a function of number of passes through centrifugation and 
resuspension steps. Cell concentrations: 1x107, 5 x106, 2.5 x106, 1x106 and 
1x105 cells/ml were tested. Conditions used throughout were: centrifugal 
speeds of 100xg at 5 min, rat aortic SMCs, and 20°C. Cell counts were 
conducted using Trypan Blue and a haemocytometer. “No. of passes” 
represents concentration cycles of centrifugation followed by resuspension 
using complete culture medium. Symbols represent averaged triplicate cell 
viability counts using Trypan Blue and a haemocytometer. Solid line 
represents line of best least squares fit through all data points. Error bars 
represent CV across data points.
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any of the media used during the processing of the mammalian cells. The 
solutions that come into contact with the cells include: complete culture 
medium, sodium citrate, 0.09M CaCI2, food colouring and N-Saline. Each 
solution was tested in turn to establish any decreasing effect on viability.
It can be seen from figure 5.8 that for all 6 conditions, none of the 
tested media cause significant cell viability reduction within 1 hour testing time. 
Certain conditions (i.e. culture medium, food colouring in buffer and N-Saline) 
appear to give more stable trends and others (CaCI2 and sodium citrate) 
appear to fluctuate greatly. This highlights the fact that cell counting using the 
haemocytometer can cause errors up to 30% (Uyeda et al. 1962). Given this 
point, the fluctuations seen by the CaCI2 and sodium citrate trends are well 
within error margins. All viabilities stay above a threshold value of 80% -  
suggesting that these conditions do not affect cell viability of cells being 
processed up to periods of 60 min. It must be noted that figure 5.8 is compiled 
from cell data taken on different days. This impacted on the initial cell viability.
5.2.5 Effect of Liquid Alginate on Cell Viability
The next tested condition was the impact of exposure to liquid alginate on cell 
viability. Since there is no literature to suggest alginate should impact on cell 
viability, it was hypothesised that alginate should have no negative impact 
(Domm et al. 2004).
Figure 5.9 suggests a significant fall of cell viability with time over a 
fixed period of 3 hours. A typical experiment to produce 3-5 tubes can easily 
result in cells suspended in alginate for up to this amount of time. The trends 
suggest a particular pattern of falling viability associated with increasing 
alginate concentration from 0.5 to 1.0%. A one-way ANOVA and TUKEY HSD 
tests reveal that there is a significant difference between the trends with an F- 
value at 6.8265 and critical 5% and 1% values at 3.89 and 6.93, respectively. 
The TUKEY test shows that the trend for 1.0% alginate is significantly different
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Figure 5.8 Effect of holding time on cellular viability. Following resuspension solutions 
were used to test impact on viability: complete culture medium (o ), 0.1 M 
trisodium citrate (□), 0.09M CaCI2 (A), 10pl/ml food colouring in NaCI buffer 
(•), N-Saline (■), and complete culture medium (A). All experiments were 
carried out at 20°C unless otherwise stated. A5r7 rat SMCs were used at 
1x105 cells/ml concentration and kept stationary over the holding time period 
tested. Results were obtained using Trypan Blue and haemocytometer. 
Symbols represent averaged cell viability. Coloured lines joins data points to 
help visualise trend rises and falls.
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Figure 5.9 Effect of exposure time in liquid alginate (Manugel DMB). The following 
alginate concentrations were tested: N-Saline (■), 0.5% alginate (A), and 
1.0% alginate (•). Rat A5r7 SMCs at 1x107 cells/ml final concentration was 
used throughout, and experiment was carried out at 20°C. All cell counts 
were obtained using Trypan Blue and haemocytometer. Symbols represent 
average cell viability. Solid lines represent lines of best least squares fit 
through each data set. R2 = 0.9224, 0.4148, and 0.8238, respectively. Error 
bars represent CV across triplicate cell counts.
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from the other two trends almost to the 1% level. The control experiment (N- 
Saline) also shows a drop with cell viability. This may be a further verification 
of holding time impacts on cell viability, regardless of the media, as well as 
toxic effects of alginate. The weak correlation of the 0.5% alginate trend (R2 = 
0.4148) could help explaining the lack of significant difference between this 
trend and that of the control. The 1.0% alginate trend (R2 = 0.8238) is more 
reliable, showing a strong correlation between time and viability. The final 
point to note is that cell death rate does not appear to be predictable. Section
5.2.1 showed a 25.4% drop in viability, section 5.2.2 showed a 73.6% drop 
within 60 min, and in this experiment we see a 30% drop within 3 hours.
5.2.6 Effect of Infusion Speeds on Cell Viability
In this study we tested the final condition -  effect of infusion rate to viability 
(normalised against an initial cell count from freshly harvested cells). Infusion 
speeds of CaCb that drives the regulator ball through the alginate could create 
shears of up to 0.0017N/m2. Although other research groups have reported 
that shears of 0.75-1 ON/m2 is necessary to begin damaging cells (Mardikar 
and Niranjan 2000), this nonetheless needed verification testing in order to be 
thorough.
Analysing the results in figure 5.10, it can be seen that there are two 
parallel lines of best least squares fit, representing a constant difference in cell 
viability between manually created cell-embedded beads and cell-alginate 
tubes. At first glance, it would be logical to assume a consistent 5% drop in 
viability throughout infusion rates due to processing through the tube-forming 
device. This would be an obvious indication of shear damage. Upon closer 
inspection there is one major fault with the results -  all of the results are in the 
region of 50-70%, indicating a drop in viability whether processed (tubes) or 
unprocessed (beads). This finding is in agreement to previous results, i.e. 
there seems to be a large drop in viability before any processing has begun.
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Figure 5.10 Study of viability as a function of infusion rate through the main tube-forming 
device. Solid lines represent lines of best fit for unprocessed cells (beads) 
(A)  and processed cells (tubes) (■), which correspond to the upper and lower 
lines, respectively. All tubes and beads were made using: (300pm wall-gap 
configuration), 1.0% alginate, rat A5r7 SMCs at 1x107 cells/ml, 20°C and 
0.09M CaCI2. All were dissolved in 1.0M trisodium citrate. Cell counts were 
performed using Trypan Blue and haemocytometer. Symbols represent 
averaged triplicate cell viability. Error bars represent CV across triplicate cell 
counts.
Table 5.2 Summarised results from sections 6.1.1 -  6.1.5 showing affect of
holding time in Manugel DMB on cell viability.
Section Cell Passage 
No.
Time of Exposure 
(mins)
Initial Viability 
(%)
Resultant Viability 
(%)
5.2.1 18 Unknown 93.1 67.7
5.2.2 13 60 97.7 29.7
5.2.5 13 180 100.0 -70.0
5.2.6 19 60 100.0 -59.0
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This time the fall in viability is -40% over an hour used to prepare the cell- 
alginate mixture, form tubes and beads, and then re-dissolve them using 
sodium citrate.
Table 5.2 shows a summary of all holding time experiments and affect 
of Manugel DMB on cell viability. These experiments highlight an inherent 
problem with this type of alginate on rat aortic SMCs (as established 
statistically in section 5.2.5). Other groups have worked with Manugel DMB 
but have not appeared to have encountered any issues regarding viability 
(Domm et al. 2004). Despite this being a pharmaceutical grade product that 
was also autoclaved, one cannot dismiss the possibility of contamination either 
in the alginate itself, or the N-Saline used to makeup the alginate affecting the 
viability of the smooth muscle cells used in this study. The latter of the two 
explanations would explain the downward sloping trend seen with N-Saline in 
figure 5.9. This coincided with a group study into spore contamination of the 
lab during the time (data not shown). In that investigation, all sterilisation 
steps were tested and the root cause isolated to the Manugel DMB.
5.2.7 Pronova SLG 100 and Static Mixer Impacts on Cell Viability
As per figure 5.6 indicates -  a control measure is necessary to manage cell 
death as a result of exposure to alginate. Furthermore, where the cell 
integration was un-automated there were many areas (harvesting, mixing cells 
and alginate, cell counting, etc.) where variability between 
experiments/batches could arise. Therefore cell viability impacts of the static 
mixer were also tested in this experiment. In order to attain more accurate 
viability results for the main tube-forming device, two people simultaneously 
did the cell counting to minimise operator errors. Alginate source was also 
replaced with sterile, liquefied alginate -  Pronova SLG 100.
Viability testing through the static-mixer involved passing cells through 
the device with no alginate present. Viability of cells through the tube-forming 
device involved forming cell-alginate tubes, instantly resolubilising them in
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tricitrate in parallel with cell/alginate beads, and cell enumeration performed. 
Shear is calculated via the shear-rate equation:
Where: t  = shear stress (N/m2)
p = viscosity (N.s/m2) 
dv = change in flowrate over area (m/s) 
dy = change pipe/tube diameter (m)
Previous studies have shown that cellular viability begins to fall 
between the 0.75-1 ON/m2 region depending on the method of measurement 
(Ludwig et al. 1992; Ma et al. 2002). In the tube-forming device used in the 
present study, at maximum practical speeds of 100ml/min, only then do shear 
rates approach 0.0083N/m2, although normal operation dictates speeds of 
20ml/min (0.0017N/m2) for maximum control. Static mixers are purposely 
designed for low shear (Bertsch et al. 2001) and they can be operated at low 
flowrates without compromising mixing efficiency. In our design we use a 
maximum flowrate of 1.87ml/min, which generates a calculated shear rate
0.00031 N/m2.
A series of experiments were performed in order to verify 
experimentally whether processing through the static mixer or the tube-forming 
device could affect cell viability. Viability testing through the static-mixer 
involved passing cells through the device with no alginate present in order to 
expose cells to a worst-case scenario (since alginate offers lubricating 
protection). Viability of cells through the tube-forming device involved forming 
cell-alginate tubes in the tube-forming device, instantly, re-dissolving them in 
1.0% sodium tricitrate, with cell/alginate beads produced and dissolved, and 
cell enumeration (Trypan Blue) performed in parallel as a timed control. 
Alginate beads are a widely used research standard and are becoming 
increasingly popular for expansion of mammalian cells for use in tissue
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engineering (Eiselt et al. 2000), and offered a relatively shear-free comparison 
(compared to cells passed through the shear a processing device).
Figure 5.11a demonstrates the viability of the cells passed through a 
12-element static mixer at varying infusion rates. As expected the static-mixer 
had no significant effect on cell viability. Normal operation would use the top 
speed of the device at 1.87ml/min. Figure 5.11b shows viability of cells 
passed through the tube-forming device to form a tube, at varying infusion 
rates. Results obtained indicated a slight trend of decreasing viability with 
increasing infusion rates, but with Pronova SLG-100 overall viability remains 
over 90% unlike figure 5.10, which used Manugel DMB. This strengthens the 
previous hypothesis that the Manugel DMB was the source of the large drops 
in viability. Here we see a viability drop -5% with infusion speeds of 
100ml/min. This result also discounts any significant negative effects of 
process shear to cell viability, both through the static mixer or the tube-forming 
device within the shear rates tested. However, normal operating speeds of 
20ml/min show a minimum fall in viability, as would be expected. This set of 
experiments shows that viability remains high for cells processed through the 
static mixer and tube-forming device in worst-case conditions, although it is 
customary to operate at much lower shear levels in the tube-forming device.
5.2.8 Cellular Apoptosis Analysis
As a final viability experiment, the Gauva capillary cytometer was used to 
analyse apoptosis. In this experiment, we wanted to investigate whether 
processing could trigger an apoptosis response, shown to be the case with 
excessive mechanical force (Kainulainen et al. 2002; Wernig and Xu 2002). 
This would verify or discount earlier shear experiments, which showed that 
there were little viability effects of processing rat smooth muscle cells through 
both the static mixer and the tube-forming device.
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Figure 5.11 Viability as a function of infusion rate for cells processed through (a) a 12- 
element static mixer with no alginate (maximum shear); and (b) cells extruded 
into an alginate tube via the main tube-forming device. Symbols represent 
averaged triplicate cell viability. Solid lines represent best-fit linear trends 
through data points. Error bars represent CV across triplicate cell counts. For 
(b) cells encapsulated in alginate beads with negligible shear were used as 
controls to calculate viability values at parallel cell-counting times. R2 = 
0.2414 and 0.7494, respectively.
188
P  Log
10e4
i » i .
S 10e2-
(a)
lOeO I0e1 10e2 10e3 I0e4
PM1 W Log (b)
S 10el'-
10el -
lOeO
lOeO lO el 10e2 PM1 I0 e 3  10©4 P  log
(C)
P  Log
10e3-
§ 10e2-
1 0 e i-
lOeO
lOeO I0e1 10e2 
P M 1
10e3 1 0 4
P Log
P  Log
S 102-
(d)
v ’
10e0 10e1 10e2 I0 e 3  I0e4
PM1 P Log
10e4
P Log
10ei-
10e0-
1C«0 tOel 1 0 2  
P M 1
10e3 1Ge4 
P Log(e)
Figure 5.12 Apoptosis analysis by capillary cytometry. One end section (a) and middle 
section (b) from a hand-mixed cell integrated tube were analysed for 
apoptosis. Corresponding sections (c) and (d) were analysed for a 12- 
element statically mixed tube, (e) Shows a sample consisting of a mixture of 
apoptotic and non-apoptotic cells. The lower left quadrant shows viable cells, 
not undergoing detectable apoptosis. The lower right quadrant demonstrates 
cells in the early stages of apoptosis. Upper right quadrant shows cells in the 
late stages of apoptosis or dead cells. And upper left quadrant demonstrates 
cellular debris. % of cells in each quadrant lower left, lower right, upper left 
and upper right were: (a) 100, 0, 0, 0%, (b) 99.86, 0.14, 0, 0%, (c) 99.86, 
0.14, 0, 0%, and (d) 100, 0, 0, 0% respectively. Analysis was carried out 
using Guava Nexin kit and Guava EasyCyte GR1 device. All tubes were 
analysed within 3h.
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For this purpose, cells were stained with Annexin V a calcium- 
dependent phospholipids binding dye that binds to phosphatidylserine (PS), a 
molecule that is expressed on the surface of cells in the early stages of 
apoptosis and that of dead cells. A second component then binds to PS to 
emit fluorescence.
Figure 5.12 demonstrates 4 separate analyses from the end and central 
sections of cell-integrated tubes formed by hand-mixing 5.12a and 5.12b, and 
by static mixing 5.12c and 5.12d, respectively. A control sample had 
approximately 0.14% apoptotic cells in the lower right quadrant. Results 
showed that 94-99% of cells are non-apoptotic having undergone processing. 
These results show that sample injection at 1.87ml/min through a 12-element 
static mixer, 20ml/min infusion rate through the tube-forming device and 
contact for prolonged periods (up to 10 hours) with sodium alginate does not 
trigger apoptosis nor substantial cell death. This backs up earlier shear cell 
viability studies.
5.3 CELLULAR SPATIAL DISTRIBUTION STUDIES
5.3.1 Initial Cell-Integrated Tube OCT Scans
In order to assess the optical clarity of images obtained by OCT for alginate 
tubes containing biological cells instead of glass beads, a series of preliminary 
scans were carried out. As an added bonus, any insight into homogeneity of 
cells spread in the solidified alginate wall would be advantageous.
The aims of this experiment were for qualitative reasons only, namely to 
determine whether the quality of OCT scans would be sufficient for analysis. 
Figure 2.11 is reiterated for convenience. The results (fig. 5.13) show that 
cells offer a great enough backscatter of light for OCT images to be of 
sufficient clarity (i.e. backscatter is necessary to illuminate the walls of the
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Figure 2.11 Experimental scanning setup and nomenclature used for Mark 1 primary OCT 
experiment. Points 1 and 3 are 180° from 2 on the opposite face of the glass 
capillary. Points 1 and 3 are on either end of the tube, with point 2 lying in the 
centre of the glass capillary. The cross-sectional scan was taken at a random 
point along the tube.
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Figure 5.13 OCT images of cell tube: (a) at position 1; (b) at position 2; (c) at position 3;
(d) cross-sectional OCT image. First line represent glass to air interface, 
second thicker line represents the cell-integrated alginate tube. Image also 
shows quantitatively the spread of cells within the tube. Tube was made 
using: 300pm gap width configuration; 1% final alginate concentration; 0.09M 
CaCI2 concentration; 1x107 cells/ml final cellular concentration; at 10°C.
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tube, due to the transparency of alginate hydrogel). Results also back how 
hand-mixed cell-integrated tubes are not sufficient -  the walls to this cell- 
integrated tube are obviously not the same thickness. Furthermore, some 
qualitative data for distribution of cells within the solidified alginate could be 
obtained. The bright points indicate clusters of cells reflecting light. In cell- 
free (pure) alginate, bright points would only be attributed to clusters of inert 
glass beads. It can quite easily be seen that cells in this tube were not 
homogeneously distributed. This is most apparent with figure 5.13d that 
shows dark patches, i.e. areas of alginate containing lower concentration of 
cells.
This experiment brings to light that although the suspension of cells 
maybe homogeneous, i.e. free from aggregates and well mixed within itself, its 
introduction to alginate and the mixing of the cells with the alginate requires a 
new engineering method to ensure consistently high cell viability with 
homogenous distribution of cells within liquid/solidified alginate.
5.3.2 Effect of Static Mixers on Cellular Distribution
The next important parameter to investigate was the spatial distribution of cells 
within the alginate hydrogel (fig. 5.14). This is important since growing cells 
require a homogeneous distribution to proliferate evenly throughout the 
alginate tube in order to form a uniform tissue -  an important parameter 
regardless of the end use of the cell-integrated tube. To reinforce this point, 
Dar carried out work that looked exclusively at optimising seeding and 
distribution of cardiomyocetes in a porous 3D alginate matrix (Dar et al. 2002). 
Evidently, the long-term success of any cell-populated scaffold will depend on 
a uniform distribution of cells and ECM (Heywood et al. 2004). From a certain 
perspective, embedding cells within the alginate maybe more efficient than 
post-seeding cells onto a porous alginate scaffold. Whilst it may be argued 
that aggregation is required to form a tissue, there is always a degree of cell
START
Can we 
control cell 
addrt>on to wan 
thicKness’’
can we 
control cen spatia 
o-stnDuton within 
aigmate’’.
can we 
maintain nign 
ceti vtaomty?
New cen 
Integration method 
required
Optimise cell 
homogeneity
Test each process 
vanaoie ana apply 
control measures 
where appfccaote
Figure 5.14 Flow diagram of experimental decisions for section 5.3.
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migration, plus an extreme case would mean a cell-alginate tube with pure 
alginate sections and pure cell sections (i.e. un-uniform tube walls). This is 
clearly undesirable, as a tube would not be formed. As we have already 
discussed, tube wall thickness is essential for cell viability of encapsulated 
cells. If cells are in-homogeneously distributed in the alginate mixture, we 
could have a resultant tube with non-uniformly thick walls, and large 
percentages of non-viable cells.
The uniformity of cell distribution was quantified by calculating the inter- 
and intra-tubular CV of the cell counts obtained (figure 5.15). Figure 5.15a 
shows data grouped per tube, showing inter-tube variation averaged over 
corresponding sections, whereas 5.15b shows intra-tube variation averaged 
over 3 tubes per cell-integration method.
Figure 5.15a shows that cell-integration via hand mixing and 8-element 
static mixing yields no substantial difference in CV. However upon increasing 
the size of the Kenics mixers from 8 to 12 elements, average CV falls to 27.8% 
for 12-element static mixing indicating a more uniform cell distribution pattern. 
A similar pattern is observed when the intra tube variation is evaluated, with 
average CVs for hand-mixed, 8-element and 12-element cell-integration of 
64.2, 52.4 and 19.2%, respectively (fig. 5.15b). Notably, the ends of the tube 
seem to generate much higher variations in cell numbers, and this is 
consistent for all three cell-integration methods. Overall, the data undeniably 
suggests that there is a marked improvement with static mixing over hand- 
mixing techniques and with increasing the number of Kenics elements within 
the static mixer. Obviously mixing improves with greater number of static 
mixer elements, but this means a larger static mixer is required and greater 
amount of dead-space (i.e. lost material in the system) results. Commercially, 
suitable static mixer elements come in 8 and 12 element sizes only, but we 
envisage custom made mixers to suit our requirements on demand being a 
possibility.
194
Figure 5.15
100
90 
80 
70 
„  60
30
20
10
0
(a)
100 
90 
80 
70 
~  60
30 
20 
10 
0
(b)
Cell distribution analysis by light microscopy. Inter (a) and intra (b) tube 
cellular distribution along the length of the tube for constructs formed by 3 
cell-integration methods: hand-mixed cell tubes or in automated fashion using 
8 or 12 element static mixers. 3 tubes were made per cell integration method. 
Tube weight/section was 0.3g/ ± 0.02g. All cell counts were normalised by 
section weight. CV was determined per tube and across sections. In (b) 
results are shown in section order from top to bottom. All tubes were made 
using: 300pm wall gap tube-forming device configuration, 1.0% alginate 
concentration, 1.87ml/min sample injection rate, 20ml/min calcium chloride 
infusion rate at 0.09M concentration and 1x107 cells/ml concentration.
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5.3.3 Visual Verification of Cell Distribution Using Light Microscopy
As with wall thickness, a visual verification of cellular spatial distribution was 
required. The aim was to attain a qualitative verification of the cellular spatial 
distribution through the alginate via use of a light microscope.
Images taken are shown in figure 5.16. It can be seen the difference 
between a pure alginate tube to one containing cells. However due to the 
inability to show cells in layers, the images show one superimposed image of 
cells within a 3D alginate gel. Both figure 5.16b and 5.16c look alike. One 
cannot distinguish a well-mixed, homogeneous tube to one that is mixed 
poorly. Although these images show us the difference between pure alginate 
and cell-integrated alginate, it did not provide a definitive qualitative conclusion 
of the benefits of using a static mixer over irreproducible hand-mixing 
techniques.
5.3.4 Visual Verification of Cell Distribution Using CLSM
In order to obtain a more distinctive, quantitative verification of cell distribution 
in-situ, confocal laser scanning microscopy (CLSM) was used. CLSM offers 
fast, non-destructive, cross-sectional, multipoint scanning. It allows a great 
range of magnification from macro to micro precision and produces high- 
resolution images of slices through a sample -  hence constructing a digital 3D 
representation ready for analysis. Because the magnification can be adjusted, 
it was more suitable than OCT, offering a larger sample size.
Figure 5.17a shows the experimental setup for tube scanning locations 
and data manipulation in order to quantify results. From the cross-sectional 
scans 5.17b, a diagonal tangent was drawn across all images. Along the 
tangent, intensity profiles could be constructed (fig. 5.17c) and by measuring 
the area under these curves, we were able to quantify number of cells per 
volume of construct.
196
(a) (b)
(c)
Figure 5.16 Light microscopy analysis of tubes: control tube containing glass beads (a);
cell-integrated tube using 12-element static mixer (b); and cell integrated tube 
using hand-mixing technique (c). All images taken at X20 magnification using 
a light microscope, haemocytometer and standard coverslip. All tubes formed 
using: 300pm wall-gap configuration, 1.0% overall alginate concentration, 
1x107 cells/ml overall cellular concentration (where used), 0.09M CaCI2 
concentration, 20ml/min infusion rate, and 20°C. Glass beads were added at 
1x1 O'3 g/ml to alginate.
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Figure 5.17dshows the results extracted from this experiment. It can clearly 
be seen that the profile for the tube processed via a 12-element static mixer 
was more uniform than the hand-mixed control tube with a CV of 28.9% 
compared to 78.5%, respectively. The hand-mixed cell-alginate tube was had 
3 sections with low area readings, indicating little presence of cells along the 
tangent. This was not the case with the statically mixed tube. Although 
variance appears high, a healthy concentration of cells is present in each 
section. In agreement with OCT and light microscopy data the CLSM results 
indicated that the presence of a 12-element static mixer improved cell 
distribution within the alginate matrix. Despite the crude results and 
experimental design, this is none-the-less a quantitative result for otherwise 
qualitative data. This experiment provides conclusive evidence, backing up 
previous figures, that by using a 12-element static mixer, cellular spatial 
distribution is improved within solidified cell-integrated alginate tubes.
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Figure 5.17 Cell distribution analysis by Confocal Laser Scanning Microscopy (CLSM).
(a) Schematic diagram (not to scale) demonstrates the longitudinal (X, Y, Z) 
and vertical (a, P) positions used for CLSM analysis, (b) Representative 
images of hand-mixed (left) and statically mixed (right) tubes at position Ya. 
A scale bar is shown against 40pm. A diagonal line approximately 352pm 
was drawn through the sample and intensity data along this tangent was used 
to compile fluorescence intensity profiles shown in (c) from hand-mixed (left) 
and statically mixed (right) tubes at position Ya. (d) Total area under the 
fluorescence intensity profiles for positions: Xa, Xp, Ya, Yp, Za, Zp 
respectively. Area was calculated using raw confocal data and trend analysis 
software. One tube per cell-integration method was produced and analysed, 
CV across positions (n=6) was 78.5 and 28.9%, for hand-mixed and statically 
mixed tubes respectively. Tubes were stained as described in Chapter 2 and 
analysed within 6h.
6 Discussion
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6.1 AIMS OF THIS THESIS
Reviewing Chapter 1, this thesis concentrated on the fundamental 
engineering aspects of the UCL tube-forming device. The device would 
provide an alternative tubular geometry to alginate structures, which could 
have end uses as a macro-encapsulation envelope or even provide a 
scaffold for tissue-engineered products. The three experimental chapters 
concentrated on three engineering aspects of said device: tube formation; 
monitoring methods; and cell integration.
How do we form alginate tubes? This was the most important 
question of all -  without a means of forming the tube in the first place, the 
process would be a failed design. The patented UCL method existed, but at 
the start of this research had no protocols, was untried and untested, and 
had not been optimised or reconciled against any theoretical predictions. 
Goals were therefore: to develop a Theory modelling tube thickness; to then 
test the current state of the device; to modify and optimise its design to 
control process variability of this key parameter; and finally to find ways to 
manipulate wall thickness.
How can we monitor process efficiency? Another important part of 
any well-engineered process is the ability to directly monitor efficiency and 
engineer inherent consistency in the process. Monitoring methods to detect 
tube wall thickness, particle size, and particle number were required. 
Furthermore, quality control methods were needed to ensure that remaining 
operator-dependant processes such as cell culture had minimum impact on 
particle suspension consistency.
How do we effectively mix cells with polymer? This third and final 
question brings together the tube formation, monitoring methods and 
biological cell integration. This section would look at how cell encapsulation 
affects tube wall thickness, and how cell-integration impacts on cell viability. 
Finally the section should consider spatial distribution of cells within the
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alginate tube since a basic requirement of any cell-integrated tube is to 
ensure that all parts of the tube contain an equal amount of cells.
6.2 RESEARCH PLAN
To achieve the research aims set out in section 1.9, the first question to 
tackle was whether or not we could form tubes using the UCL tube-forming 
device. This question was tackled in a two-pronged fashion. With the help of 
Prof. Ian Eames (Mechanical Engineering, UCL) and Dr. Mark Landeryou 
(Medical Physics, UCL), a Theory was developed based on Reynolds Laws 
of Lubrication, to see whether tube formation with the tube-forming device 
was theoretically possible, and the calculated tube wall thickness was 
determined. This was validated by experimentation firstly via pure alginate. 
Furthermore, a protocol for the device was developed to ensure consistency 
with human operator variables, and the device was tested for any 
inconsistencies and these would be rectified.
Next the monitoring methods were investigated. Chapter 4 
concentrated on tube wall thickness, using Optical Coherence Tomography 
(OCT) as a means of directly monitoring this. This wall thickness could be 
compromised by aggregates of cells, plus large aggregates maybe contain 
necrotic centres hence by utilising several possible techniques at UCL -  a 
Malvern Particle Sizer, a Leica QWin automated microscope, and a 
haemocytometer/Trypan Blue -  a reliable method was found to consistently 
monitor cell aggregation and enumeration. Furthermore a high resolution, 
high-speed camera was used to directly analyse the tube formation process. 
Finally, we looked at developing controls to limit impact of laboratory 
techniques on cell homogeneity.
Chapter 5 brought together the tube formation, monitoring methods 
and biological cell aspects. After possible effects to tube wall thickness, the 
next variable to control was cell viability -  if the cell viability was low at the 
start of the process, or heavily reduced as a result of processing this would
202
be inefficient. Chapter 5 concentrated on how to mix cells with alginate 
without compromising either the cell viability or the tube wall consistency. 
This was achieved using a technology from industries outside of conventional 
(bio)-chemical engineering -  i.e. Kenics static mixers. This small plastic tip 
contained many elements that split, fold and recombine fluids to create 
mixtures. The economics of such mixers meant that they could be used once 
and disposed of, maintaining system sterility, and the negligible shear of the 
mechanics made them ideal for mixing cells with alginate. A syringe driver 
was modified for this technology and this was tested for impact on cell 
viability and also wall thickness consistency of tubes formed using these 
mixtures. The Kenics mixer was also tested on impact to cell spatial 
distribution within alginate, and CLSM used to quantify this distribution.
6.3 DISCUSSION
6.3.1 Tube Formation
In Chapter 3, a Theory to predict tube geometry was developed by solving a 
lubrication analysis based on the tube-forming device. This Theory is 
universal to any system of two liquids at the time of tube formation, however, 
when applied to reacting systems such as alginate-CaCI2 it is only valid at the 
time of tube formation. After tube formation, other factors such as alginate 
shrinkage occur to tube wall thickness (Zhang et al. 2000). This Theory 
resulted in the % Approximation, relevent as gap width becomes increasingly 
small, i.e. the predicted tube wall thickness is approximately equal to 2/3 of 
the gap width. Due to the lack of fluid property terms in the final equations,
i.e. fluid viscosity or density, the tube wall thickness is therefore independent 
of such properties. This is useful since it is undesirable for small fluctuations 
(e.g. viscosity changes due to cell lysis within alginate) to affect final tube 
wall thickness. The Theory goes on to describe how matrix fluid flows 
upwards, dragged by the spherical regulator, and due to end effects, results
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in a slightly thicker tube wall thickness than that predicted. The experimental 
verification (fig. 3.4) shows data points falling within a preset range 
determined by computational fluid dynamics and the Theory.
At this early stage tube wall thickness was identified as the key 
geometry variable to control. This variable was decided upon consultation of 
existing literature. Glickis et al. outlined how oxygen and nutrient supply 
depends on mass diffusion (Glickis et al. 2004). Diffusional gradients are 
formed in large aggregates, often leading to a necrotic centre. The group 
found that hepatocyte spheroids any larger than 100pm in diameter began to 
have detrimental effects of oxygen limitation (fig. 6.1a). This means that a 
wall of mammalian cells cannot be any thicker than 50pm without a vascular 
network to supply nutrients. However, the oxygen limitations depends on 
other factors such as reactor agitation, immobilisation method and cell 
concentration (Khattak et al. 2007). Viability was consistently high for 
hepatocytes encapsulated in alginate beads (fig. 6.1b). In our alginate tubes, 
the possibility of nutrient flow on the outside and lumen of the tube, plus the 
inherent porosity of alginate should mean no oxygen limitations for wall 
thicknesses several hundreds of micrometers thick. In addition, cell- 
integrated alginate tubes will not initially contain cells at such a great 
concentration -  with less demand of oxygen, less supply is necessary and 
walls can be thicker still. Another consideration is that, depending on the end 
use of the tube wall thickness will also determine its mechanical strength. 
But before mechanical strength can be tested in future work, we first 
concentrated on the ability to produce a tube with uniformly thick walls.
The robustness testing of the tube-forming device then began. Initial 
experiments showed fluctuations of tube length with alginate concentrations 
ranging from 0.5% to 1.0%. Correlation of data points to the line of best least 
squares fit had a R2 value of less than 0.9 although a consistent CV under 
5% indicated a level of precision within the tube-forming device, comparable 
to other well engineered cell-alginate encapsulating devices (Serp et al. 
2000). R2 values and robustness to alginate concentration changes between
204
(a) (b)
1.0
0.8
06
I>
0.4
0.0
300 400 500 6000 100 200
1.1
0.99
0.88
0.77 
p  0.66 
1  0.55 
>  0.44 
0J3  
0.22 
0.11 
0
! <
Distance from the spheroid surface (microns)
Figure 6.1
4 6
Time (days)
8 10
(a) Distribution profiles of viable cells in spheroids with a diameter ranging 
from 30-600|im. (b) Fraction of hepatocytes as a function of time in ( • )  
alginate scaffolds, (■) spinners, and ( A)  rotating t-flasks. The fraction of 
viable cells was calculated by dividing the number of viable cells according 
to MTT assay by the total number of cells according to DNA quantification 
assay. The error bars indicate the standard deviation around the mean 
value of the data point (n = 3) (Glickis et al. 2004).
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0.5 and 1.0% was improved with a new protocol. However sensitivity to 
slight changes in alginate concentration still significantly affects tube length 
and therefore the design of the tube-forming device was reconsidered.
The heart of the tube-forming device consists of the dual port base 
unit and the spherical regulator. The mark 1 device has a narrow metal 
injector nozzle upon which the spherical regulator sits. When propelling fluid 
is expelled via this cylindrical nozzle the spherical regulator is pushed 
upwards. With the mark 1 design, the regulator travels upwards with little 
directional control, like a rocket sitting on a pad. The idea behind the mark 2 
device design was to offer greater directional control, much like a barrel of a 
firearm and a bullet. The spherical regulator sits tightly within the eggcup-like 
design of the mark 2 device, offering less lateral movement on lift-off from the 
injector nozzle.
Tube length/back-calculated thickness consistency improved with the 
new design. R2 averaged across all three trends was 0.9995, and all three 
alginate concentration trends now overlapped, showing impact of alginate 
concentrations from 0.5-1.0% was no longer significant. This was verified by 
a repeat experiment. The improvements from this new design was largely 
noticeable from the quality of tubes across its entire length in parallel OCT 
scans on mark 2 design, compared to mark 1 design tubes (where the initial 
~7cm was not consistent in tube wall thickness). Furthermore the dead 
space within the base unit was reduced from 112jul to 89|nl (21% reduction), 
saving materials that could potentially be scarce or valuable. Perhaps more 
subtle is the improvements of nominal wall thickness (T0) to more closely 
match predicted tube wall thickness (Tb), as a result of the injector nozzle 
diameter more closely matching alginate tube lumen diameter, which in turn 
reduces end effects of matrix fluid flow.
Attention was then turned to manipulating wall thickness by altering 
glass barrel and spherical regulator radii and subsequent repercussions on 
wall thickness consistency. When spherical regulator radius was decreased 
from 1.700 to 1.587mm to give a resultant gap width change from 300 to 
413pm, the R2 value of the best-fit trend remained high at 0.9998 and 
average CV of 1.8%. Likewise, glass barrel radii was altered from 2.000 to
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1.825mm decreasing the gap width from 300 to 238pm, yet still R2 remained 
at 0.9996 and average CV was 1.4%. Gap widths of 238, 300 and 413pm 
yielded back-calculated tube wall thicknesses of 143.4, 188.4 and 277.3pm, 
almost exactly matching the %  Approximation. This was somewhat of a 
oddity of a result, since this approximation only applies as the gap width 
becomes very small. At gap widths of this magnitude, nominal wall 
thicknesses ought to be -136, 150 and 41.3pm, respectively. By testing the 
Theory with reacting and non-reacting fluids, we were able to ascertain the 
cross-linking nature of the CaCI2-alginate system was freezing the initial 
thickness of the deposited alginate layer, neutralising contraction effects 
caused by drag created by the upwards flowing motion of the spherical 
regulator. The systems that more closely resembled the Theory were in fact 
non-reacting fluids. This result could be useful in a practical sense -  to be 
able to consistently manufacture alginate tubes with a wall thickness 2/3 the 
size of the gap width. To summarise, the wall thickness of the alginate tube 
will depend on several factors:
• Contraction effects as a result of spherical regulator drag (affects non­
reacting fluid systems only)
• End effects as a result of base unit design
• Radii of the glass barrel and spherical regulator
• Reacting or non-reacting fluid system
• Shrinkage after tube formation
The final point we have not yet seen at this point in the research. The prior 
points are all effective at the time of tube formation, whereas the final point 
happens sometime after the alginate structure has been formed. Shrinkage 
is a direct result of multivalent ions such as Ca2+ ionically bonding strands of 
guluronic acid together. As this occurs, water molecules are shed and the 
alginate structure shrinks as a result. Therefore, degree of gelation has been 
established by wet/dry ratio of slices in larger alginate structures in the past 
(Martinsen et al. 1989). Unfortunately, this makes the reproducibility of 
alginate structures somewhat lacking. The degree of shrinkage can be better
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controlled using much slower internal gelation as opposed to external 
gelation methods such as CaCfe (Quong et al. 1998). Figure 6.2 shows how 
shrinkage can cause a relative size difference from 20 to 50% depending on 
alginate concentration and gelation technique.
6.3.2 Monitoring Methods
It is these shrunk alginate tubes that were scanned using OCT. So far, we 
have assumed that both sides of the alginate tube are equal in thickness, and 
have back-calculated wall thickness based on the length of the tube. OCT 
provided a direct way to visualise wall thickness consistency. The scans of 
the mark 1 tubes showed that some of the tubes did not in fact have walls of 
equal thickness. Glass beads were incorporated for light scatter purposes, 
but increasing concentration caused a much thicker tube. They therefore 
made a poor model for cells. It must be reiterated that we cannot refer to the 
Theory at this point, since the effects of shrinkage after tube formation have 
occurred and wall thicknesses are between 20-50% less than nominal tube 
wall thicknesses. Only the central third of all alginate tubes were uniform 
enough to scan using OCT. The most important observation was that the 
wall thickness at the start of the tube was repeated along its entire length, 
meaning that the directional control at the start of tube formation is integral to 
the consistency of the entire tube. This prompted the mark 2 device design.
The scans were repeated for shrunk mark 2 alginate tubes. Glass 
beads were again used, but at a low 0.0005g/ml concentration. Results 
showed that when the walls are equal in size the wall thickness ought to be 
1/2  of gap width. CV deteriorated from the mark 1 tubes, although the entire 
tube length could be scanned, and percentage of failed tubes drastically 
decreased with the new base unit design.
OCT was then adapted to try to measure the rate of shrinkage. By 
monitoring a fixed point on a freshly formed alginate tube, and taking an A- 
scan at split-second intervals, we formed a graph of alginate tube wall
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Figure 6.2 Bead mass reduction during gelification for 1 hour, followed by storage in 
water for 24 hours, simulated Gl incubation for 24 h at pH 1.2, followed by 
72 hours of incubation at pH 7.0. (a) Percent relative bead size for 1 (•), 2 
(■) and 3% (A ) medium guluronic alginate, (b) Percent relative bead size 
for low (O) medium (□) and high (A) guluronic alginate at 3% concentration,
(c) Percent relative bead size for 2% (w/v) medium G alginate beads formed 
using the external (T ) and internal (V ) gelation techniques. Error bars 
represent standard deviations of three replicates about the mean (Quong et 
al. 1998).
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shrinkage. Compared to other groups that have used wet/dry ratio of 
alginate slices (Martinsen et al. 1989), or time taken before alginate no longer 
runs (Kuo and Ma. 2001), this novel approach is much more accurate and 
quantifiable. The results show an exponentially shaped graph, stabilising at 
-12 minutes. Wall thicknesses of ~225pm fall to 180pm, rather than the 
expected 188 to 150pm for a gap width of 300pm. It was thought this error 
was either caused by the addition of glass beads, which we know can 
increase expected final wall thickness, or the spoiling of fresh alginate, due to 
transportation from London to Cranfield.
In all, OCT presented itself to be a very useful and versatile tool. As 
well as portability, and the ability to scan in real time through air, the OCT 
scanner could also be altered to measure sample thickness up to 3mm 
(Fujimoto et al. 2000), moving fluids within a capillary using Doppler 
velocimetry (Mason et al. 2004) and now shrinkage by measuring a set point 
in the tube, by simply altering the associated Matlab programme.
The high-speed camera also elaborated several points. Firstly, that 
the velocity profile of the matrix fluid is parabolic about the spherical 
regulator. Secondly that the spherical regulator does not spin during tube 
formation. This explains why a lopsided tube will have the same thickness 
repeated throughout its length. Since the eggcup shaped design of the mark 
2 device was meant to increase stability, analogous to a firearm and a 
projectile, it is interesting that bullets are stabilised in air by spin (fig. 6.3). 
The spinning is created in rifles by the rotating band engaging grooves cut 
into the barrel of the firearm. At a muzzle velocity of 2800 ft/s the spin rate 
would equate to 250 rev/s (USAFAS 1999). In our tube-forming system 
however, spherical regulator spin does not occur. Propelling fluid and also 
buoyancy of the material used projects the spherical regulator. It may be that 
in fluid systems at low velocities, stability is unnecessary. Perhaps by 
inducing spin, we may correct tube lopsided-ness. In any case, regulator 
spin would be a further development to the fluid dynamics Theory. With this 
current system however, only one point per tube need be monitored to gain a 
geometrical understanding of the rest of the tube.
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Figure 6.3 Spin stabilised projectiles (www.fas.ora).
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Figure 6.4 A schematic representation of the proposed mechanism of cell damage 
occurring at low shears (Mardikar and Niranjan 2000).
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As well as monitoring overall alginate tube geometry, we must also 
control the particles that may be integrated within the tube such as biological 
cells. If left unchecked these may impact on alginate tube wall thickness, as 
we have shown by varying glass bead concentration and OCT. Therefore 
the next phase of experiments looked at particle size detection and 
enumeration. The aim of initial experiments was to find monitoring methods 
that could give a representation of size distribution of the particles (i.e. single 
and aggregates of cells) and methods that could enumerate the 
concentration of particles in a suspension. The particle sizer shows size 
distribution profiles for differing cell concentrations from 1x106 -  2x106 
cells/ml. Combined with one-way ANOVA tests and TUKEY HSD analysis, 
this monitoring method was also sensitive enough to detect abnormally high 
aggregates in the 5x105 cells/ml concentration sample and differentiate this 
from the other sample concentrations. The 1x105 cells/ml concentration was 
too dilute to show any statistical similarities with the other sample. This only 
means that we cannot compare concentrations in the order of 2x106 with 
1x105 cells/ml. Also the profile shape was not the expected bell-shaped 
curve with a peak at 20pm (Alberts et al. 2002), but instead a tri-peaked 
profile with peaks at 10, 30 and 60pm. The 30pm peak was decided the 
single cell peak. The other two peaks were to be further investigated. The 
Leica QWin system could only give limited size distribution information with 
peaks of 1 and 2 cell diameters (pre-determined to be ~30pm for a single cell 
by graticule). ANOVA and TUKEY showed a slight statistical difference 
between 1x105 and 1.5x105 cells/ml concentration samples, namely the 
1.5x105 cells/ml profile contained an abnormally high level of estimated cells. 
The same statistical tests were applied between Malvern and Leica data and 
showed that they were not highly significantly different, yet not statistically 
similar, a result expected given the two monitoring methods used. From this 
initial comparison test, it was acknowledged that the Malvern particle sizer 
was more useful for giving size distribution information.
Micrographs taken from the Leica show how cell size differs largely in 
a single sample. The resultant peaks of 10, 30 and 60pm may infact be a 
result of three distinct cell size populations in a single sample. Such size
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differences have been explained by other groups to arise from adjustments 
over several passages in mammalian cells as a result of nutrient availability 
(Conlon and Raff 2003). The 10|iim peak could be the result of papilation of 
cytoplasm (fig. 6.4) as a result of shear damage and healing of cells 
(Mardikar and Niranjan 2000).
For quantifying cell numbers, the experiment proved inconclusive. At 
concentrations up to 1x106 cells/ml the standard haemocytometer and 
Trypan Blue were more accurate, and above this concentration the Leica 
QWin was more favourable. Ultimately both methods rely on a similar 
principle of glass slide and coverslip, which gives way for errors as a result of 
aggregates too large to fit underneath. Yet the area of the sample analysed 
by the Leica QWin is a fraction of that counted manually, making the 
accuracy of the data questionable. Since dilution would normally be used to 
enumerate using the haemocytometer, this was decided the better of the two 
methods for our system. This result does not help improve inter-operator 
errors (Peebles et al. 1981) that are associated with manual counting.
Therefore the Guava EasyCyte capillary cytometer was trialled as a 
cell enumeration method. Results were promising when compared with the 
haemocytometer giving better inter-tubular (CVs of 29.8 and 17.6%, Trypan 
Blue vs. Viacount Flex) and comparable intra-tubular (CVs of 37.3 and 
44.8%, Trypan Blue vs. Viacount Flex) cell counts for sectioned cell- 
integrated alginate tubes. With further optimisation the Guava EasyCyte 
could make a realistic alternative to manual counting.
Now that the monitoring methods are in place, we turn to 
implementing control measures for the tube-forming process. Unavoidably, 
part of the process still involves much manual work, particularly the cell 
culture aspects. Therefore it was aimed to minimise variability by part- 
automating these processes and then monitoring them using the methods 
established. In particular, we aimed to create a suspension of single cells. 
From a perspective of organ development, cell aggregation is desirable -  
hepatocyte spheroids exhibit greater cell-cell interactions than monolayer 
cells and morphology more closely mimics the native liver lobule. 
Furthermore Glickis and her team found such spheroids to exhibit improved
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liver-specific functions and differentiation (Glickis et al. 2000). However from 
a mass transfer angle, cell aggregation can have a detrimental effect to cell 
viability if aggregate diameter is not duly controlled (Glickis et al. 2004; Sen 
et al. 2002). We have seen how glass bead concentration can impact on 
wall-thickness, large aggregates may also cause wall distortions, and 
therefore this aspect ought to be controlled. Since the aims of this research 
extend not only to tissue-engineered organs but also cell-encapsulated 
solutions, we will focus on single cells of high viability and abundant nutrient 
availability. After analysing the protocols for cell culture (Appendix A), the 
following cell culture processes were studied for impact on aggregate 
formation:
1. Effect of micro-pipetting.
2. Holding time.
3. Centrifugation speed and duration.
4. Cell passage/generation number.
Despite the different shaped profiles formed from the different number 
passes through a micro-pipette, ANOVA analysis showed no significant 
statistical difference between the size distribution profiles. The profile did 
show two main peaks at 20 and 40pm, as well as a mini peak at 5pm. 
Firstly, since we know that mammalian cells are between 11-22pm (Alberts 
et al. 2002) in diameter that this initial 5pm peak cannot represent a whole 
cell. This result also meant that the degree of micro-pipetting up to 20 
passes has no significant shear affect: neither further damaging cells and 
increasing the mini-peak of cytoplasm/cell debris; nor disengaging the larger 
40pm peak into single 20pm cells. This profile is also oddly comparable to 
the 30 and 60pm peaks seen in initial visualisation experiments. This could 
mean that the pipetting method is an ineffective means of disassociating 
small cell aggregates, or that the 40pm peak is indeed a single cell 
population as supported by Leica micrographs. Since pipetting is a 
commonly used method to disassociate cell aggregates (Serra et al. 1997; 
Serra et al. 2007; Colomer et al. 2005), the latter explanation is more likely.
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Similar research was suggested by Bongrand & Golstein (Bongrand and 
Golstein 1983) who looked at calibrated shear to dissociate lymphocyte 
aggregates. However it was found that the magnitude of the shear was not 
important as the cell-to-cell bonds were highly variable.
Holding time is the next important variable. The aggregation of 
suspended cells can be described by Smoluchowski’s Theory, which is 
based on Brownian motion (Longmire and Frojmovic 1990). When two cells 
collide they may form intercellular bonds. This is also possible in a non­
suspended culture by settlement and movement of cells on a culture surface 
(Neelamegham et al. 1997). It stands to reason that the longer the time 
given for such instances to occur, the more occurrences there will be. For 
cell-integrated alginate tube formation, this can typically extend up to 3 hours, 
and therefore this timeframe was chosen. Results reveal a significant impact 
of holding time upon cell size distribution. ANOVA and TUKEY analysis 
reveals that upon 3 hours the profile is statistically different to the 5% 
confidence level. As a control, an autoclaved gauze filter was used to 
process the same cell sample at the same time intervals. The cell size 
distribution profile at the corresponding control at 3 hours revealed no 
statistical difference indicating a positive effect of holding time. It is therefore 
logical to conclude that filtration could be a control measure, and holding 
times minimised to under 2 hours during cell-integrated tube manufacture.
A team in Japan experimented on rotational culture based on the 
principles of centrifugation in order to induce chondrocyte aggregation 
(Furukawa et al. 2003). The aim of their work was to control differentiation 
into fibroblasts associated with monolayer culture. Since a centrifuge only 
gives a single pellet, rotational culture was used to form a 3 dimensional 
layer of chondrocytes that may be developed in tissue-engineered cartilage. 
Similarly shaking a suspended chondrocyte culture at 80rpm was sufficient to 
speed aggregation of cells by enhancing cell-cell collisions and interactions. 
To tailor conditions to those realistically used for generic mammalian cell 
culture, centrifugal speeds up to 500rpm and durations up to 5 mins were 
tested. Upon resuspension, the cell size distribution profiles and statistical
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analyses revealed no significance of centrifugal speed treatment to cellular 
aggregation.
From combined and collated data over several experiments, we could 
now also look for cell aggregation and cell size distribution traits associated 
with cell passage/generation number. Cell banks were able to provide rat 
aortic smooth muscle cells, as a model for any potential cell type, at passage 
10 and typically the age of this type of cell would not be used beyond 
passage 21 despite them being immortalised lines. Beyond this amount of 
cell generations, cells were observed to be much larger in size and much 
more prone to form aggregates (data not shown), an observation in line with 
the work of Conlon and Raff describing the gradual adaptation of mammalian 
cells over time with environmental changes such as media (Conlon and Raff 
2003). Despite all this literature, the cell size distribution profiles show no 
apparent pattern with passage number, and statistical analyses reveals no 
significant difference between cell samples.
6.3.3 Impact of Cellular Integration
We have seen in the Chapter 3 that we can reliably form alginate tubes, and 
in Chapter 4 that we can monitor both the geometry of the tubes formed, and 
the size distribution profile of the cellular suspension separately. But the end 
result aims to integrate cells within the alginate tube. The two separate 
aspects must be brought together and considered as a whole, using the 
monitoring methods to measure change to consistency. Therefore Chapter 5 
explored the impacts of cell integration to tube geometry consistency, effects 
of alginate on cell viability and cellular spatial distribution within the alginate 
tube. The importance of particle concentration on tube wall thickness has 
been seen by glass bead additions in Chapter 3, and we have discussed how 
alginate concentration could be altered by cell cytosol leakage and therefore 
affect tube wall thickness (Sen et al. 2002). Cell seeding efficiency and 
maintenance of viability are key considerations at the early stages of 
construct manufacture. Low seeding efficiency and high viability of
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embedded cells is usually associated with approaches that rely on cell 
seeding onto a pre-formed matrix. In approaches that rely on entrapment of 
cells into a liquid matrix, cell-seeding efficiency is inherently high but there is 
a concern that non-viable cells could potentially be entrapped in the 
construct. Shear forces generated by manipulation and processing even at a 
small scale can be sufficiently high to damage mammalian cells. Issues such 
as cellular distribution and viability have also been the focus of other work 
involving cardiac tissue engineering within an alginate structure (Dar et al. 
2002). Cellular spatial distribution allows for greater loading of cells within 
alginate without impacting bead consistency. It also impinges on cell viability 
due to less competition for nutrients (Schneider et al. 2004) and results in 
more even ECM formation (Heywood et al. 2004).
An initial experiment comparing pure alginate tubes with cell- 
integrated alginate tubes of comparable alginate concentration revealed 
consistently high R2 trend correlation indicators, which further strengthens 
the previous studies on tube wall thickness robustness of the mark 2 tube- 
forming device. However an increase in the gradient of the slopes for hand- 
mixed cell-integrated equivalents showed that resultant tubes were on 
average 4% thicker and shorter than pure alginate controls. The explanation 
of this is hypothesised due to the ability or inability of the matrix fluid to flow 
upward along the glass barrel with spherical regulator drag. As solid 
particles such as glass beads and cells are imbedded this ability to flow is 
impeded and results in a thicker deposited layer. Despite wall thickness 
variations not exceeding 5%, acceptable compared with other well- 
engineered processes (Serp et al. 2000), hand-mixing cells into alginate is 
not desirable for a well-controlled system.
In order to establish greater confidence in the cell-integration process 
we turned our experiments towards static mixers. Other automated methods 
of cell integration were considered. But roller mixing would take too long, 
and as we have seen in the from section 6.3.2 holding time is a significant 
variable to cell viability. Impeller mixing or vortexing is associated with high 
shears, which are known to reduce cell viability in mammalian cells (Abu- 
Reesh and Kargi 1991). Kenics mixers are disposable (and therefore sterile),
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plastic (and therefore autoclavable) and negligible shear (Bertsch et al. 2001) 
solution. The results show how pure alginate control tubes are comparable 
in wall thickness consistency compared with 12-element statically mixed cell- 
integrated tubes. Hand-mixed tubes fared poorly against the other two sets 
of tubes.
Previously we have seen the mechanism of cell damage with low 
shears (fig. 6.5) (Mardikar and Niranjan 2000). This leads us to ask the 
question of whether cell damage indeed occurs at a significant level within 
our process. The importance of impact of process on cell viability is echoed 
throughout other cell-integrated alginate processes (Sakai et al. 2004; Takei 
et al. 2006). In our system viability could be important due to the scarcity of 
the cells involved. Poor viability is not a good indication of a well-designed 
process. Also large amounts of cell lysis may impact on alginate 
concentration (Klokk and Melvik 2002) and ultimate wall thickness 
consistency. In these experiments, we integrated cells into an alginate tube, 
re-dissolved this and then counted cells using Trypan Blue. Despite 
concerns that re-solubilisation using citrate may subsequently affect viability 
of the cells, this is a pier reviewed and accepted method established in 
literature (Orive et al. 2003; Markusen et al. 2006; Jiang et al. 1995). Initial 
counts comparing after cell harvesting and full tube formation and re­
solubilisation yielded a 25.4% fall in viability. Factors suspected to have 
reduced viability included: toxicity of media used with cells, centrifugation, 
shear via pipetting, shear via processing both using the static mixer assembly 
or the mark 2 tube-forming device.
A repeat experiment was conducted viability counting of cells at 
harvesting, prior to tube formation and after tube formation. The largest drop 
(73.6% drop in viability) was found to be prior to tube formation, ushering a 
round of investigatory experiments on centrifugation and all the media that 
comes into direct contact with cells.
Centrifugal affects have been reported by other groups (Chien et al. 
2006; Katkov and Mazur 1999) but results of up to 5 consecutive 
concentration cycles (at 100xg) of centrifugation and resuspension gave no 
evidence of noticeably reduced cell viability.
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Figure 6.5 The effect of shear on the viable cell count (%) in K562 cl.6 cells (Mardikar 
and Niranjan 2000).
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The media tests included: complete culture medium, sodium citrate, 0.09M 
CaCb, food colouring and N-Saline. Results showed no drop in cell viability 
below 80% within an exposure time of 1 hour with cells. Since alginate is 
consistently used with cells, it was anticipated that no toxic effects should 
occur with direct contact (Domm et al. 2004). However, over a 3-hour period, 
we see a consistent drop in viability particularly with a 1.0% alginate 
concentration. ANOVA and TUKEY HSD analyses show that the result is 
highly significant well beyond the 5% level. We also establish that we cannot 
control the rate of viability drop, with no apparent pattern in viability drop and 
time cells are exposed to alginate.
Initial tests of the effects of processing through the mark 2 tube- 
forming device show this impact of alginate on cell viability. This time, a fall 
of 40% over 1 hour strengthens the fact that there is an inherent problem with 
the alginate source. Despite the fact that the alginate is autoclaved, this 
problem seems to be due to contamination from the alginate source.
The effects of shear damage on cell viability were repeated, this time 
incorporating those from the static mixer assembly and those from the mark 2 
tube-forming device. Alginate source was switched from Manugel DMB to 
Pronova SLG 100, highly sterilised alginate, pre-liquified and used 
throughout cell proliferation studies involving GRGDY ligand (Rowley and 
Mooney 2002). Both processing methods showed consistently high viabilities 
above 90% after processing. Only at 100ml/min in the tube-forming device 
do we see a 5% fall in viability, but since 20ml/min is usually used for 
maintaining a level of control, this should not be the case. This result is 
expected since the static mixer assembly and mark 2 tube forming tube- 
forming device give shears of 0.00031 N/m2 and 0.0017N/m2, respectively. 
Only at low shear rates, between 0.75-1 ON/m2, is cell viability likely to be 
affected (Ludwig et al. 1992; Ma et al. 2002).
Although mechanical force can induce apoptosis (Kainulainen et al. 
2002; Wernig and Xu 2002), the Guava EasyCyte capillary cytometer and 
Guava Nexin reagent showed no apoptosis resulting from processing effects. 
Previous studies by Reis et al have shown significant apoptotic activity in rat
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medial SMCs within the hour after mechanical damage of a angioplasty 
guide-wire (Reis et al. 2000).
OCT was used for preliminary scans on cell-integrated tubes for 
qualitative analysis of spatial distribution of cells. Results showed that cells 
offered sufficient backscatter for OCT scans to be carried out, where 
previously glass beads were needed. The tube did not have uniform 
thickness -  as the cell-integration method was via hand mixing. Finally we 
can see how poorly distributed the cells are in a hand mixed cell-integrated 
alginate tube.
Inter and intra-tubular coefficient of variance showed how spatial 
distribution of cells improved with increasing number of static mixer elements 
from hand mixing to 8-element to 12-element. However, in all cases the 
ends tend to have high variations in cell numbers, perhaps a result of non­
optimised priming of cells with alginate prior to injection into the side port of 
the mark 2 base unit. Whilst we can confidently predict better results with 
increasing number of Kenics design static mixer elements, literature tells us 
that Sulzer-Koch design mixers are far superior in inefficiency and should 
drastically reduce the amount of dead space and hence wasted sample 
material (Douroumis and Fahr 2006).
A visual verification of the effectiveness of static mixing was verified 
using confocal laser scanning microscopy (CLSM). It is clear that by 
comparing a set of hand mixed cell-integrated tubes with a set of 12-element 
statically-integrated cell tubes that cells are more evenly distributed using the 
latter cell-integration method. Unfortunately, the CLSM data could not verify 
what other groups have seen in cell embedded alginate beads that show 
greater presence of cells closer to the surface of the bead than in the centre 
(Zohar-Perez et al. 2004). This is associated with solidification and 
shrinkage at the reaction plane but a liquid core and emphasised by beads 
many times the thickness of our tube walls.
6.4 CONCLUSIONS
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This research has described a generic system capable of forming alginate 
tubes at high precision. A novel interpretation of fluid dynamics has been 
adapted into a model that has been verified by experimentation. This Theory 
predicts the thickness of the deposited layer of fluid (at time of tube 
formation) in any system of two fluids to approach 2/3 the gap width as the 
gap width becomes very small compared to the spherical regulator diameter. 
The system has been optimised for robustness against infusion speed, as 
well as fluctuations in alginate concentration, which may arise from 
temperature changes or due to embedded particles such as cells. We can 
manipulate this tube wall thickness by altering spherical regulator radius or 
glass barrel radius without compromising the reliability of the system.
Tube wall thickness can be monitored using OCT, an original use of 
the technique. OCT was also adapted to measure tube wall shrinkage over 
time to establish a shrinkage time of 12 mins. High-speed video camera also 
elaborated there to be no regulator spin during tube formation, and hence 
any lop-sided tubes would have the same trait throughout its length. Cell 
sample homogeneity, consisting of no aggregates -  a factor that impacts on 
cell viability and cell-integrated tube wall thickness -  was measured using the 
Malvern particle sizer by monitoring cell size distribution plots. Three peaks 
observed at differing sizes were concluded to be cellular debris, and two 
discrete populations of cells at different diameters. Cell quantification could 
also be automated by methods such as the Gauva capillary cytometer, which 
proved to be comparable to haemocytometer. For the manual aspects of cell 
culture, pipetting was neither proven nor disproved for effectiveness to 
disassociate cell aggregates, but holding time was shown to cause 
aggregation after 3 hours. A control measure of gauze filtration can be used 
to manage particle sizes however. Centrifugation speed and rate, and 
passage number statistically showed to have no significant impact to cell size 
distribution.
These alginate tubes maybe seeded with cells or they could be 
embedded. Hand mixing cells into alginate was shown to influence wall
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thickness up to 4%, and hence Kenics static mixers were introduced to add 
more consistency to such fluctuations. The results showed how 12-element 
statically mixed cell-integrated tubes were far superior in wall thickness 
variability compared to hand mixed techniques. Large falls in cell viability 
prior to processing cell/alginate mixture into a hydrogel tube were isolated to 
be caused by a contamination from the Manugel DMB used. A switch to 
Pronova SLG 100 showed viabilities above 90% for all aspects of cell- 
integrated tube production. Media toxicity was negligible up to 1 hour 
exposure times, as well as concentration steps and shear damage via 
processing through the static mixer assembly and mark 2 tube-forming 
device. This was confirmed by apoptosis analysis using Guava Nexin 
reagent. The Kenics static mixers also allowed improved spatial distribution 
of single cells embedded in alginate. Again the 12-element mixer was 
superior to 8-element mixer and hand mixing. This was verified via OCT, cell 
counting (haemocytometer) and confocal laser scanning microscopy.
The variables chosen to be monitored in this thesis were mechanical,
i.e. wall thickness, cell dispersion, etc. The only cell related variables 
monitored were viability and apoptosis due to the versatility of the device to 
be used with any system of fluids and any type of cell. Rat aortic smooth 
muscle cells were used as a model, as were glass beads. The focus of this 
work has been on the ability: to reproducibly create alginate tubes with 
uniformly thick walls of predictable thickness; to be able to monitor and 
quality control the tubes and the cell suspension, including controlling 
aspects of mammalian cell culture via automation; and to integrate the cells 
into the tube without compromise to wall thickness, cell viability and cellular 
spatial distribution within the alginate tube.
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A1 Tube Forming Protocol
Standard conditions:
0.9% wt/vol saline, pH 7.3-7.4
0.09M CaCI2 (propelling fluid)
0.50-1.00% Manugel DMB (matrix fluid)
1. Lubricate 100ml syringe using silicon gel and load using propelling 
fluid.
2. Fit loaded syringe into syringe driver.
3. Fit dual port base unit onto 100ml syringe.
4. Prime device using propelling fluid to the top of the injector nozzle of 
the plastic base unit at 1ml/min.
5. Prime 1ml luer-lock syringe (Fisher, Loughborough, UK) with desired 
volume (300-1000pl) of matrix fluid.
6. Fit 1 ml syringe to side port of dual port base unit.
7. Remove excess propelling fluid from injector nozzle.
8. Position spherical regulator on top of injector nozzle.
9. Fit glass barrel onto stub of dual port base unit.
10. Inject entire volume of matrix fluid.
11. Infuse propelling fluid from syringe driver at 20ml/min*.
12. Leave tube to set for 10 min before removal.
Further:
1. Any run with air bubbles present, either during setup or during run, 
should be discarded.
2. Triplicates to be performed for each matrix fluid volume (after 3.2.3).
Note: Appendices A 1-5 were developed by Dr. Julia Markusen, UCL and A6-
7 were written by Prof. Ricky Wang, Cranfield University Silsoe.
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* N.B. Infusion speed was reduced to 20ml/min to increase control on tube 
formation.
A2 THAWING VIAL AND SEEDING FLASK OF CRL-1444
This protocol thaws one vial of (CRL-1444) A7r5 smooth muscle cells 
(SMCs) and then seeds the cells into 1 x T150 flask.
Passage 10, Date__________(Vials were frozen at P9, so first passage is
P10)
1. Pull the following medium for passaging cells:
a) Complete medium DMEM (Cambrex, NJ 07073) supplemented 
with 10% FBS (Cambrex, NJ 07073), 1% (2 mM) L-glutamine 
(Cambrex, NJ 07073) and 1% pen/strep (Cambrex, NJ 07073) - 
stored at 4°C, pre-warm to room temperature
b) Need 1 flask x 29 ml/flask = 29 ml for new flask. Complete
medium formulated on______________
2. Using a 25 ml pipette, add 29 ml of complete medium to new 1 x T150 
flask (Sigma-Aldrich, MO 63103)
3. Label flask with CRL-1444, passage number (P10), initials, and date.
4. Place new flask into 37°C/10% C02 incubator to equilibrate. (Ensure 
water bath is turned on and set to 37°C)
5. Remove one vial from frozen, liquid nitrogen storage. Safety note: 
Must wear protective gloves and face shield to protect against extreme 
cold temperature and possibility of vial exploding if liquid nitrogen is 
inside vial. Place vial into Styrofoam container with dry ice (preferred) 
or ice. Transfer as quickly as possible to lab.
Time cells removed from liquid nitrogen:__________  am/pm
Note: Appendices A1-5 were developed by Dr. Julia Markusen, UCL and A6-
7 were written by Prof. Ricky Wang, Cranfield University Silsoe.
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6. Rapidly thaw vial in a 37°C water bath by gently swirling in the water 
(takes 2-3 minutes). Do not submerge vial cap under water during 
thaw, as water will wick up threads in cap. Safety note: Must wear 
face shield during thaw.
Time start thaw of cells:__________ am/pm
Time complete thaw of cells:__________ am/pm
7. Using 50 pi micropipette remove 10 pi of cell suspension from vial and
add directly into a sample tube containing 90 pi of PBS for cell count. 
Using a 1 ml pipette, add entire remaining volume (ca. 0.9 to 1.0 ml) of 
cell suspension drop-wise to the T150 flask containing 29 ml of 
complete medium. Gently rock medium as drops of cells are added. 
Volume of cell suspension added to flask:___________ml
8. Gently rock the flask so that the cells and medium mix well and are 
coated evenly over the growth surface. Remove 0.5 ml sample from 
the flask (only if you want to do metabolite analysis).
9. Time flask placed into 37°C/10% C02 incubator_______________
am/pm
10. For samples (if needed):
a) 1 x 0.5 ml diluted cell suspension, label with info. (e.g. JM2-01, 
Pxx, dil.cell, Day xx, date)
b) Place into sample box in -70C freezer
11. Perform cell count:
Using 100 pi sample in PBS, add 20 pi of sample to 20 pi of trypan 
blue dye. Perform 3 replicate counts. Count the number of live and 
dead cells in 10 squares: 
viable/nonviable
a)
b)
c)
Note: Appendices A1 -5 were developed by Dr. Julia Markusen, UCL and A6-
7 were written by Prof. Ricky Wang, Cranfield University Silsoe.
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Percent Viable = (total number viable) / (total viable + nonviable) x 100 
= (expect >80%)
Total viable cells/ml = total number viable / 3 x 1000 x 20 = (expect ~ 
2 x 106 cells/ml in vial)
(Multiply by vial volume for total viable cells/flask, and divide by 150 
cm2 for cells/cm2)
A3 PREPARATION OF COMPLETE DMEM CULTURE MEDIUM
This protocol is used to prepare complete DMEM medium for culturing 
Smooth Muscle Cells [DMEM (Cambrex, NJ 07073) supplemented with 10% 
FBS (Cambrex, NJ 07073), 1% (2 mM) l-glutamine (Cambrex, NJ 07073) and 
1 % pen/strep (Cambrex, NJ 07073)]
Date_________
1. Thaw the following supplements in water bath - make sure container 
closures do not get submerged in the water (this is a common source 
of contamination).
a) FBS (Cambrex, NJ 07073) - stored at -20°C or colder Lot
number used:________________________
i) Aliquoted into ~59ml sample bottles
b) 200 mM l-glutamine (Cambrex, NJ 07073) - stored at -20°C or
colder - Lot number used:_____________________
i) Aliquoted into 15 ml tubes - combined 6.5 ml of I-
glutamine and 6.5 ml of pen/strep
c) Pen/strep (Cambrex, NJ 07073) - stored at -20°C or colder - Lot
number used:________________________
Note: Appendices A 1-5 were developed by Dr. Julia Markusen, UCL and A6-
7 were written by Prof. Ricky Wang, Cranfield University Silsoe.
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i) Aliquoted into 15 ml tubes - combined 6.5 ml of I- 
glutamine and 6.5 ml of pen/strep
2. Prepare the complete DMEM medium
a) Remove from refrigerator the bottle(s) of DMEM (Cambrex, NJ
07073) - Lot number used:___________________
b) Place all components into laminar flow hood. Spray each bottle 
with 70% ethanol prior to placing in hood.
c) Add 57 ml of FBS to the DMEM bottle
d) Add 12 ml of the combined l-glut and pen/strep to the DMEM 
bottle
e) Replace and tighten DMEM bottle cap. Mix components by 
inverting the DMEM bottle several times.
f) Label DMEM bottle “complete medium, Date”.
g) Store complete medium in refrigerator or use directly.
A4 PASSAGING CRL-1444
This protocol passages 5 x T150 flasks to 15 x T150 flasks. Any combination 
can be substituted, using a 1:3 split ratio (e.g. one flask becomes three new 
flasks).
Passage_________ , Date_________
1. Pull the following media for passaging cells
a) Complete medium DMEM (Cambrex, NJ 07073) supplemented
with 10% FBS (Cambrex, NJ 07073), 1% (2 mM) l-glutamine 
(Cambrex, NJ 07073) and 1 % pen/strep (Cambrex, NJ 07073) - 
stored at 4°C, pre-warm to room temperature
i) need 5 flasks x 18 ml/flask = 90 ml for quench
Note: Appendices A1-5 were developed by Dr. Julia Markusen, UCL and A6-
7 were written by Prof. Ricky Wang, Cranfield University Silsoe.
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ii) need 15 flasks x 22 ml/flask = 330 ml for new flasks
Complete medium formulated on______________
b) PBS (Cambrex, NJ 07073) - stored at room temperature
i) need 5 flasks x 30 ml/flask = 150 ml for rinse
PBS lot number______________
c) Trypsin/EDTA (Sigma-Aldrich, MO 63103) - stored frozen - thaw 
in 37°C water bath
i) need 5 flasks x 6 ml/flask = 30 ml
Trypsin/EDTA lot number______________
2. Add 22 ml/flask of complete medium to new 15 x T150 flasks (Corning, 
Cat# 430825)
3. Label flasks with CRL-1444, passage number (e.g. P14), and date.
4. Place new flasks into 37°C/10% C02 incubator to equilibrate.
5. Remove 5 x T150 flasks (flasks to be passaged) from 37°C/10% C02
incubator. Flasks are typically passaged every 3-4 days.
Indicate flasks used   Time cells
removed from incubator:__________ am/pm
6. Observe cells under microscope and indicate % confluency, absence 
of microbial contamination (abnormal pH), excessive detached cells, 
or degeneracy of monolayer.
7. Using 25 ml pipette in BSC, remove spent medium from each flask. 
Pool spent medium from all 5 flasks into a sterile bottle (e.g. Nalgene 
125 ml).
8. Add 30 ml/flask of PBS. Rinse PBS over the cell growth surface (to 
remove residual FBS proteins) and on top of flask (to remove 
condensation). Remove PBS from each flask and discard.
Note: Appendices A1-5 were developed by Dr. Julia Markusen, UCL and A6-
7 were written by Prof. Ricky Wang, Cranfield University Silsoe.
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9. Add 6 ml/flask of Trypsin/EDTA. Rinse Trypsin/EDTA over cell growth 
surface and let flask sit for ~ 5 minutes. (Occasionally rock flask 
during this time to ensure trypsin coated evenly over surface.)
Start trypsinisation:___________ am/pm
10. After 5 minutes, detach cells from growth surface by firmly tapping 
flask against palm of hand. (This is required to detach SMCs.) Quickly 
check cells are detached under microscope.
11. Add 18 ml/flask of complete medium (to quench trypsin activity). 
Medium should be completely washed over cell growth surface.
Time quenched: _____________  am/pm (this should be less than 10
minutes total)
12. Pool cell suspension into one flask. Mix by twirling flask and remove 2 
x 0.5 ml samples.
13. Add 8 ml cell suspension into each new 15 x T150 flask (pre­
equilibrated). Evenly divide cell suspension over last three flasks (e.g. 
7 2/3 ml/flask) due to 1 ml removed for samples. Mix cell suspension 
and medium and remove 1 ml sample from 3 individual flasks.
14. Time last flask placed into 37°C/10% CO2 incubator 
_______________ am/pm
15. Take the following samples:
a) 3 x 1 ml spent medium, label with info. (e.g. JM2-01, Pxx,
spent, Day xx, date)
b) from step 12, 1 x 0.5 ml cell suspension, label (e.g. JM2-01,
Pxx, conc.cell, Day xx, date)
c) 3 x 1 ml diluted cells suspension, label with info. (e.g. JM2-01,
Pxx, dil.cell, Day xx, date)
d) Place into sample box in -70C freezer
16. Perform cell count:
Note: Appendices A1-5 were developed by Dr. Julia Markusen, UCL and A6-
7 were written by Prof. Ricky Wang, Cranfield University Silsoe.
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a) Using remaining 1 x 0.5 ml sample from step 12, add 100 ul of 
sample to 100 jxl of trypan blue dye. Perform 4 replicate 
counts. Count the number of live and dead cells in 10 squares: 
viable/nonviable
i)
ii)
iii)
iv)
Percent Viable = (total number viable) / (total viable + nonviable) x 100 
- (expect >95%)
Total viable cells/ml = total number viable / 4 x 1000 x 2 = (expect ~ 
1 x 105 cells/ml)
A5 CELL BANKING CRL-1444
Passage_________ , Date_________
Pull the following media for passaging cells:-
a) PBS at room temperature
b) Complete medium DMEM (Cambrex, NJ 07073) supplemented 
with 10% FBS (Cambrex, NJ 07073), 1% (2 mM) l-glutamine 
(Cambrex, NJ 07073) and 1 % pen/strep (Cambrex, NJ 07073) - 
stored at 4°C, pre-warm to room temperature
c) DMSO (Sigma-Aldrich, MO 63103) (10ml)
d) FBS (~35ml)
e) Trypsin/EDTA (Sigma-Aldrich, MO 63103) (thaw 2x100 ml in 
water-bath)
Note: Appendices A 1-5 were developed by Dr. Julia Markusen, UCL and A6-
7 were written by Prof. Ricky Wang, Cranfield University Silsoe.
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Need:-
a) Complete medium (need 27 T-150 flasks x 18 ml/flask = 486 ml
for quench)
Complete medium formulated on______________
2. Trypsin/EDTA (Sigma-Aldrich, MO 63103) - stored frozen - 
thaw in 37°C water bath (need 27 T-150 flasks x 6 ml/flask = 
162 ml)
Trypsin/EDTA lot number______________
3. PBS (Cambrex, NJ 07073) - stored at room temperature (need 
27 T-150 flasks x 30 ml/flask = 810 ml)
PBS lot number______________
Procedure:-
I. Remove flasks from incubator (process in groups of ~6 flasks).
4. Check confluency with microscope and make note of it.
5. Remove spent medium with a pipette.
6. Add 30 ml PBS (T150) to each flask. Rinse over cell sheet. Hold PBS
on cells until next set of flasks processed.
7. Remove PBS, discard as waste.
8. Add 6 ml trypsin/EDTA (T15). Let it sit for ~5 mins, then tap flask to 
detach cells.
9. Add 18 ml complete medium for quench (T150) to quench trypsin 
activity. Rinse over growth surface to ensure cells detached & 
homogenous. Pool cell suspension into common flask.
10. Remove 2 x 0.5ml conc. Cell suspension samples (ensure cells well
mixed by twirling flask).
I I .  Aliquot conc. cell suspension into 50 ml centrifuge tubes - baring in
mind to keep both tubes of a pair balanced in mass.
27 flasks x 24 ml/flask = 648 ml to centrifuge -  1ml cell sample = 
647ml
Note: Appendices A 1-5 were developed by Dr. Julia Markusen, UCL and A6-
7 were written by Prof. Ricky Wang, Cranfield University Silsoe.
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=> 12 tubes @ « 50ml each, 2 tubes @ *  24ml each
12. Centrifuge 50 ml tubes at 100xg (centrifuge setting of 100 RCF) for 10 
minutes.
13. Concurrently (during centrifugation) perform cell counts: 100 pi sample 
+ 100 pi trypan blue (dilution factor 2)
14. Let cells (pelleted) sit in tubes until next group of flask trypsinised.
15. Repeat steps 1-11 on second set of flasks.
16. Aliquot remaining cell-suspension into 50 ml centrifuge tubes.
17. Centrifuge set #2.
18. Concurrent 14 cell counts (set #2 flasks). Based on combined cell 
counts calculate the amount of viable cells/ml.
19. Calculate amount of cells to be frozen.
20. Prepare “freeze FBS medium” by adding 15 ml FBS to 50 ml complete 
medium.
21. Without disturbing cell pellet, remove supernatant from each 50 ml
tube (~ 0.5ml residual medium in each tube after supernatant
removed). Resuspend pellet by gently tapping onside with hand until
pellet/cells become unclumped. Add 1ml “freeze FBS medium” to
each centrifuge tube and again resuspend pellet by tapping side with 
hand.
22. After resuspending pellets combine all cells into one tube.
23. Rinse each tube (serially) with total of 2 ml to wash residual cells from
tubes => set # 1 volume « 13ml
(1.5 x 6 = 11 ml + 2ml last rinse = 13ml)
24. Repeat steps 24, 25 & 26 for 2nd set of tubes.
25. Measure final resuspension of combined cells from both sets in “freeze 
FBS medium” as prepared in step 26 & 27 with a pipette. Add 
additional FBS freeze medium to get concentration to 2.2 x 106 cell/ml
26. Transfer into 200 ml glass bottle, place on magnetic stirrer plate inside 
hood and mix at 10 rpm.
Note: Appendices A1-5 were developed by Dr. Julia Markusen, UCL and A6-
7 were written by Prof. Ricky Wang, Cranfield University Silsoe.
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27. Add using e.g. 1 ml pipette, first 1 ml, then 0.7 ml of DMSO (1.7ml
total) dropwise into mixing cell suspension (depending on cell
concentration -  check calculation)
28. Aliquot e.g. 35 x 1 ml into 1.5ml Nalgene Cryovials, and label.
29. Place into -70°C freezer in large Styrofoam box. Transfer to liquid
nitrogen within 24 hours.
Concentration Calculation
Final resuspension volume (set # 1 + 2 ) _________ml (e.g. « 26ml)
Want to resuspend cells to 2 x 106 cells/ml = 2 .2 x106 cell/ml
0.90
(Want 10% DMSO 90% cells in FBS freeze medium)
Add additional FBS freeze medium to the 26ml to make it 2.2 x 106 cell/ml 
(e.g. 12.2 ml)
Then add DMSO to final conc. 10%: (0.10) x 38.2 ml = 3.8ml DMSO added 
dropwise
[Verify check:
3.8ml + 38.2ml = 42ml
Recall 8.411 x 107 cells = 42ml which is what we wanted for 2 x 106 cells/ml ] 
2 x 106
E.g. cell count (average) is 1.3 x 105 cell/ml x 647 ml (centrifuged)
=> 8.411 x 107 cells = 38.2 ml -  26.0 ml resuspension volume = 12.2 ml 
additional FBS freeze medium to be added 
2.2 x 106 cell/ml
Note: Appendices A1-5 were developed by Dr. Julia Markusen, UCL and A6-
7 were written by Prof. Ricky Wang, Cranfield University Silsoe.
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A6 PREPARING CELLS FOR ADDITION TO ALGINATE TO FORM 
BEADS/TUBES
1. Trypsinise cells as per usual protocol. Pool the cells into one flask.
2. Dispense cell suspension into centrifuge tubes (Measure volume of 
cell suspension, so you can calculate the total volume).
3. Perform cell count as per usual protocol. Calculate total number of 
cells. Determine the cell concentration you want to have in the 
alginate (this is usually 1e6 to 1e7/ml). Calculate the volume of 
alginate + cells.
Example: Trypsinise 4 flasks @ 3e6 cells/flask = 12e6 cells total 
Want 5e6 cells/ml, so dividing by total cells = 2.4 ml of alginate + cell 
solution.
4. Centrifuge cells at 100xg for 5 min., temperature can be set to 8-1OC.
5. Remove supernatant without disturbing the pellets. Gently tap pellets 
to loosen cells.
6. Resuspend the cells with culture medium (about 2 ml), combine all of 
the cells into one tube. Maximise the number of cells recovered by 
rinsing tubes with medium and adding to the last tube with all the cells. 
Resuspend the cells to a total volume of 5-8ml. This step is performed 
to removed/dilute residual trypsin/EDTA, which will interfere with 
alginate cross-linking.
7. Centrifuge cells at 100xg for 5 mins, temperature can be set to 8-1 OC.
8. Remove supernatant without disturbing the pellet. Gently tap pellet to 
loosen cells.
9. Resuspend the cells with culture medium, volume as calculated below. 
The pellet volume must be accounted for, so the total volume includes 
medium + cells. Avoid excess bubbles, pipette slowly until cells + 
medium are homogenous.
Note: Appendices A1-5 were developed by Dr. Julia Markusen, UCL and A6-
7 were written by Prof. Ricky Wang, Cranfield University Silsoe.
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Example: For 1% alginate solution, a 75% alginate, 25% cells mix 
works well. So for 2.4 ml alginate + cells this is 0.6ml of cells, 1.8ml of 
alginate. It works well to put a small volume of culture medium into a 
separate container, so you don’t have to change pipettes to get the 
volume accurate (and you don’t lose cells with each pipette change).
10. Add the volume of alginate to a small sample tube. Flat bottom tube 
mixes better.
11 .Add the cell suspension to the alginate, swirling the end of the pipette 
as you slowly add the cells (this mixes like a spoon). Do not pipette 
up and down. Twirling the tube or placing the on roller also works 
well.
12. Make beads/tubes.
A7 OCT DATA ANALYSIS MATLAB PROGRAMME
clear
N =27650;%////69500////104250; 
nf = 0;
MN =2; 
figno = 11; 
ispec = 1; 
specfigno = 10002;
filenaml = sprintfCoct.TXT'J^/oSeSmm 18bead 4 
fid = fopen(filenam1 ,'r+'); 
shft = 2*N*nf;
status = fseek(fid, shft, 'bof); 
for (kk=1 :MN) 
count = fix(kk/5) - kk/5; 
if (count == 0) kk
Note: Appendices A 1-5 were developed by Dr. Julia Markusen, UCL and A6-
7 were written by Prof. Ricky Wang, Cranfield University Silsoe.
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end
date = fread(fid,N, ‘short');
%date(1) = date(2);
y = date*10000.0/4096.0 - 5000.0; %Convert into voltage 
clear date;
a = mean(y); y = (y - a)/20; 
if ((fix((nf+kk)/2)-((nf+kk)/2)) == 0) 
y1 = flipud(y);
y=yi;
end
% figure(11)
% plot(y)
% [B,F,T] = specgram(y, 128,20000,[],38);
%[B,F,T] = specgram(y,256,200000,100,65);
[B,F,T] = specgram(y,256,20000,100,65);
if (kk == ispec)
figure(specfigno)
imagesc(log(abs(B)));
figure(10000)
specgram(y,256,20000,140,45); 
end
C=abs(B(50:75,:)); %19:46 
F1 = F(50:75);
XSUM = sum(F1);
XYSUM = C'*F1;
fist(:,kk) = 20*log(XYSUM/XSUM);
%fist(:,kk) = log(max(C, [], 1)');
% nt = max(size(T));
% nf = max(size(F));
% C=20*log(abs(B));
Note: Appendices A 1-5 were developed by Dr. Julia Markusen, UCL and A6-
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% for (jk = 1 :nt)
% fist(jk, kk) = max(C(26:39,jk)); %
% end
clear C B y y1 a aver;
%shft = 2*N*2;
%status = fseek(fid, shft, 'cof'); 
end
fclose('aH');
xx = T*240000*0.008434/1000/1.5;
yy(1 :MN) = (1 :MN)*12.6/1000; %1.5/60; %spatial resolution 
bb = min(min(fist)); 
fist = fist - bb;
A = max(max(fist)); 
fist = fist/A;
%fist1 = (fist.*fist); 
load map_plate.m 
figure(figno)
%subplot(3,2,6) 
imagesc(yy,xx, fist, [0 3]); 
colormap(map_plate);
%ylabel('Depth (mm)', 'fontsize', 24, 'fontweight1, 'bold');
%xlabel('Spatial length (mm)', 'fontsize', 24, 'fontweight', 'bold');
%set(gca, 'fontsize', 20, 'fontweight', 'bold','Position', [0.160 0.180 0.750
0.75]);
%jpgfilename = strrep(filenam1,'TXT','jpg');
%saveas(gcf, jpgfilename);
%figfilename = strrep(filenam1 ,'TXT‘,'fig');
%saveas(gcf, figfilename);
%aaa = sum(fist,2)/MN;
%figure(49)
Note: Appendices A 1-5 were developed by Dr. Julia Markusen, UCL and A6-
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%hold
%plot(xx, aaa, 'b-')
%hold on 
figure(1)
sm = sum(fist, 2)/size(fist,2);
bkgarray =sm(2:22);
bkg = sum(bkgarray)/size(bkgarray,1)
sm = sm - bkg;
plot(sm);%T*65/1.4,
effpixels = find(sm > 0.15);
for (ii=2:size(effpixels, 1))
increament(ii)=effpixels(ii)-effpixels(ii-1);
end
[bb,idx]=max(increament); 
if (bb >= 10)
thickness = (size(effpixels,1)-idx)*(T(2)-T(1))*240000*0.008434/1000/1.4
size(effpixels,1)-idx
else
thickness = size(effpixels,1)*(T(2)-T(1))*240000*0.008434/1000/1.4
size(effpixels,1)
end
aaa= mean(mean(fist((360:390),:))) %
fist = (fist - aaa);
counts = find(fist > 0);
cuntnum = size(counts ,1)
clear all
Note: Appendices A1-5 were developed by Dr. Julia Markusen, UCL and A6-
7 were written by Prof. Ricky Wang, Cranfield University Silsoe.
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A8 OCT MATLAB PROGRAMME EXTENSION -  THICKNESS
figure(1)
sm = sum(fist, 2)/size(fist,2);
bkgarray =sm(2:22);
bkg = sum(bkgarray)/size(bkgarray,1);
sm = sm - bkg - 0.08;
plot(sm);%T*65/1.4,
effpixels = find(sm>0);
for (ii=2:size(effpixels, 1))
increament(ii)=effpixels(ii)-effpixels(ii-1);
end
[bb,idx]=max(increament) 
if (bb >= 10)
thickness = (size(effpixels,1)-idx)*(T(2)-T(1))*240000*0.008434/1000/1.4 
else
thickness = (size(effpixels,1 )-3)*(T(2)-T(1 ))*240000*0.008434/1000/1.4 
end
clear all
Note: Appendices A1-5 were developed by Dr. Julia Markusen, UCL and A6-
7 were written by Prof. Ricky Wang, Cranfield University Silsoe.
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Appendix B: Fluid Mechanics Theory
B1 Theoretical Considerations
The aim of the theoretical analysis is to understand the physical processes 
responsible for the tube forming process and to provide practical estimates, testable 
experimentally, of the tube wall thickness. As we shall demonstrate, the tube 
forming process does not depend on having dissimilar charging and propelling 
fluids. For this reason, we first simplify our analysis by considering the case when 
both fluids are Newtonian and have identical physical properties. A rigid, neutrally 
buoyant sphere of radius r0 being propelled along a cylinder whose inner radius is a, 
as illustrated in Figure 3.1. The cylinder is assumed to be infinitely long so that the 
influence of the end conditions on the flow is negligible. The sphere is propelled 
along the cylinder by a fluid whose mean velocity is u . Both the matrix and 
propelling fluid are assumed to have the same properties, and the same density as 
the sphere. A lubrication analysis of the Newtonian flow around a tightly fitting 
sphere is first considered and the predictions of the thickness of a layer are tested 
against numerical calculations using FEMLAB. This estimation of the thickness of 
the deposited layer forms the new component of the study, which draws on the 
lubrication analysis of Dowson (Dowson et al. 1992).
B2 Lubrication Analysis
In the vicinity of the narrowest region between the sphere and cylinder, the local 
Reynolds number based on the minimum gap width is Re^ = v50p /  f i ,  where p , p
are the density and viscosity of the fluid respectively and S0 is the minimum gap
separation between the sphere and tube wall. Typically Re^ = 0.01, so that inertial
forces are weak. Therefore, the radial pressure gradient is small, and the axial flow 
can be described by the lubrication equation (Batchelor 1965),
Note: All mathematical Theory was developed by Prof. Ian Eames,
(Department of Mechanical Engineering, UCL) and Dr. Mark
Landeryou (Department of Medical Physics, UCL).
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v  X
► r
Velocity profile of the 
vertical component of flow 
across the cylinder
Figure 3.1 Schematic to show the arrangement of the spherical regulator in a cylinder 
propelled upwards by a flow at the inlet.
Note: All mathematical Theory was developed by Prof. Ian Eames,
(Department of Mechanical Engineering, UCL) and Dr. Mark
Landeryou (Department of Medical Physics, UCL).
Integrating this equation leads to a parabolic velocity profile, which after including 
the non-slip condition on the wall and sphere yields
uX
v(r - a )  I dp
S(x) 2p dx
■—- ■ ( r - a X r - a  + S(x)), (2)
Where ux is the vertical component of velocity and 6 is the gap separation. The 
cylindrical coordinates (r ,* )  refer to the radial distance from the centreline and the 
vertical distance above the centre of the sphere. The gap separation between the 
sphere and cylindrical tube £(x) is a function of vertical distance.
The solution to (2) for the problem we consider is well known (Matar et al. 
2006; Udofia and Jin 2003) but the application to determining the thickness of the 
deposited layer of the fluid appears new. To solve (2), we first make use of the fact 
that the flux of fluid between the sphere and tube, across a horizontal plane, is 
independent of vertical position of the plane. Since the gap thickness can be 
considered small compared to the tube radius (S0 « a ), conservation of the vertical 
mass flux reduces
27tf +(u - v ) m 2 =0 (3)
Where the circumferential flux is
8 3 dp
(4)
Note: All mathematical Theory was developed by Prof. Ian Eames,
(Department of Mechanical Engineering, UCL) and Dr. Mark
Landeryou (Department of Medical Physics, UCL).
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Since the pressure gradient is largely controlled by the vertical pressure difference 
across the thin gap, the pressure difference between above and below the sphere is 
estimated to be
AP =  f  — dx = 6iuvl2- l 2 [ t f l :s,
•L o o  / / vdx
(5)
Where / 2 and / 3 are defined by /„ = j~ . The shear induced force, per unit 
circumferential distance is
5 =  / / dux
dr
■ dx = //(4V/! —6JJ2). (6)
r=a-S
We are interested in the case when the sphere is neutrally buoyant, so that the total 
force on the sphere is zero, with the shear stress and pressure forces balancing, 
that is
F, = 2 naS — m 2AP = 0. (7)
By substituting (5) and (6) into (7), the relative slip between the sphere and ambient 
flow is estimated to be:
v — u _ 4/, - 3 1-,a
(9)
Within the vicinity of the narrowest point between the sphere and tube, the gap 
thickness, to second order, is approximately
5(x)= S0 + (10)
Note: All mathematical Theory was developed by Prof. Ian Eames,
(Department of Mechanical Engineering, UCL) and Dr. Mark
Landeryou (Department of Medical Physics, UCL).
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Where the radius of curvature of the gap (or the sphere radius) is rQ. Evaluating
f dx_{(SQ+ x 2/2roy  ’ (11)
we obtain
1,2 V2
1 tfi/2 ' - 2  2<y3/V0l/2 ’ "3 8<?5,V '2 ''o
(12)
Thus from (9) the sphere slip velocity is
3 rn
l-8<yo/3r0  ^
vl-4<y0 / 3r0 ,
(13)
Thus the sphere moves faster than the average fluid velocity. The physical picture 
that emerges is one where the flow up and downstream of the sphere is parabolic
and described by ux = 2 u ( \ -  r2 / a2) , but in the vicinity of the sphere and near the
narrow gap, it is determined by the lubrication analysis. We attempt to confirm this 
solution numerically before proceeding to estimate the layer thickness.
B3 Numerical Calculation of the Flow Field
To test the asymptotic analysis, we calculated the viscous flow around a neutrally 
buoyant sphere translating along the axis of cylindrical tube using a scripted set of 
equations within FEMLAB 3.1. The output from FEMLAB was processed using 
MATLAB. Figure B1 shows a schematic of the computational domain, with a
Note: All mathematical Theory was developed by Prof. Ian Eames,
(Department of Mechanical Engineering, UCL) and Dr. Mark
Landeryou (Department of Medical Physics, UCL).
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Figure B1 Schematic of the computational domain, with a parabolic velocity input 
velocity profile, a prescribed exit pressure and prescribed velocity of the 
sphere.
Note: All mathematical Theory was developed by Prof. Ian Eames,
(Department of Mechanical Engineering, UCL) and Dr. Mark
Landeryou (Department of Medical Physics, UCL).
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parabolic velocity input velocity profile, a prescribed exit pressure and prescribed 
velocity of the sphere. For Stokes flows, the flow is determined by the 
instantaneous boundary conditions on the flow. The translation velocity of the 
sphere is unknown and is calculated iteratively by determining when the vertical 
force on the sphere was zero, consistent with the requirement from (7). The mesh 
in the small gap was refined and its influence on the resulting solution tested. Both 
three dimensional and axisymmetric formulations were considered and found to give 
the same results. Figure B2 shows a comparison between the calculated slip 
velocity of the sphere and the asymptotic expression (13), with excellent agreement 
for S0/ a <  0.1.
B4 Estimation of the Layer Thickness
As the sphere is propelled along the tube, fluid in front of the sphere is deposited on 
the inner wall of the cylindrical tube and forming a thin layer. The purpose is to 
estimate the thickness of the layer deposited. Two methods are used to estimate 
the thickness of a deposited layer: an approximation of the average layer thickness 
and calculation of the thickness by following the flow. We describe both approaches 
and show how they differ, but this difference can be reconciled by a more detailed 
analysis of the flow. We elaborate on the implications for interpreting the 
experimental results.
To estimate the deposited thickness we consider the experimental setup, 
where a cylinder is initially charged with a fluid of height A . As the propelling fluid 
is injected into the cylinder (with an average velocity u ), the height of the matrix fluid 
is lifted by A + u t , while the sphere moves a distance vt . The sphere breaks 
through the surface of the liquid after time t = A / ( v - u ) , producing a layer whose 
nominal thickness is
(14)
Note: All mathematical Theory was developed by Prof. Ian Eames,
(Department of Mechanical Engineering, UCL) and Dr. Mark
Landeryou (Department of Medical Physics, UCL).
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Figure B2 (i) Numerical results for the flow field for Re = 1 and S0/ a =  0.1. The
contours show values of the radial component of the velocity field (ur). The 
dots denote the path of a fluid particle released adjacent to, and near the 
surface, of a rising sphere and are representative of the interface shape.
(ii) Calculated interface from tracking a number of particles distributed 
across the sphere-cylinder wall gap.
Note: All mathematical Theory was developed by Prof. Ian Eames,
(Department of Mechanical Engineering, UCL) and Dr. Mark
Landeryou (Department of Medical Physics, UCL).
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The second method involves releasing tracer particles in the flow, which were swept 
past the sphere as it translated along the tube. Figure B2{i) shows a line of tracer 
particles released along the narrowest gap between the wall and sphere. Tracer 
particles in the vicinity of the sphere are carried forward as the sphere advances, 
while particles closest to the wall move much slower. As a consequence the sheet 
of tracer particles is deformed. The tube thickness T0 may be found from the
maximum thickness of the tracer layer far downstream of the sphere. Figure 3.4 
shows numerical calculations of this thickness.
It is clear by comparing the results of (14) with those of the tracer particle 
study that the thicknesses are different, and this is caused by a subtlety in the 
problem. Once the tracer particles have been advected beyond the influence of the 
sphere, they do not come to rest, but continue to move in the presence of the 
viscous parabolic flow that propels the sphere. This flow induces the particles to 
move in the direction of the sphere. At this distance, x, from the sphere to where the 
tracer curve makes contact with the tube wall, the fluid interface is advected with 
speed ux(rf ) by the parabolic flow. For thin gap separations, the flow is
approximately a linear shear in the vicinity of the wall, and the particles move 
according to X f (t)= X f (t0) + 4uTf t la . This self-similar portion of the tracer layer
is connected by a layer of uniform thickness, which increases in length, in proportion 
to the speed of the sphere. The total volume of fluid in the two layers is 
approximately constant with time. Figure B2(ii) shows the shape of the fluid 
interface downstream of the sphere where the interface is not changing in r. The 
end region forms a finite fraction of the tube length and causes the mean thickness 
of the layer estimated from volume conservation (14) to be slightly smaller than the 
true thickness.
Note: All mathematical Theory was developed by Prof. Ian Eames,
(Department of Mechanical Engineering, UCL) and Dr. Mark
Landeryou (Department of Medical Physics, UCL).
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0 8
0.7
0.6
T/So
0.5
0.4
0 3
Thickness (Vs volume)
0 2 Final Thickness (tracking)
Mean Thickness (tracking)
0 1 * Alginate with CaCI2 (setting)
0 0
0 0.05 0.1 0.15 0.2
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Figure 3.4 Tube wall thickness, T  as a fraction of gap width, ‘80’ versus gap width as a 
fraction of cylinder radius ‘a’. Alginate infused with CaCI2 wall thickness 
data, T0 is marked as (X). The predicted wall thickness (TB) (14) is plotted 
as a green line.
Note: A ll mathematical Theory was developed by Prof. Ian Eames,
(Department of Mechanical Engineering, UCL) and Dr. Mark
Landeryou (Department of Medical Physics, UCL).
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Appendix C: Statistical Analyses
All statistical tests were performed with the aid of http://facultv.vassar.edu 
statistical calculator.
Table C1
D a ta  S u m m a ry
Statistical results for ANOVA and TUKEY tests of the particle size data 
from figure 4.9b.
N
£ X
M e an
v x 2
V a ria n c e
S td .D e v .
S td .E rr .
1
32
1 0 2 2 6 4 2 .3
3 1 9 5 7 .5 7 1 9
2
32
1 0 3 0 3 4 9 .4
3 2 1 9 8 .4 1 8 8
S a m p le s
3
32
7 1 0 3 0 0 .8
2 2 1 9 6 .9
4
32
4 7 6 0 8 4 .6
1 4 8 7 7 .6 4 3 8
5
32  
8 0 1 1 6 .3  
2 5 0 3 .6 3 4 4
T o ta l
160
3 3 1 9 4 9 3 .4
2 0 7 4 6 .8 3 3 7
1 0 9 2 5 5 3 2 9 3 9 6 .8 7  8 9 5 6 6 0 3 1 1 4 5 .8 6  4 2 1 6 1 9 6 5 1 4 1 .2  2 2 3 9 8 4 3 4 9 5 0 .3 4  5 7 6 6 9 4 2 8 3 .4 9  2 6 3 9 5 8 4 5 4 9 1 7 .7 6 0 1  
2 4 7 0 1 3 4 3 4 1 .6 8 4  1 8 1 9 0 4 5 4 7 4 .3 8 2 2  8 5 1 4 6 7 3 9 7 .2 1 5 5  4 9 4 0 4 5 7 3 7 .9 5 7 4  1 2 1 3 2 6 5 6 .8 0 0 4  1 2 2 6 9 7  7 8 4 4 .1 1 1 6
4 9 7 0 0 .4 4 6 1
8 7 8 5 .8 8 0 6
4 2 6 5 0 .2 6 9 3
7 5 3 9 .5 7 3 7
2 9 1 7 9 .9 1 4 3
5 1 5 8 .3 2 8 8
2 2 2 2 7 .1 3 9 7
3 9 2 9 .2 4 0 3
3 4 8 3 .1 9 6 3
6 1 5 .7 4 7 9
3 5 0 2 8 .2 4 3 5
2 7 6 9 .2 2 5 8
A N O V A  S u m m a ry  
S ou rce
T re a tm e n t
.'betw een group si 
E rro r  
S s /B I  
T o ta l
SS  d f
2 0 0 3 7 8 8 3 3 6 4 .5 1 3 4  4
M S F P
5 0 0 9 4  7 0 8 4 1 .1 2 8 4  1 0 .6 8 1 6  < .0 0 0 1
5 8 1 5 3 8 6 6 8 8 2 .7 6 6 7  124  4 6 8 9 8 2 7 9 7 .4 4 1 7
1 1 6 8 9 7 7 2 6 9 6 6 .4 5 7 7  31
1 9 5 0 8 9 4 7 7 2 1 3 .7 3 7 8  159
T u k e y  H S D  Test
M S D [.05] = 1 4 9 9 3 .2 8 ; H S D [.0 1 ]  = 1 8 0 4 4 .6 7
M l vs M2 nonsignificant
M l vs M 3 nonsignificant
M l vs M4 P < .05
M l vs M 5 P< 01
M2 vs M3 nonsignificant
M2 vs M4 P < .0 5
M2 vs M5 P< 01
M3 vs M4 nonsignificant
M3 vs M 5 P< 01
M4 vs M5 nonsignificant
M l -  m ean of Sam ple 1 
M2 « m ean of Sam ple 2 
and so forth.
HSD -  th e  absolute [unsigned] 
difference b e tw e e n  any tw o  
sam ple m eans required for 
significance at th e  designated  
level. H S O ',05] for the  ,05 level; 
H S D '.O l] for th e  .01 level.
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Table C2
Table C3
Statistical results for ANOVA and TUKEY tests of the Leica QWin data 
from figure 4.10.
D«t« Summary
Sample*
1 2 3 4 5 Total
N 12 12 12 12 12 6 0
I * 273 311 191 1 3 1 5 17.5 9 2 4
Mean 22 .7 5 2 5 .9 16 7 15.9167 10.9583 1 .4583 15 4
£ X 2 2 9 5 0 8  8 75 2 4 6 4 2 .2 5 8 5 6 3  6 75 3 3 6 8 .3 7 5 7 8 .3 7 5 6 6 1 6 1 .7 5
Variance 2 1 1 8 .0 1 1 4 150 7 .4 69 7 5 02 .16 29 175 .214 4 .8 0 4 9 8 8 0 .2 0 5 9
Sid. Dev. 4 6 .0 2 1 9 3 8 .8 26 1 22.409 13.2368 2 192 29 6 68 3
Std.Err. 1 3 .2 85 4 11.2081 6 .4 6 8 9 3 .8 2 11 0 .6 3 2 8 3 .8 3 02
ANOVA Summary  
Source SS df MS F P
Treatm ent 4 S 4 7 .8 5 8 3  4 113 6 .9 64 6  3 .319 0 .0 1 8 4 4 4
.'betw een groups;
Error
Ss/B I
Total
1 5 0 7 2 .8 9 1 '
3 23 11 .4
5 19 32 .15
44
11
59
342 -5657
Ss/BI *  Subjects or Blocks depending on th e  design. 
Applicable only to correlated-sam ples ANOVA.
Tukey USD Test
H S O ;.0 5 ]-2 1 .5 6 : H S D [.0 1 ]-2 6 .2 2
M l vs M2 nonsignificant
M l  vs M3 nonsignificant
M l  vs M4 nonsignificant
M l vs M5 nonsignificant
M2 vs M3 nonsignificant
M2 vs M4 nonsignificant
M2 vs M5 P c .0 5
M3 vs M4 nonsignificant
M3 vs MS nonsignificant
M4 vs M5 nonsignificant
M 1 -  m ean of Sam ple 1 
M2 « m ean of Sam ple 2 
and so forth.
HSD -  th e  absolute 'unsigned; 
difference b e tw e e n  any tw o  
sam ple m eans required for 
significance a t th e  designated  
level. HSO ;.05] for th e  .05 level; 
H S D [.01] for th e  01 level
Statistical results for ANOVA test on a correlated sample comparing 
data from the Leica QWin and Malvern Particle Sizer.
D a ta  S u m m a ry
N
IX
M ean
IX2
V arian ce
S td .D e v .
S td .F rr.
S a m p le s  
1 2
5 5
2 9 9 9 4 3 .5  2 73
5 9 9 8 8 .7  5 4 .6
2 5 5 9 9 8 8 4 4 /8 .4  7 2 9 5 0 8  8 7 5  
1 9 0 1 6 6 5 9 6 0 .0 0 5  3 6 5 0 .7 6 8 8  
4 3 6 0 8 .0 9 5 1  6 0 4 2 1 6
1 9 5 0 2 .1 3 3  2 7 .0 2 1 4
3 4 5 T o ta l
10
3 0 0 2 1 6 .5
3 0 0 2 1 .6 5
2 5 5 9 9 9 1 3 9 8 7 .3 4 5
1 8 4 2 9 9 1 0 3 3 .3 4 6 7
4 2 9 3 0 .0 7 1 4
1 3 5 7 5 .6 8 0 6
A N O V A  S u m m a ry  
S ou rce SS df M S
T r e a tm e n t 8 9 8 0 2 4 0 8 5 7 .0 2 5  
b e tw e e n  groups]
1 8 9 8 0 2 4 0 8 5 7 .0 2 5  9 ,4 2 6 3  0 .0 3 7 2 8 5
E rro r
S s /0 1
T o ta l
3 8 1 0 7 3 2 4 4 9 .1 9 7 5  4 9 5 2 6 8 3 1 1 2 .2 9 9 4  
3 7 9 5 9 4 5 9 9 3 .8 9 7 5  4  
1 6 5 8 6 9 1 9 3 0 0 .1 2  9
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Table C4 Statistical results for ANOVA test on a correlated sample comparing 
data for the effect of passes using an auto-pipette, figure 4.15.
Data Summary
N
I X
Mean
vx1
Variance
Std.Oev.
Std.Frr.
1
32
7 23 46 5 .1
2 2 6 0 8 .2 8 4 4
7
32
7 8 3 8 8 4 2  
2 4 4 9 6 .3 8 1 3
Sample*
3
32
6 7 3 5 9 4
2 1 0 4 9 .8 1 2 5
32
1 27 66 6 9  4 
3 9 9 5 8  4 1 8 8
5
32
9 9 0 6 8 2  2 
3 0 9 5 8 .8 1 8 8
Total
160 
445029 -1 .9  
27814  3431
6 3 0 /4 3 9 5 1 0 6 .2 5  8 4 4 1 6 1 /6 0 2 0 .4  7 7 6 1 1 9 0 9 6 2 2 .4 4  1 5 /0 9 7 9 4 5 /4 9 .1 6  1 /6 9 1 1 4 5 8 6 5 1  3 5 5 9 1 0 6 8 8 5 1 4 9  SS
1 5 0 /0 3 5 1 7 3 .8 /3  2 1 0 3 6 7 2 5 /4  2371  2 0 4 6 2 2 2 0 0 7 .1 3 9 2  3 4 1 9 3 3 3 4 9 / 4 5 6 4  4 /1 /4 5 5 0 9 6 .2 1 4 5  27 3789217-1.802  
3 88 7 0 .5 5 0 9  4 5 8 6 5 .8 1 0 5  4 5 7 3 5 .185S 5 8 4 7 5 .0 6 7 3  6 8 6 8 3  7 374 S 2 3 2 4 .8 7 1 5
6 8 6 2 .5 6 8 7  8 1 0 8  0 06 4  7 9 9 6 .5 2 6 6  1 0 3 3 7 .0 2 9 2  1 71 4 1 .6 8 3 2  4 1 3 6 .6 4 4 3
ANOVA Summ ary  
Source SS
7 7 1 9 5 8 6 9 7 6  9 88 9tre a tm en t
Error 
S«/B i 
Total
MS F
1 9 2 9 8 9 6 7 4 4 .2 4  72 1 .6264
P
0 .1 7 1 /6 3
1 4 7 1 3 8 3 1 5 2 0 9 .4 7 1 1  124 1 1 8 6 5 9 9 3 1 6 .2 0 5 4  
2 8 0 4 6 6 9 5 3 6 0 7  0 57 5  31
4 3 S 3 2 4 8 S 5 7 9 3  512 4  159
S5/BI -  <x BKVkf a-tpm d-ng on 4ec*jn
AppccaWc or*> to  ion« ijt«J-»an ipU -4  a n Ova
Table C5 Statistical results for ANOVA and TUKEY HSD tests on a correlated 
sample comparing data for the effect of holding time (unfiltered), figure
4.16.
Data Summary
Samples
N
v X 
Mean
IX*
Variance
Std.Oev.
S td .lrr.
1
32
109 30 6 8 .5  
34158  3 90 6
2
32
1 2 4 1 5 9 3 8  
3 8 7 9 9  806 2
3
32
1 6 / 3 6 3 3
5 2 3 0 1 .0 3 1 3
4
32
2 0 2 /  160. 1 
6 3 3 4 8  7531
lo ta l
128  
6 0 3 5 4 5 5  4 
4 71 51  9 95 3
1 69 1 9 9 9 0 9 2 6 4 .7 5 0 1  1 7 7 5 4 6 4 8 5 6 9 8 .3 4  2 6 8 2 5 1 9 8 8 7 3 9  56 4 9 4 9 3 6 1 5 8 2 1 8 .4  1 1 1 0 9 9 3 4 5 4 1 9 2 1  0 6
4 2 5 3 6 2 7 3 6 9 .7 3 7 7  4 1 7 3 3 1 8 9 2 9  S8S1 5 8 2 9 6 5 3 4 4 8 .5 6 5 4  1 182316 -1306.4084  6 4 9 8 8 2 5 0 1 7  2 55 6
b 5 2 19.8 38 8  6 4 6 0 1 .2 3 0 1  7 6 3 5 2 .1 6 7 3  108734 3 /5  8 0 6 1 5  290 2
1 1 5 2 9 3 4 /b  1 1 4 1 9 .9 9 2  13497 283 8  1 9 2 2 1 /0 3 5  7 t7 5  4 57 5
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A N O V A  S u m m a ry
S ou rce  S S  d f M S F P
T r e a tm e n t  1 6 8 7 8 0 9 1 5 0 8 .2 6 2 9  3 5 6 2 6 0 3 0 5 0 2 .7 5 4 3  3 .1 9 7 7  0 .0 2 7 0 1 1
[b e tw e en  groups]
E rro r 1 6 3 6 2 6 1 4 7 7 9 5 .5 5 2 3  9 3  1 7 5 9 4 2 0 9 4 4 .0 3 8 2
S s /B I 6 4 4 8 4 6 5 3 7 8 8 7 .6 4 2 2  31
T o ta l 8 2 5 3 5 0 7 7 7 1 9 1 .4 5 7 4  127
Ss/BI » Subjects or Blocks depend ing on th e  design,
Applicable only to correl3 ted -sam ples  ANOVA.
T u k e y  H S D  T e s t
H S D (.05 ] = 2 7 5 1 3 .0 5 ; H S D f.0 1 ] = 3 3 5 4 3 .2 1  
M l vs M2 nonsignificant 
M l vs M3 nonsignificant 
M l vs M 4 P < .05  
M2 vs M3 nonsignificant 
M2 vs M4 nonsignificant 
M3 vs M 4 nonsignificant
M l *  m ean of Sample 1 
M2 -  m ean of Sample 2 
and so forth
HSO -  th e  absolute [unsigned] 
difference b e tw ee n  a n , tw o  
sam ple m eans reau ired  for 
significance a t the  des ignated  
level. H S D [.05] for th e  .05 le .e i;  
HSO'..01 ] for the .01 level.
Table C6 Statistical results for ANOVA and TUKEY HSD tests on a correlated 
sample comparing data for the effect of holding time (filtered), figure
4.17.
D a ta  S u m m a ry
N
iX
M e a n
ZX2
V a ria n c e
S td .D e v .
S td .E rr .
1
32
1 1 8 8 0 3 4 .1
3 7 1 2 6 .0 6 5 6
2
32
1 1 4 4 1 4 2 .1
3 5 7 5 4 .4 4 0 6
S a m p le s
3
32
1 3 0 0 7 4 2 .5
4 0 6 4 8 .2 0 3 1
4
32
1 5 5 2 2 0 8 .5
4 8 5 0 6 .5 1 5 6
T o ta l
128
5 1 8 5 1 2 7 .2
4 0 5 0 8 .8 0 6 3
1 7 4 5 2 0 4 7 3 0 1 8 .7 7  1 8 9 9 8 8 2 9 7 8 3 9 .3 1  1 9 0 8 3 7 6 6 4 3 8 3 .8 9  2 7 3 4 6 2 5 3 5 8 2 3 .5 9 0 1  8 2 8 8 0 8 9 7 1 0 6 5  5 6 0 2  
4 2 0 6 8 8 5 1 9 5 .4 0 1  4 8 0 9 0 3 6 6 7 9 .2 9 9 9  4 4 5 0 4 7 8 0 3 3 .2 4 4 2  6 3 9 2 5 9 0 6 4 4 .0 3 4 9  4 8 7 2 1 7 0 5 3 4 .9 5 4
6 4 8 6 0 .5 0 5 7  6 9 3 4 7 .2 1 8 3  6 6 7 1 1 .9 0 3 2
1 1 4 6 5 .8 2 5 8  1 2 2 5 8 .9 7 2 1  1 1 7 9 3 .1 0 9 8
A N O V A  S u m m a ry  
S o u rce  S S  d f
3 1 3 6 9 5 0 8 2 7 .7 7 3 8  3
7 9 9 5 3 .6 /8 1
1 4 1 3 3 .9 4 7
6 9 8 0 0 .9 3 5 1
6 1 6 9 .5 8 9 3
T r e a tm e n t
[b e tw e en  groups]
E rro r  
S s /B I 
T o ta l
Ss/BI *  Subjects or Blocks depend ing  on the design. 
Applicable only to  correla ted -sam ples  ANOVA.
8 1 4 8 9 7 6 3 8 1 9 .2 3 6 2  9 3  
5 3 4 1 3 8 9 4 3 2 9 2 .1 4 5  31
6 1 8 7 6 5 6 5 7 9 3 9 .1 5 5  127
m s r
1 0 4 5 6 5 0 2 7 5 .9 2 4 6  1 .1 9 3 3  0. 
8 7 6 2 3 4 0 1 9 .5 6 1 7
P
116705
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Table C7 Statistical results for ANOVA test on a correlated sample comparing 
data for the effect of holding time at 3 hours (unfiltered vs. filtered), 
figures 4.16 & 4.17.
D a ta  S u m m a ry
Samples 
1 2
H 32 32
£ X  2 0 2 7 1 6 0 .1  1 5 5 2 2 0 8 .5
M e an  6 3 3 4 8 .7 5 3 1  4 8 5 0 6 .5 1 5 6
£ X 2 4 9 4 9 3 6 1 5 8 2 1 8 .4 1  2 7 3 4 6 2 5 3 5 8 2 3 .5 9 0 1
V a ria n c e  1 1 8 2 3 1 6 4 3 0 6 .4 0 8 4  6 3 9 2 5 9 0 6 4 4 .0 3 4 9
S td .O e v . 1 0 8 7 3 4 .3 7 5  7 9 9 5 3 .6 7 8 1
S td .E rr . 1 9 2 2 1 .7 0 3 5  1 4 1 3 3 .9 4 7
3 4  5 T o ta l
64
3 5 7 9 3 6 8 .6
5 5 9 2 7 .6 3 4 4
7 6 8 3 9 8 6 9 4 0 4 2
9 0 1 9 2 5 5 1 6 9 .6 4 8 3
9 4 9 6 9 .7 5 9 2
1 1 8 7 1 .2 1 9 9
A N O V A  S u m m a ry
S ou rce  S S  d f
3 5 2 4 6 7 2 2 2 4 .1 0 2 4  1T r e a tm e n t
[b e tw e en  groups]
E rro r
Ss/BI
T o ta l
M S F P
3 5 2 4 6 7 2 2 2 4 .1 0 2 4  1 .7 3 1 9  0 .1 9 7 8 1 7
6 3 0 8 9 6 8 7 6 2 3 .2 6 7 4  31 2 0 3 5 1 5 1 2 1 3  6 5 3 8
5 0 1 5 9 8 7 1 5 8 4 0 .4 7 4 4  31 
5 6 8 2 1 3 0 7 5 6 8 7 .8 4 4 2  6 3
Table C8 Statistical results for ANOVA test on a correlated sample comparing 
data for the effect of centrifugation, figure 4.18.
D a ta  S u m m a ry
S a m p le s
1 2  3
N 32 32 32
£ X  1 1 2 7 7 6 5 .7  1 3 9 6 0 6 8 .2  1 4 6 6 7 0 7 .7
M e a n  3 5 2 4 2 .6 7 8 1  4 3 6 2 7 .1 3 1 3  4 5 8 3 4 .6 1 5 6
£ X 2 1 5 6 7 2 9 2 9 7 5 4 8 .4 7  2 0 0 8 2 0 6 2 4 8 8 9 .2 6  2 3 7 5 7 3 1 7 9 4 3 7 .0 3 0 1
V a ria n c e  3 7 7 3 6 7 1 4 1 8 .8 0 5  4 5 1 3 3 6 0 4 6 1 .0 9 3 8  5 4 9 5 0 7 0 8 3 1 .3 0 6 8
S td .D e v . 6 1 4 3 0 .2 1 5 8  6 7 1 8 1 .5 4 8 5  7 4 1 2 8 .7 4 5
S td .E rr . 1 0 8 5 9 .4 3 0 5  1 1 8 7 6 .1 3 2 1  1 3 1 0 4 .2 3 4 6
4 5 T o ta l
9 6
3 9 9 0 5 4 1 .6  
4 1 5 6 8 .1 4 1 7  
5 9 5 1 2 3 1 0 1 8 7 4  76  
4 5 1 8 3 5 4 7 7 1  7 8 1 4  
6 7 2 1 8 .7 0 8 5  
6 8 6 0 .4 8 0 7
A N O V A  S u m m a ry  
S o u rce  SS
1 9 9 8 5 1 9 2 6 9  0 6 7 7T re a tm e n t
[b e tw e en  groups]
E rro r
S s /B I
T o ta l
d f M S F P
2 9 9 9 2 5 9 6 3 4 .5 3 3 9  2 .5 7 2 2  0 .0 8 4 4 9 6
2 4 0 8 5 8 0 4 0 5 7 .0 1 2 2  62  3 8 8 4 8 0 7 1 0  5 97
4 0 3 1 5 9 3 7 9 9 9 3 .1 5 3 5  31 
4 2 9 2 4 3 7 0 3 3 1 9 .2 3 3 4  95
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Table C9 Statistical results for ANOVA test on a correlated sample comparing 
data for the cell distributions at passage number 19, 28,14 and 13.
Data Summary
N
vX
Mean
I X J
Variance
Std.Oev.
Std.Err.
1
32
1022642  3 
3 1957  5 71 9
2
32
7 2 3 4 6 4 .8 3 5 4  
2 2 6 0 8  2761
Samples
3
32
1 0 9 3 0 6 8 .4 4 4 5
3 4 1 5 8 .3 8 8 9
4
32
1 1 2 7 7 6 5 /7 7 8  
3 5 2 4 2 .6 8 0 6
Total
1 / 8
3 966941  55 76 
3 0 9 9 1 .7 2 9 4
1 0 9 2 5 5 3 2 9 3 9 6 .8 7  6 3 0 7 4 3 9 0 0 7 7  2 61 6  1 6 9 1 9 9 9 0 1 7 1 7 .5 3 9 5  1 5 6 7 2 9 3 0 8 6 1 3 .3 2 5 5  4 9 8 7 5 8 9 /9 8 0 4 .9 9 6 6  
2 4 7 0 1 3 4 3 4 1  684  1 50 7 0 3 5 3 9 7  5 98 9  4 2 5 3 6 2 7 2 4 8 .6 5 4 5  3 7 7 3 6 7 1 5 9 8  9 4 6 5  7 95 5 7 4 8 4 7 9 :1 4 6 1
4 9 7 0 0  4461  
8 7 8 5 .8 8 0 6
3 8 8 2 0  553 8  
6 8 6 2 .5 6 9 2
6 5 2 1 9 .8 3 7 8
11S 29.3474
6 1 4 3 0 .2 1 7 3
1 08S 9.4308
5 43 67  1977  
4 8 0 4  9 8 4 8
ANOVA Summary
Source SS df
3 1 7 8 0 3 0 6 8 3  5 59 8  3Treatm ent
groups)
Error 
Ss/BI 
Total
MS F P
1 0 5 9 3 4 3 5 6 1 .1 8 6 6  0 7423  0  5 2 9 5 0 8
1 3 2 7 1 6 9 5 8 5 8 9  6 87 9  9 3  1 4 2 7 0 6 4 0 7 0  856 9
7 39 4  715 6  7 6 0 3 .7 17 7  31
3 7 5 3 1 6 5 5 6 8 7 6 .9 5 9 9  127
Table C10 Statistical results for ANOVA and TUKEY HSD tests on a correlated 
sample comparing data for cell viability when exposed to N-Saline 
(Control), 0.5% and 1.0% alginate for 3 hours.
D a ta  S u m m a ry
S a m p le s
1 2 3  4  5 T o ta l
N 7 7 7 21
v  X 6 5 3 .7 6 6 8 .1 5 9 7 .4 1 9 1 9 .2
M e a n 9 3 .3 8 5 7 9 5 .4 4 2 9 8 5 .3 4 2 9 9 1 .3 9 0 5
£ X 3 6 1 2 6 8 .3 7 6 3 8 8 2 .5 3 5 1 8 1 2 .4 2 1 7 6 9 6 3 .3 2
V a ria n c e 3 7 .0 2 1 4 1 9 .5 2 6 2 1 3 8 .0 9 9 5 7 8 .3 3 5 9
S td .D e v . 6 .0 8 4 5 4 .4 1 8 8 1 1 .7 5 1 6 8 .8 5 0 8
S td .E rr . 2 .2 9 9 7 1 .6 7 02 4 .4 4 1 7 1 .9 3 14
A N O V A  S u m m a ry  
S ou rce
T r e a tm e n t
[between oroups]
E rro r
S s /B I
T o ta l
SS
3 9 8 .8 3 5 2
d f M S F P
2 1 9 9 .4 1 7 6  6 8 2 6 5  0 .0 1 0 4 7 8
3 5 0 .5 4 4 8  12 2 9 .2 1 2 1
8 1 7 .3 3 8 1  6
1 5 6 6 .7 1 8 1  20
M2 -  m ean of Sample 2 
and so fo rth .
T u k e y  IIS D  T e s t
H 5 D [.0 5 ] = 7 .7 1 ; H 5 D [.0 1 ] = 10 .31  *1  -  m ean of Samp]e 1 
M l vs M2 nonsignificant 
M l vs M3 P< 05  
M2 vs M3 P c .0 5  HSD -  th e  absolute [unsigned]
deference b e tw e e n  any r.vo  
sam ple m eans iequ ired  for 
significance at th e  designated  
level. MSOf.OS] for the  .05  level; 
HSDl.O i'. for th e  01 level
